Innospec
Annual Report 2011

Plain-text annual report

INNOSPEC INC. FORM 10-K (Annual Report) Filed 02/17/12 for the Period Ending 12/31/11 Address Telephone CIK Symbol SIC Code Industry Sector Fiscal Year 8310 SOUTH VALLEY HIGHWAY SUITE 350 ENGLEWOOD, CO, 80112 7203556451 0001054905 IOSP 2800 - Chemicals and Allied Products Specialty Chemicals Basic Materials 12/31 http://www.edgar-online.com © Copyright 2022, EDGAR Online, a division of Donnelley Financial Solutions. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, a division of Donnelley Financial Solutions, Terms of Use. Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K  ANNUALREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 or (cid:3) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13879 INNOSPEC INC. (Exact name of registrant as specified in its charter) DELAWARE 98-0181725 State or other jurisdiction of incorporation or organization (I.R.S. Employer Identification No.) 8375 South Willow Street Littleton Colorado 80124 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (303) 792 5554 Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered N/A N/A Securities registered pursuant to Section 12(g) of the Act: Common stock, par value $0.01 per share Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes (cid:3) No  Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes (cid:3) No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No (cid:3) Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No (cid:3) Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. (cid:3) Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. Large accelerated filer (cid:3) Accelerated filer  Non-accelerated filer (cid:3) (Do not check if a smaller reporting company) Smaller reporting company (cid:3) Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes (cid:3) No  The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant as of the most recently completed second fiscal quarter (June 30, 2011) was approximately $537 million, based on the closing price of the common shares on the NASDAQ on June 30, 2011. Shares of common stock held by each officer and director and by each beneficial owner who owns 5% or more of the outstanding common stock have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for any other purpose. As of February 10, 2012, 23,047,419 shares of the registrant’s common stock were outstanding. DOCUMENTS INCORPORATED BY REFERENCE Portions of Innospec Inc.’s Proxy Statement for the Annual Meeting of Stockholders to be held on May 9, 2012 are incorporated by reference into Part III of this Form 10-K. Table of Contents TABLE OF CONTENTS 2 TABLE OF CONTENTS 2 PART I 4 Item 1 Business 4 Item 1A Risk Factors 9 Item 1B Unresolved Staff Comments 17 Item 2 Properties 18 Item 3 Legal Proceedings 19 Item 4 Mine Safety Disclosures 19 PART II 20 Item 5 Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 20 Item 6 Selected Financial Data 23 Item 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations 26 Item 7A Quantitative and Qualitative Disclosures About Market Risk 44 Item 8 Financial Statements and Supplementary Data 47 Item 9 Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 94 Item 9A Controls and Procedures 94 Item 9B Other Information 95 P ART III 96 Item 10 Directors, Executive Officers and Corporate Governance 96 Item 11 Executive Compensation 96 Item 12 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 96 Item 13 Certain Relationships and Related Transactions, and Director Independence 97 Item 14 Principal Accountant Fees and Services 97 PART IV 98 Item 15 Exhibits and Financial Statement Schedules 98 SIGNATURES 101 Table of Contents CAUTIONARY STATEMENT RELATIVE TO FORWARD-LOOKING STATEMENTS FORWARD-LOOKING STATEMENTS This Form 10-K contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like “expects,” “anticipates,” “may,” “believes” or similar words or expressions), for example, which relate to operating performance, events or developments that we expect or anticipate will or may occur in the future (including, without limitation, any of the Company’s guidance in respect of sales, gross margins, pension liabilities and charges, net income, growth potential and other measures of financial performance). Although forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, and our actual performance or results may differ materially from these forward-looking statements. You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading “Risk Factors.” The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. 3 Table of Contents PART I When we use the terms the “Corporation,” “Company,” “Registrant,” “we,” “us” and “our,” we are referring to Innospec Inc. and its consolidated subsidiaries (“Innospec”) unless otherwise indicated or the context otherwise requires. General Innospec develops, manufactures, blends and markets fuel additives, personal care and fragrance products and other specialty chemicals. Our products are sold primarily to oil refineries, personal care and fragrance companies, and other chemical and industrial companies throughout the world. Our fuel additives help improve fuel efficiency, boost engine performance and reduce harmful emissions. Our specialty chemicals provide effective technology-based solutions for our customers’ processes or products focused in the Personal Care; Household, Industrial & Institutional; and Fragrance Ingredients markets. Our principal executive offices are in Littleton, Colorado. We became an independent company on May 22, 1998, when we were spun off from our then parent corporation Chemtura Corporation, previously known as Great Lakes Chemical Corporation. We changed our name from Octel Corp. to Innospec Inc. on January 30, 2006. Our common stock is listed on the NASDAQ under the symbol “IOSP.” Segmental Information Innospec divides its business into three segments for management and reporting purposes: Fuel Specialties, Active Chemicals and Octane Additives. The Fuel Specialties and Active Chemicals segments operate in markets where we actively seek growth opportunities but their end customers are different. The Octane Additives segment is generally characterized by volatile and declining demand. For financial information about each of our segments, see Note 3 of the Notes to the Consolidated Financial Statements. Fuel Specialties Our Fuel Specialties segment develops, manufactures, blends and markets a range of specialty chemical products used as additives to a wide range of fuels. The segment specializes in manufacturing and supplying fuel additives that help improve fuel efficiency, boost engine performance and reduce harmful emissions. The segment’s products are used in the efficient operation of automotive, marine and aviation engines, power station generators, and heating and diesel particulate filter systems. The segment has grown organically through the development of new products to address what we believe are the key drivers in demand for fuel additives. These drivers include increased focus on fuel economy, changing engine technology and legislative developments. We have devoted substantial resources towards the development of new and improved products that may be used to improve fuel efficiency. 4 Item 1 Business Table of Contents Our customers are national oil companies, multinational oil companies and fuel retailers. Active Chemicals Our Active Chemicals segment provides effective technology-based solutions for our customers’ processes or products focused in the Personal Care; Household, Industrial & Institutional; and Fragrance Ingredients markets. This segment has also grown organically, through the development and marketing of innovative products to the personal care and fragrance industries. The focus for our Active Chemicals segment is to develop high performance products from its technology base in a number of targeted markets. Our customers range from large multinational companies and manufacturers of personal care and household products, to specialty chemical manufacturers operating in niche industries. Octane Additives Our Octane Additives segment, which we believe is the world’s only producer of tetra ethyl lead (“TEL”), comprises sales of TEL for use in automotive gasoline and trading in respect of our environmental remediation business. We are continuing to manage the decrease in the sales of TEL for use in automotive gasoline to maximize the cash flow through the decline. Cost improvement measures continue to be taken to respond to declining market demand. Sales of TEL for use in automotive gasoline are made principally to state owned refineries located in the Middle East and Northern Africa. Our environmental remediation business then serves these customers to manage the clean up of the associated redundant plants as refineries complete the move away from leaded fuel. Strategy Our strategy is to develop new and improved technologies to continue to strengthen and increase our market positions within our Fuel Specialties and Active Chemicals segments. The segments together have had average organic revenue growth of 10% per annum, and average operating income growth of 15% per annum, since 2006. We also actively continue to assess potential strategic acquisitions, partnerships and other opportunities that would enhance and expand our customer offering. We focus on opportunities that would extend our technology base, geographical coverage or product portfolio. We believe that focusing on the Fuel Specialties and Active Chemicals segments, in which the Company has existing experience, expertise and knowledge, provides opportunities for positive returns on investment with lower operating risk. Geographic Area Information Financial information with respect to our domestic and foreign operations is contained in Note 3 of the Notes to the Consolidated Financial Statements. 5 Table of Contents Working Capital The nature of our customers’ businesses generally requires us to hold appropriate amounts of inventory in order to be able to respond quickly to customers’ needs. We therefore require corresponding amounts of working capital for normal operation. We do not, however, believe that this is materially different to what our competitors do (with the exception of cetane number improvers, in which case we maintain high enough levels of inventory, as required, to retain our position as market leader in sales of these products). The purchase of large amounts of some raw materials for our Fuel Specialties segment can create some variations in working capital requirements, but these are generally planned and well managed by the business. We do not believe that our terms of sale, or terms of purchase, differ markedly from those of our competitors. Raw Materials and Product Supply We use a variety of raw materials and chemicals in our manufacturing and blending processes and believe that sources for these are adequate for our current operations. Our major purchases are cetane number improvers, various solvents and ethylene. These purchases account for a substantial portion of the Company’s variable manufacturing costs. These materials are, with the exception of ethylene in Germany, readily available from more than one source. Although ethylene is, in theory, available from several sources, it is not permissible to transport ethylene by road in Germany. As a result, we source ethylene for our German operations via a direct pipeline from a neighboring site, making it effectively a single source. Ethylene is used as a primary raw material in products representing approximately 9% of the Company’s sales. We use long-term contracts (generally with fixed costs or formula based costs) to help ensure availability and continuity of supply, and to manage the risk of cost increases. For some raw materials the risk of cost increases is managed with commodity swaps. The chemical industry, in general, is experiencing some tightness in the supply of certain commodity materials. We continue to monitor the situation and adjust our procurement strategies as we deem appropriate. The Company forecasts its raw material requirements substantially in advance, and seeks to build long-term relationships and contractual positions with supply partners to safeguard its raw material positions. In addition, the Company operates an extensive risk management program which seeks to source key raw materials from multiple sources and to develop other contingency plans. Intellectual Property Our intellectual property, including trademarks, patents and licenses, forms a significant part of the Company’s competitive edge, particularly in the Fuel Specialties and Active Chemicals segments. The Company does not, however, consider its business as a whole to be dependent on any one trademark, patent or license. 6 Table of Contents The Company has a portfolio of trademarks and patents, both granted and in the application stage, covering products and processes in several jurisdictions. The majority of these patents were developed by the Company and, subject to maintenance obligations including the payment of renewal fees, have at least 10 years life remaining. The trademark “Innospec” and the Innospec device in Classes 1, 2 and 4 of the “International Classification of Goods and Services for the Purposes of the Registration of Marks” are registered in all countries or jurisdictions in which the Company has a significant market presence. The Company also has trademark registrations for certain product names in all countries or jurisdictions in which it has a significant market presence. We actively protect our inventions, new technologies, and product developments by filing patent applications and maintaining trade secrets. In addition, we vigorously participate in patent opposition proceedings around the world, where necessary, to secure a technology base free from infringement of our intellectual property. Customers In 2011 the Company had a significant customer in the Fuel Specialties segment, Royal Dutch Shell plc and its affiliates (“Shell”), who accounted for $78.7 million (10%) of net group sales. In 2010 and 2009, Shell accounted for $67.8 million (10%) and $76.1 million (13%) of net group sales, respectively. We have sales contracts with customers using fixed or formula based prices, as appropriate, to maintain our gross profits. Competition Certain markets in which the Company operates are subject to significant competition. The Company competes on the basis of a number of factors including, but not limited to, product quality and performance, specialized product lives, customer relationships and service, and regulatory and toxicological expertise. Fuel Specialties: The Fuel Specialties market is fragmented and characterized by a small number of competitors in each submarket. The competitors in each submarket differ with no one company holding a dominant position in the Fuel Specialties market. We consider our competitive edge to be our proven technical development capacity, independence from major oil companies and strong long-term relationships with refinery customers. Active Chemicals: We operate in three principal markets within Active Chemicals – Personal Care; Household, Industrial & Institutional; and Fragrance Ingredients. The Personal Care and Household, Industrial & Institutional markets are both highly fragmented, and the Company experiences substantial competition from a large number of multinational and specialty chemical suppliers in each geographical region in which we operate. The Fragrance Ingredients market is more concentrated, with a small number of principal competitors. Our competitive position in all three markets is based on us supplying a superior, diverse product 7 Table of Contents portfolio which solves particular customer problems or enhances the performance of new or existing products. In a number of specialty chemicals markets, we also supply niche product lines, where we enjoy market-leading positions. Octane Additives: We believe our Octane Additives segment is the world’s only producer of TEL and accordingly is the only supplier of TEL for use in automotive gasoline. The segment therefore competes with marketers of products and processes that provide alternative ways of enhancing octane performance in automotive gasoline. Research, Development, Testing and Technical Support Research, product/application development and technical support (“R&D”) provide the basis for the growth of our Fuel Specialties and Active Chemicals segments. Accordingly, the Company’s R&D activity has been, and will continue to be, focused on the development of new products and formulations. Technical support is provided for all of our reporting segments. Expenditures to support R&D services were $18.3 million, $17.6 million and $16.4 million in 2011, 2010 and 2009, respectively. We consider that our proven technical capability provides us with a significant competitive edge. In the last three years, the Fuel Specialties segment has developed new detergent, cold flow, stabilizers, anti-foulants, lubricity and combustion improver products, in addition to the introduction of many new cost effective fuel additive packages. This proven technical capability is now also instrumental in us producing innovative new products within our Active Chemicals segment including Iselux and Statsafe . Health, Safety and Environmental Matters We are subject to environmental laws in all of the countries in which we conduct business. Management believes that the Company is in material compliance with applicable environmental laws and has made appropriate provision for the continued costs of compliance with environmental laws. The principal site giving rise to environmental remediation liabilities is the Octane Additives manufacturing site at Ellesmere Port in the United Kingdom, which management believes is the last ongoing manufacturer of TEL. There are also environmental remediation liabilities on a much smaller scale in respect of our other manufacturing sites in the U.S. and Europe. At Ellesmere Port there is a continuing asset retirement program related to certain manufacturing units that have been closed. We regularly review the future expected costs of remediation and the current estimate is reflected in Note 12 of the Notes to the Consolidated Financial Statements. We recognize, at fair value, environmental liabilities when they are probable and costs can be reasonably estimated, and asset retirement obligations when there is a legal obligation and costs can be reasonably estimated. This involves anticipating the program of work and the associated future expected costs, and so involves the exercise of judgment by management. 8 ™ ® Table of Contents The European Union legislation known as the Registration, Evaluation and Authorization of Chemical Substances Regulations (“REACH”) requires most of the Company’s products to be registered with the European Chemicals Agency. Under this legislation the Company has to demonstrate that its products are appropriate for their intended purposes. During this registration process the Company will incur expense to test and register its products. The Company estimates that the cost of complying with REACH will be approximately $5 million over the next six years. Employees The Company had approximately 850 employees in 20 countries as at December 31, 2011. Available Information Our corporate web site is www.innospecinc.com. We make available, free of charge, on or through this web site our annual, quarterly and current reports, and any amendments to those reports, as soon as reasonably practicable after electronically filing such material with, or furnishing it to, the SEC. The Company routinely posts important information for investors on its web site (under Investor Relations). The Company uses this web site as a means of disclosing material, non-public information and for complying with its disclosure obligations under SEC Regulation FD (Fair Disclosure). Accordingly, investors should monitor the Investor Relations portion of the Company’s web site, in addition to following the Company’s press releases, SEC filings, public conference calls, presentations and webcasts. The factors described below represent the Company’s principal risks. We are subject to regulation of our international operations that could adversely affect our business and results of operations. Due to our global operations, we are subject to many laws governing international commercial activity, conduct and relations, including those that prohibit improper payments to government officials, restrict where and with whom we can do business, and limit the products, software, and technology that we can supply to certain countries and customers. These laws include but are not limited to the U.S. Foreign Corrupt Practices Act (“FCPA”), the U.S. sanctions and assets control programs administered by the U.S. Department of the Treasury, and the U.S. export control laws such as the Export Administration Regulations, as well as equivalent laws and regulations in other countries relevant to our business operations. For example, a number of the countries in which we operate are known to experience corruption and our operations there are subject to the risks of an unauthorized payment or other improper activity by one of our employees or agents, which could expose us to a liability under relevant anti-bribery laws, such as the FCPA or the United Kingdom anti-bribery laws. Similarly, unauthorized activity or conduct by employees or agents in or with foreign countries could 9 Item 1A Risk Factors Table of Contents cause us to be in violation of sanctions and assets control programs or export control laws. Violations of any of these types of laws, which are often complex in their application, may result in criminal or civil penalties that could have a material adverse effect on our results of operations, financial position and cash flows. We may be required to make additional cash contributions to the defined benefit pension plan that we operate in the United Kingdom and recognize greater pension charges. The Company maintains a defined benefit pension plan (the “Plan”) covering a number of its current and former employees in the United Kingdom. The Plan is closed to future service accrual but has a large number of deferred and current pensioners. A full triennial actuarial valuation of the Plan was performed as at December 31, 2008 and an update performed as at December 31, 2011, the results of which are reflected in these consolidated financial statements. Movements in the underlying plan asset value and Projected Benefit Obligation (“PBO”) are dependent on actual return on investments as well as our assumptions in respect of the discount rate, annual member mortality rates, future return on assets, future pension increases and future inflation. A change in any one of these assumptions could impact the plan asset value, PBO and pension charge recognized in the income statement. In addition, should future investment returns prove insufficient to meet future obligations, or should future obligations increase due to actuarial factors or changes in pension legislation, then the Company may be required to make additional cash contributions. These events could adversely impact our results of operations, financial position and cash flows. Competition and market conditions may adversely affect our operating results. In certain markets in which the Company operates, our competitors are larger than us and may have greater access to financial, technological and other resources. As a result, these competitors may be better able to adapt to changes in conditions within the industries in which the Company operates, fluctuations in the costs of raw materials or changes in global economic conditions. Competitors may also be able to introduce new products with enhanced features that may cause a decline in the demand and sales of our products. Consolidation of customers or competitors, or economic problems of customers, in the market areas in which the Company operates may cause a loss of market share for the Company’s products, place downward pressure on prices, result in payment delays or non-payment, or declining plant utilization rates. Any of these risks could adversely impact our results of operations, financial position and cash flows. We could be adversely affected by technological changes in our industry. Our ability to maintain or enhance our technological capabilities, develop and market products and applications that meet changing customer requirements, and successfully anticipate or respond to technological changes in a cost effective and timely manner will likely impact our future business success. The Company competes on the basis of a number of factors including, but not limited to, product quality and performance. For some of our products our competitors are larger than us and may have greater access to financial, technological and other resources. 10 Table of Contents Competitors may be able to introduce new products with enhanced features that may cause a decline in the demand and sales of our products, and accordingly could adversely impact our results of operations, financial position and cash flows. Our reliance on a small number of significant customers may have a material adverse impact on our results of operations. Our principal customers are major multinational and state owned oil companies, and large multinational manufacturers of personal care and household products. These industries are characterized by a concentration of a few large participants. The loss of a significant customer, a material reduction in purchases by a significant customer, or non-renewal of a significant customer contract, could adversely impact our results of operations, financial position and cash flows. Our success depends on our management team and other key personnel, the loss of any of whom could disrupt our business operations. Our future success will depend in substantial part on the continued services of our senior management. The loss of the services of one or more of our key personnel could impede implementation of our business plan and result in reduced profitability. Our future success will also depend on the continued ability to attract, retain and motivate highly-qualified technical, sales and support staff. We cannot guarantee that we will be able to retain our key personnel or that we will be able to attract, assimilate or retain qualified personnel in the future. If we are unsuccessful in our efforts in this regard, this could adversely impact our results of operations, financial position and cash flows. Continuing adverse global economic conditions could materially affect our current and future businesses. The ongoing concern about the stability of global markets generally, and specifically the Eurozone, and the strength of counterparties in particular has led many lenders and institutional investors to reduce, or cease to provide, credit to businesses and consumers. These factors have led to a substantial and continuing decrease in spending by businesses and consumers, and a corresponding decrease in global infrastructure spending. The availability, cost and terms of credit have been, and may continue to be, adversely affected by the foregoing factors and these circumstances have produced, and may in the future result in, illiquid markets and wider credit spreads. Continued turbulence in the U.S. and international markets and economies, the generally restricted environment for credit, and prolonged declines in business and consumer spending could adversely impact our results of operations, financial position and cash flows. We may not be able to consummate, finance or successfully integrate future acquisitions, partnerships or other opportunities into our business, which could hinder our strategy or result in unanticipated expenses and losses. It is part of our stated strategy that we intend to pursue strategic acquisitions, partnerships and other opportunities to complement and expand our existing business. The success of these 11 Table of Contents transactions will depend on our ability to integrate assets and personnel acquired in these transactions, apply our internal control processes to these acquired businesses and cooperate with our strategic partners. The expense incurred in consummating acquisitions, partnerships or other opportunities, the time it takes to integrate an acquisition, or our failure to integrate businesses successfully, could result in unanticipated expenses and losses. The process of integrating acquired operations into our existing operations may result in unforeseen operating difficulties and may require significant financial resources that would otherwise be available for the ongoing development or expansion of existing operations. Furthermore, we may not realize the degree or timing of benefits we anticipate when we first enter a transaction. Any of these risks could adversely impact our results of operations, financial position and cash flows. We may have additional tax liabilities. We are subject to income taxes and state taxes in the U.S., as well as numerous foreign jurisdictions. Significant judgment is required in determining our worldwide provision for income taxes. In the ordinary course of our business, there are many transactions and calculations where the ultimate tax determination is uncertain. Although we believe our tax estimates are reasonable, the final determination of tax audits and any related litigation could be materially different to that which is reflected in our consolidated financial statements. Should any tax authority take issue with our estimates, this could adversely impact our results of operations, financial position and cash flows. We are exposed to fluctuations in foreign currency exchange rates, which may adversely affect our results of operations. The Company generates a portion of its revenues and incurs some operating costs in currencies other than the U.S. dollar. In addition, the financial position and results of operations of some of our foreign subsidiaries are reported in the relevant local currency and then translated to U.S. dollars at the applicable currency exchange rate, for inclusion in our consolidated financial statements. Fluctuations in exchange rates between these foreign currencies and the U.S. dollar will affect the recorded levels of our assets and liabilities, to the extent that such figures reflect the inclusion of foreign assets and liabilities which are translated into U.S. dollars for presentation in our consolidated financial statements, as well as our results of operations. The primary foreign currencies in which we have exchange rate fluctuation exposure are the European Union euro, British pound sterling and Swiss franc. We cannot accurately predict the nature or extent of future exchange rate variability amongst these currencies or relative to the U.S. dollar. While the Company takes steps to manage currency exposure, including entering into hedging transactions, it cannot eliminate all exposure to future exchange rate variability. Exchange rates between these currencies and the U.S. dollar have fluctuated significantly in recent years and may continue to do so in the future, which could adversely impact our results of operations, financial position and cash flows. 12 Table of Contents Sharp and unexpected fluctuations in the cost of our raw materials and energy could adversely affect our profit margins. We use a variety of raw materials, chemicals and energy in our manufacturing and blending processes. Many of the raw materials that we use are derived from petrochemical-based feedstocks which can be subject to periods of rapid and significant cost instability. These fluctuations in cost can be caused by political instability in oil producing nations and elsewhere, or other factors influencing global supply and demand of these materials, over which we have little or no control. We use long-term contracts (generally with fixed costs or formula based costs) to help ensure availability and continuity of supply, and to manage the risk of cost increases. We have entered into hedging arrangements for certain raw materials, but do not typically enter into hedging arrangements for all raw materials, chemicals or energy costs. Should the costs of raw materials, chemicals or energy increase, and should we not be able to pass on these cost increases to our customers, then profit margins and cash flows from operating activities would be adversely impacted. Should raw material costs increase significantly, then the Company’s need for working capital could similarly increase. Any of these risks could adversely impact our results of operations, financial position and cash flows. Failure to implement our common information system platform successfully could adversely affect our ability to conduct business. We are continuing with the implementation of a new, company-wide, information system platform. The platform provider is well established in the market. The implementation will be a phased, risk-managed, site deployment and follow a multistage user acceptance program with the existing platform providing a fallback position. There is a risk that the new information system platform may cost more than projected or we may not realize its anticipated benefits. Either, or a combination, of these factors could adversely impact our results of operations, financial position and cash flows. Our reliance on a small number of significant stockholders may have a material adverse impact on our stock price. Approximately 30% of the Company’s common stock is held by three stockholders. A decision by any of these stockholders to sell all or a significant part of its holding in the Company, or a sudden or unexpected disposition of Company stock, could result in a significant decline in the Company’s stock price which could in turn adversely impact our ability to access equity markets which in turn could adversely impact our results of operations, financial position and cash flows. A disruption in the supply of raw materials or transportation services would have a material adverse impact on our results of operations. The transportation industry is in a situation where supply and demand are currently broadly in balance. However, the chemical industry, in general, is experiencing some tightness in the supply of certain commodity materials. When we identify a situation where an imbalance may occur or is occurring in raw materials or transportation services we may build certain 13 Table of Contents inventories of strategic importance. Any significant disruption in the supply of either of these could affect our ability to obtain raw materials or transportation services at accessible costs, if at all, which could adversely impact our results of operations, financial position and cash flows. We face risks related to our foreign operations that may adversely affect our business. We serve global markets and accordingly operate in certain countries which do not have stable economies or governments. Specifically, we trade in countries experiencing political and economic instability in the Middle East, Northern Africa, Asia Pacific, Eastern Europe and South America regions. Our international operations are subject to international business risks including, but not limited to, unsettled political conditions, risk of expropriation, import and export restrictions, exchange controls, national and regional labor strikes, high or unexpected taxes, government royalties and restrictions on repatriation of earnings or proceeds from liquidated assets of foreign subsidiaries. The occurrence or imposition of any, or a combination, of these factors could adversely impact our results of operations, financial position and cash flows. Failure to protect our intellectual property rights could adversely affect our future performance and cash flows. Failure to develop or protect our intellectual property rights may result in the loss of valuable technologies, or us having to pay other companies for infringing on their intellectual property rights. Measures taken by us to protect our intellectual property may be challenged, invalidated, circumvented or rendered unenforceable. We may also face patent infringement claims from our competitors which may result in substantial litigation costs, claims for damages or a tarnishing of our reputation even if we are successful in defending against these claims, which may cause our customers to switch to our competitors. The occurrence of any, or a combination, of these events could adversely impact our results of operations, financial position and cash flows. We are subject to extensive government regulation. We are subject to regulation by federal, state, local and foreign government authorities. In some circumstances these authorities must approve our products, manufacturing processes and facilities before we may sell certain products. Many of the Company’s products are required to be registered with the U.S. Environmental Protection Agency and with comparable government agencies in the European Union and elsewhere. We are also subject to ongoing reviews of our products, manufacturing processes and facilities by government authorities including the requirement to produce product data. In order to obtain regulatory approval of certain new products we must, amongst other things, demonstrate to the relevant authorities that the product is appropriate and effective for its intended uses, and that we are capable of manufacturing the product in accordance with applicable regulations. This approval process can be costly, time consuming, and subject to unanticipated and significant delays. Accordingly, we cannot be sure that approvals will be 14 Table of Contents granted on a timely basis, or at all. Any delay in obtaining, or any failure to obtain or maintain, these approvals would adversely affect our ability to introduce new products and to generate income from those products. It is possible that new laws and regulations may be introduced in the future that could result in additional compliance costs and prevent or inhibit the development, manufacture, distribution and sale of our products. Such outcomes could adversely impact our results of operations, financial position and cash flows. Legal proceedings and other claims could impose substantial costs on us. We are occasionally involved in legal proceedings that result from, and are incidental to, the conduct of our business, including employee and product liability claims. We have insurance coverage to mitigate anticipated potential damages in a wide variety of such proceedings, however, if our insurance did not adequately cover such claims, this could adversely impact our results of operations, financial position and cash flows. Unexpected environmental matters and compliance with current or new environmental laws or regulations could have a substantial adverse impact on our results of operations. The Company operates a number of manufacturing sites. As such, it is subject to extensive federal, state, local and foreign environmental, health and safety laws and regulations concerning emissions to the air, discharges to land and water, and the generation, handling, treatment and disposal of hazardous waste and other materials on these sites. The Company is required to obtain various environmental permits and licenses, many of which require periodic notification and renewal, which is not automatic. It is also possible that new laws and regulations may be introduced in the future that could adversely impact the Company’s costs or its ability to develop, manufacture, distribute and sell products. The Company’s operations, and the historic operations of companies that have previously operated on sites that the Company has acquired, pose the risk of environmental contamination which may result in fines or criminal sanctions being imposed against the Company or may require the Company to pay material remediation or fines to address the effects and to remediate this contamination. The Company further anticipates that certain manufacturing facilities may cease production over the medium to long-term. On closure of some of our manufacturing operations in the future, we expect to be subject to environmental laws that will require these facilities to be safely decommissioned and a degree of environmental remediation to be undertaken. The degree of environmental remediation required will depend on the plans for the future use of the operating sites that are affected and the environmental legislation in force at the time. The Company has currently made a decommissioning and remediation provision based on the Company’s current known obligations, the anticipated plans for those sites and existing environmental legislation. Should there be unexpected or unknown contamination at these facilities, or the Company’s future plans for the sites or environmental legislation change, then current provisions may prove inadequate and this could adversely impact our results of operations, financial position and cash flows. 15 Table of Contents The inability of counterparties to meet their contractual obligations could have a substantial adverse impact on our results of operations. The Company sells a range of Fuel Specialties, Active Chemicals and Octane Additives to major oil refineries and chemical companies throughout the world. Credit limits, ongoing credit evaluation and account monitoring procedures are used to minimize bad debt risk. Collateral is not generally required. The Company has in place a financing facility with a syndicate of banks. The Company uses derivatives, including interest rate swaps, commodity swaps and foreign currency forward exchange contracts, in the normal course of business to manage market risks. The Company enters into derivative instruments with a diversified group of major financial institutions in order to manage the exposure to non-performance of such instruments. The Company remains subject to market and credit risks including the ability of counterparties to meet their contractual obligations and the potential non-performance of counterparties to deliver contracted commodities or services at the contracted price. The inability of counterparties to meet their contractual obligations could have an adverse impact on results of operations, financial position and cash flows. The terms of our finance facility may restrict our ability to incur additional indebtedness or to otherwise expand our business. The Company’s finance facility contains restrictive clauses which may constrain our activities and limit our operational and financial flexibility. The facility obliges the lenders to comply with a request for utilization of finance unless there is an event of default outstanding. Events of default are defined in the finance facility and include a material adverse change to our assets, operations or financial condition. The facility contains a number of restrictions that limit our ability, amongst other things, and subject to certain limited exceptions, to incur additional indebtedness, pledge our assets as security, guarantee obligations of third parties, make investments, undergo a merger or consolidation, dispose of assets or materially change our line of business. In addition, the facility requires the Company to meet certain financial ratios defined therein including net debt to EBITDA and net interest expense to EBITDA. EBITDA is a non-GAAP measure of liquidity defined in the finance facility. The ability to meet these financial covenants depends upon the future successful operating performance of the business. If the Company fails to meet agreed financial covenants then it would be in technical default under the finance facility and the maturity of the Company’s outstanding debt could be accelerated unless we were able to obtain waivers from our lenders. If the Company were found to be in default under the finance facility, this could adversely impact our results of operations, financial position and cash flows. Our business is subject to the risk of manufacturing disruptions, the occurrence of which would adversely affect our results of operations. We are subject to hazards common to chemical manufacturing, blending, storage, handling and transportation including fires, labor strikes or slowdowns, explosions, mechanical failure, 16 Table of Contents extreme weather, transportation interruptions, remediation, chemical spills and the release or discharge of toxic or hazardous substances. These hazards could result in loss of life, property damage, environmental contamination and temporary or permanent manufacturing cessation. Any, or a combination, of these factors could adversely impact our results of operations, financial position and cash flows. Domestic or international natural disasters or terrorist attacks may disrupt our operations, decrease the demand for our products or otherwise have an adverse impact on our business. Chemical related assets, and U.S. corporations such as ourselves, may be at greater risk of future terrorist attacks than other possible targets in the U.S., United Kingdom and throughout the world. Extraordinary events such as natural disasters may negatively affect local economies, including those of our customers or suppliers. The occurrence of such events cannot be predicted though they can be expected to continue to adversely impact the economy in general and our specific markets. The resulting damage from such an event could include loss of life, property damage or site closure. Any, or a combination, of these factors could adversely impact our results of operations, financial position and cash flows. Our Octane Additives segment could decline faster than expected. The remaining sales of the Octane Additives segment are now concentrated in a relatively small number of customers and therefore could decline with unpredictable volatility and severity and adversely impact the Company’s future results of operations, financial position and cash flows. The Company expects that it will cease all sales of TEL for use in automotive gasoline in 2013. None. 17 Item 1B Unresolved Staff Comments Table of Contents A summary of the Company’s principal properties is shown in the following table. Each of these properties is owned by the Company except where otherwise noted: Manufacturing Capacity We believe that our plants and supply agreements are sufficient to meet current sales levels. Operating rates of the plants are generally flexible and varied with product mix and normal sales swings. We believe that all of our facilities are maintained to appropriate levels and in good operating condition though there remains an ongoing need for capital investment. 18 Item 2 Properties Location Reporting Segment Operations Littleton, Colorado Fuel Specialties and Active Chemicals Corporate Headquarters Business Teams Sales/Administration Newark, Delaware Fuel Specialties Sales/Administration Research & Development High Point, North Carolina Active Chemicals Manufacturing/Administration Research & Development Spencer, North Carolina Active Chemicals Manufacturing/Administration Research & Development Ellesmere Port, United Kingdom Fuel Specialties, Active Chemicals and Octane Additives European Headquarters Business Teams Sales/Manufacturing/Administration Research & Development Fuel Technology Center Singapore, Singapore Fuel Specialties and Active Chemicals Asia-Pacific Headquarters Business Teams Sales/Administration Widnes, United Kingdom Active Chemicals Manufacturing/Administration Research & Development Herne, Germany Fuel Specialties Sales/Manufacturing/Administration Research & Development Leuna, Germany Fuel Specialties and Active Chemicals Sales/Manufacturing/Administration Research & Development Vernon, France Fuel Specialties Sales/Manufacturing/Administration Research & Development Zug, Switzerland Octane Additives Sales/Administration (1) Leased property (1) (1) (1) (1) (1) Table of Contents While we are involved from time to time in claims and legal proceedings that result from, and are incidental to, the conduct of our business including business and commercial litigation, employee and product liability claims, there are no other material pending legal proceedings to which the Company or any of its subsidiaries is a party, or of which any of their property is subject, although an adverse resolution of an unexpectedly large number of these individual items could in the aggregate have a material adverse effect on results of operations for a particular year or quarter. Not applicable. 19 Item 3 Legal Proceedings Item 4 Mine Safety Disclosures Table of Contents PART II Market Information and Holders The Company’s common stock is listed on the NASDAQ under the symbol “IOSP.” As of February 10, 2012 there were approximately 1,251 registered holders of the common stock. The following table shows the closing high and low prices of our common stock for each of the last eight quarters: On December 14, 2011 we entered into a five-year revolving credit facility which contains no restrictive covenants with respect to dividends and the Company is allowed to repurchase its own common stock provided that it does not affect compliance with the financial covenants in this facility. Issuer Purchases of Equity Securities Repurchases of common stock are held as treasury shares unless reissued under equity compensation plans. 20 Item 5 Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities First Quarter Second Quarter Third Quarter Fourth Quarter 2011 High $ 31.94 $ 37.66 $ 35.69 $ 31.49 Low $ 19.16 $ 30.86 $ 21.74 $ 22.33 2010 High $ 12.31 $ 14.59 $ 15.23 $ 22.40 Low $ 8.69 $ 9.38 $ 8.68 $ 15.38 Period (a) Total Number of Shares Purchased (b) Average Price Paid per Share (c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (d) Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs Carried forward $ 24.8 million October 1 – October 31, 2011 126,220 $ 25.76 126,220 $ 21.6 million November 1 – November 30, 2011 81,716 $ 28.62 81,716 $ 19.3 million December 1 – December 31, 2011 103,841 $ 28.90 103,841 $ 16.3 million Total 311,777 $ 27.56 311,777 $ 16.3 million Table of Contents On November 3, 2010 the Company announced that the Board of Directors had authorized share repurchases under Rule 10b5-1 and/or 10b-18 repurchase plans of up to $5.0 million of common stock annually in 2010, 2011 and 2012, dependent on market conditions. The first Rule 10b5-1 repurchase program commenced on November 8, 2010. On September 7, 2011 the Company announced that the Board of Directors had authorized an increase in share repurchases under Rule 10b5-1 and/or 10b-18 repurchase plans in 2011 from up to $5.0 million of common stock to up to $40.0 million of common stock, dependent on market conditions. The Rule 10b5-1 repurchase program under the increased plan commenced on September 12, 2011 and continued until December 31, 2011. The Company has authorized securities for issuance under equity compensation plans. The information contained in the table under the heading “Equity Compensation Plans” in the Proxy Statement is incorporated herein by reference. The current limit for the total amount of shares which can be issued or awarded under the Company’s five share option plans is 2,640,000. As disclosed in Note 18 of the Notes to the Consolidated Financial Statements, 195,313 shares of Innospec common stock were transferred to NewMarket Corporation as part of the settlement of the NewMarket Corporation civil complaint. These shares, which were taken from treasury stock, were provided to NewMarket in reliance upon the exemption from registration under Section 4(2) of the Securities Act of 1933 relating to non-public offerings. 21 Table of Contents Stock Price Performance Graph The graph below compares the cumulative total return to stockholders on the common stock of the Corporation, S&P 500 Index, NASDAQ Composite Index and Russell 2000 Index since December 31, 2006, assuming a $100 investment and the re-investment of any dividends thereafter. Value of $100 Investment made December 31, 2006* * Excludes purchase commissions 22 2006 2007 2008 2009 2010 2011 Innospec Inc. 100.00 74.37 26.12 45.66 92.32 127.03 S&P 500 Index 100.00 103.53 63.69 78.62 88.67 88.67 NASDAQ Composite Index 100.00 109.81 65.29 93.95 109.84 107.86 Russell 2000 Index 100.00 97.25 63.41 79.40 99.49 94.07 Table of Contents FINANCIAL HIGHLIGHTS 23 Item 6 Selected Financial Data (in millions, except financial ratios, share and per share data) 2011 2010 2009 2008 2007 Summary of performance Net sales $ 774.4 $ 683.2 $ 598.5 $ 640.5 $ 602.4 Impairment of Octane Additives segment goodwill (2.0 ) (2.2 ) (2.2 ) (3.7 ) (12.1 ) Operating income 49.6 72.2 20.7 43.6 47.9 Income before income taxes 52.6 70.7 18.3 18.9 47.8 Income taxes (3.7 ) 3.0 (11.9 ) (6.3 ) (18.2 ) Net income 48.9 73.7 6.4 12.6 29.6 Net income attributable to the non-controlling interest 0.0 0.0 0.0 (0.1 ) (0.1 ) Net income attributable to Innospec Inc. 48.9 73.7 6.4 12.5 29.5 Net cash provided by operating activities 34.7 58.2 87.4 14.4 47.9 Financial position at year end Total assets 568.8 549.4 543.1 494.3 551.1 Long-term debt (including current portion) 35.0 47.0 51.0 73.0 81.0 Cash and cash equivalents, and short-term investments 81.0 111.3 68.6 13.9 24.3 Stockholders’ equity $ 343.1 $ 300.7 $ 157.6 $ 229.3 $ 271.5 Financial ratios Net income attributable to Innospec Inc. as a percentage of sales 6.3 10.8 1.1 2.0 4.9 Effective tax rate as a percentage 7.0 (4.2 ) 65.0 33.3 38.1 Current ratio 2.2 2.0 1.6 1.4 1.6 Share data Earnings per share attributable to Innospec Inc. – Basic $ 2.07 $ 3.10 $ 0.27 $ 0.53 $ 1.23 – Diluted $ 1.99 $ 2.97 $ 0.26 $ 0.51 $ 1.19 Dividend paid per share $ 0.00 $ 0.00 $ 0.05 $ 0.10 $ 0.09 Shares outstanding (basic, thousands) – At year end 23,047 23,703 23,664 23,598 23,777 – Average during year 23,568 23,756 23,642 23,595 23,920 Closing stock price – High $ 37.66 $ 22.40 $ 15.63 $ 25.29 $ 31.82 – Low $ 19.16 $ 8.68 $ 2.79 $ 4.54 $ 16.26 – At year end $ 28.07 $ 20.40 $ 10.09 $ 5.89 $ 17.16 (1) The effective tax rate is calculated as a percentage of income before income taxes. (2) Current ratio is defined as current assets divided by current liabilities. (1) (2) Table of Contents QUARTERLY SUMMARY (UNAUDITED) (see Note 4 below) NOTES 24 (in millions, except per share data) First Quarter Second Quarter Third Quarter Fourth Quarter 2011 Net sales $ 185.3 $ 186.5 $ 202.1 $ 200.5 Gross profit 52.8 58.1 57.7 57.8 Operating income/(loss) 23.9 22.4 (20.2 ) 23.5 Net income/(loss) 21.5 24.6 (16.8 ) 19.6 Net cash provided by operating activities $ 5.7 $ 5.8 $ 9.4 $ 13.8 Per common share: Earnings/(loss) – basic $ 0.91 $ 1.04 $ (0.71 ) $ 0.85 – diluted $ 0.88 $ 1.00 $ (0.71 ) $ 0.82 2010 Net sales $ 163.5 $ 168.4 $ 174.0 $ 177.3 Gross profit 51.4 54.0 54.6 54.1 Operating income 11.3 24.8 20.9 15.2 Net income 7.4 12.0 30.0 24.3 Net cash provided by operating activities $ 8.4 $ 12.0 $ 22.0 $ 15.8 Per common share: Earnings – basic $ 0.31 $ 0.50 $ 1.26 $ 1.02 – diluted $ 0.30 $ 0.48 $ 1.20 $ 0.98 (1) In view of the fact that a net loss of $(16.8) million was made in the third quarter, 2011, the basic and diluted loss per common share are the same for this quarter. (2) Special items, before tax, during the year ended December 31, 2011 comprised the following: (in millions) First Quarter Second Quarter Third Quarter Fourth Quarter 2011 Civil complaint settlement $ 0.0 $ 0.0 $ (45.0 ) $ 0.0 Foreign currency exchange gains/(losses) 5.5 7.9 (4.3 ) (2.6 ) Civil complaint legal and professional expenses (1.0 ) (3.0 ) (1.5 ) 0.0 Adjustment of income tax provisions (0.1 ) 0.0 (3.1 ) (0.8 ) Acquisition-related costs 0.0 0.0 (3.0 ) 0.0 Restructuring charge 0.0 0.0 0.0 (0.6 ) Pension charge $ (0.1 ) $ (0.1 ) $ (0.1 ) $ (0.2 ) (2) (1) (3) Table of Contents QUARTERLY SUMMARY (UNAUDITED) (continued) 25 (3) Special items, before tax, during the year ended December 31, 2010 comprised the following: (in millions) First Quarter Second Quarter Third Quarter Fourth Quarter 2010 OFFP/FCPA settlement accrual $ 3.0 $ 0.0 $ 0.0 $ 0.0 OFFP/FCPA legal and professional expenses (3.9 ) 0.0 0.0 0.0 Civil complaint legal and professional expenses 0.0 0.0 (1.0 ) (3.2 ) Retention bonuses 0.0 0.0 0.0 (2.3 ) Pension charge (3.8 ) (2.1 ) (2.5 ) (2.4 ) Restructuring charge (8.2 ) (0.3 ) 0.0 (0.2 ) Foreign currency exchange (losses)/gains (0.2 ) (10.9 ) 11.6 2.6 Adjustment of income tax provisions $ 0.0 $ 5.0 $ 4.2 $ 3.0 (4) During the second quarter of 2011, the Company revised the classification of certain amortization of intangible assets expenses in its results for 2011 and comparable information for 2010. Previously, these expenses were disclosed separately within operating expenses. This has no impact on 2011 or any prior periods’ reported net sales, income before income taxes, net income, earnings per share, net cash provided by operating activities or any balance sheet category. The classification of expenses of $1.2 million for the three months ended March 31, 2011, and $4.7 million for the year ended December 31, 2010, with respect to amortization of intangible assets has been revised from operating expenses to an increase in costs of goods sold of $0.8 million and $3.1 million, respectively, and an increase in selling expenses of $0.4 million and $1.6 million, respectively. The impact on gross profit and selling, general and administrative expenses for the previously reported quarters is provided below: 2011 (in millions) First Quarter Previously reported: Gross profit $ 53.6 SG&A expenses (23.6 ) Amortization of intangible assets (1.2 ) Revised classification: Gross profit 52.8 SG&A expenses $ (24.0 ) 2010 First Quarter Second Quarter Third Quarter Fourth Quarter Full Year Previously reported: Gross profit $ 52.2 $ 54.7 $ 55.4 $ 54.9 $ 217.2 SG&A expenses (26.9 ) (23.7 ) (28.2 ) (33.1 ) (111.9 ) Amortization of intangible assets (1.2 ) (1.1 ) (1.2 ) (1.2 ) (4.7 ) Revised classification: Gross profit 51.4 54.0 54.6 54.1 214.1 SG&A expenses $ (27.3 ) $ (24.1 ) $ (28.6 ) $ (33.5 ) $ (113.5 ) Table of Contents Item 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations This discussion should be read in conjunction with our consolidated financial statements and the notes thereto. CRITICAL ACCOUNTING ESTIMATES Note 2 of the Notes to the Consolidated Financial Statements includes a summary of the significant accounting policies and methods used in the preparation of the consolidated financial statements. Contingencies We are subject to legal, regulatory and other proceedings and claims. The Company discloses information concerning contingent liabilities in respect of these claims and proceedings for which an unfavorable outcome is more than remote and the potential loss could materially impact our results of operations, financial position and cash flows. We recognize liabilities for these claims and proceedings when it is probable that the Company has incurred a loss and the amount of the loss can be reasonably estimated and to fairly present, in conjunction with the disclosures of these matters in our consolidated financial statements, management’s view of our exposure. We review outstanding claims and proceedings with external counsel as appropriate to assess probability and estimates of loss. The Company will recognize within selling, general and administrative expenses a liability related to claims and proceedings at such time as an unfavorable outcome becomes probable and the amount can be reasonably estimated. When the reasonable estimate is a range, the recognized liability will be the best estimate within the range. If no amount in the range is a better estimate than any other amount then the minimum amount of the range will be recognized. The Company recognizes its legal and other related professional expenses within selling, general and administrative expenses as and when the associated course of action is committed to. We re-evaluate these assessments each quarter or as new and significant information becomes available to determine whether a liability should be recognized or if any existing liability should be adjusted. The actual cost of ultimately resolving a claim or proceeding may be substantially different from the amount of the recognized liability. In addition, because it is not permissible to recognize a liability until the loss is both probable and estimable, in some cases there may be insufficient time to recognize a liability prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement). Environmental Liabilities Remediation provisions at December 31, 2011 amounted to $27.1 million and relate principally to our Ellesmere Port site in the United Kingdom. We recognize, at fair value, environmental liabilities when they are probable and costs can be reasonably estimated, and asset retirement obligations when there is a legal obligation and costs can be reasonably 26 Table of Contents estimated. The Company has to anticipate the program of work required and the associated future expected costs, and has to comply with environmental legislation in the relevant countries in which it operates or has operated in. The Company views the costs of vacating our Ellesmere Port site as a contingent liability because there is no present intention to exit the site. The Company has further determined that, due to the uncertain product life of TEL, particularly in the market for aviation gasoline, there exists such uncertainty as to the probability and timing of such cash flows that it is not possible to estimate them sufficiently reliably to recognize a provision. Pensions The Company maintains a defined benefit pension plan (the “Plan”) covering a number of its current and former employees in the United Kingdom, although it does also have other much smaller pension arrangements in the U.S. and overseas. The Plan is closed to future service accrual but has a large number of deferred and current pensioners. A full triennial actuarial valuation of the Plan was performed as at December 31, 2008 and an update performed as at December 31, 2011, the results of which are reflected in these consolidated financial statements. Movements in the underlying plan asset value and Projected Benefit Obligation (“PBO”) are dependent on actual return on investments as well as our assumptions in respect of the discount rate, annual member mortality rates, future return on assets, future pension increases and future inflation. A change in any one of these assumptions could impact the plan asset value, PBO and pension charge recognized in the income statement. Such changes could adversely impact our results of operations and financial position. A 0.25% change in the discount rate assumption would change the PBO by approximately $20 million and the net pension charge for 2012 by approximately $0.5 million. A 0.25% change in the level of price inflation assumption would change the PBO by approximately $16 million and the net pension charge for 2012 by approximately $1.9 million. Further disclosure is provided in Note 6 of the Notes to the Consolidated Financial Statements. Deferred Tax and Uncertain Income Tax Positions At December 31, 2011, we had a valuation allowance aggregating $7.5 million against part of our foreign tax credit carry forwards within deferred tax. The valuation allowance requires an assessment of both negative and positive evidence when measuring the need for a valuation allowance. Objective evidence, such as operating results during the most recent periods, is given more weight than our expectations of future profitability, which are inherently uncertain. Management believes there are uncertainties around whether all the foreign tax credit carry forwards can be utilized in future periods and this represents sufficient negative evidence to require a partial valuation allowance. No deferred taxes have been provided for the unremitted earnings of our overseas subsidiaries as any tax basis differences relating to investments in these overseas subsidiaries are considered to be permanent in duration. 27 Table of Contents The calculation of our tax liabilities involves evaluating uncertainties in the application of complex tax regulations. We recognize liabilities for anticipated tax audit issues based on our estimate of whether, and the extent to which, additional taxes will be required. If we ultimately determine that payment of these amounts is unnecessary, we reverse the liability and recognize a tax benefit during the period in which we determine that the liability is no longer necessary. We also recognize tax benefits to the extent that it is more likely than not that our positions will be sustained, based on technical merits, when challenged by the taxing authorities. To the extent that we prevail in matters for which liabilities have been established, or are required to pay amounts in excess of our liabilities, our effective tax rate in a given period may be materially affected. An unfavorable tax settlement may require cash payments and result in an increase in our effective tax rate in the year of resolution. A favorable tax settlement may be recognized as a reduction in our effective tax rate in the year of resolution. We report interest and penalties related to uncertain income tax positions as income taxes. For additional information regarding uncertain income tax positions see Note 7 of the Notes to the Consolidated Financial Statements. Goodwill The Company’s reporting units, the level at which goodwill is tested for impairment, are consistent with the reportable segments: Fuel Specialties, Active Chemicals and Octane Additives. All of the components in each segment (including products, markets and competitors) have similar economic characteristics and therefore the segments reflect the lowest level at which operations and cash flows can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the Company. The Company tests goodwill annually for impairment, or between years if events occur or circumstances change which suggest that an impairment may have occurred. The Company elected to perform its annual tests in respect of Fuel Specialties and Active Chemicals goodwill as at December 31 each year. In reviewing for any impairment charge the fair value of the reporting segments are estimated using an after tax cash flow methodology based on management’s best available estimates at that time. The key assumptions underpinning these calculations include future revenue growth, gross margins and the Company’s weighted average cost of capital. At December 31, 2011 we had $108.8 million and $30.1 million of goodwill relating to our Fuel Specialties and Active Chemicals segments, respectively. At this date we performed annual impairment tests and concluded that there had been no impairment because the estimated fair values of those reporting segments substantially exceeded the carrying values. In light of the continuing decline in the Octane Additives market globally, as the Company makes sales of Octane Additives in each quarter, the remaining sales and corresponding cash flows that can be derived from the Octane Additives segment are reduced, and accordingly the fair value of the Octane Additives segment is reduced. As a result, the Company determined that quarterly impairment tests be performed from January 1, 2004 and any impairment charge 28 Table of Contents arising be recognized in the relevant quarter. As a result of the Octane Additives impairment tests performed during 2011, 2010 and 2009 impairment charges of $2.0 million, $2.2 million and $2.2 million, respectively, have been recognized. These charges are non-cash in nature and have no impact on taxation. In 2011 some of the assumptions and estimates underpinning the Octane Additives segment discounted cash flows were revised as part of our planning processes although the methodology was unchanged. These revisions had no material impact on the reporting of goodwill. The most significant revisions were that the Company’s weighted average cost of capital was changed to reflect the changing proportion of debt to equity funding of the Company and effective October 1, 2011, the Company extended its estimate for the future life of the Octane Additives segment from December 31, 2012 to December 31, 2013. There is $2.6 million of goodwill remaining at December 31, 2011 which relates to the Octane Additives segment and equates to the fair value of the goodwill at that date. Given the quantum and predictability of the remaining future cash flows from the Octane Additives segment the Company expects goodwill impairment charges to be recognized in the income statement on an approximate straight-line basis to December 31, 2013. However, since the remaining sales of the Octane Additives segment are concentrated in a relatively small number of customers, there is an inherent risk that they could decline with unpredictable volatility and severity resulting in an accelerated impairment of the Octane Additives segment goodwill as the forecast discounted cash flows from that segment would be reduced. We believe that the assumptions used in our annual and quarterly impairment tests are reasonable, but that they are judgmental, and that variations in any of the assumptions may result in materially different calculations of impairment charges, if any. Intangible Assets, Net of Amortization At December 31, 2011 we had $17.7 million of intangibles that are discussed in Note 9 of the Notes to the Consolidated Financial Statements. These intangible assets relate to all of our reporting segments and are being amortized straight-line over periods of up to 13 years. We continually assess the markets and products related to these intangibles, as well as their specific carrying values, and have concluded that these carrying values and amortization periods remain appropriate. We also evaluate these intangibles for any potential impairment when events occur or circumstances change which suggest that an impairment may have occurred. If events occur or circumstances change it may cause a reduction in periods over which these intangibles are amortized or result in a non-cash impairment of a portion of the intangibles’ carrying value. A reduction in amortization periods would have no effect on cash flows. 29 Table of Contents RESULTS OF OPERATIONS The following table provides operating income by reporting segment: 30 (in millions) 2011 2010 2009 Net sales Fuel Specialties $ 521.2 $ 458.1 $ 422.7 Active Chemicals 177.0 152.7 130.2 Octane Additives 76.2 72.4 45.6 $ 774.4 $ 683.2 $ 598.5 Gross profit Fuel Specialties $ 149.3 $ 145.9 $ 146.0 Active Chemicals 40.6 33.3 26.0 Octane Additives 36.5 34.9 14.2 $ 226.4 $ 214.1 $ 186.2 Operating income Fuel Specialties $ 81.7 $ 77.6 $ 81.4 Active Chemicals 22.6 16.7 8.8 Octane Additives (22.4 ) 25.8 (44.8 ) Pension charge (0.5 ) (10.8 ) (6.4 ) Corporate costs (29.2 ) (26.3 ) (13.3 ) Restructuring charge (0.6 ) (8.7 ) (2.8 ) Impairment of Octane Additives segment goodwill (2.0 ) (2.2 ) (2.2 ) Profit on disposal, net 0.0 0.1 0.0 Total operating income $ 49.6 $ 72.2 $ 20.7 Table of Contents Results of Operations – Fiscal 2011 compared to Fiscal 2010: Fuel Specialties Net sales: the table below details the components which comprise the year on year change in net sales spread across the markets in which we operate: Gross margin: the year on year decrease of 3.2 percentage points primarily reflected a higher proportion of sales of lower margin products and the competitive pressure on margins resulting from increased raw material costs. Operating expenses: the year on year decrease of 1%, or $0.7 million, was primarily due to the release of an accrual in respect of an old customer claim in the first quarter of 2011. The 31 (in millions, except ratios) 2011 2010 Change Net sales Fuel Specialties $ 521.2 $ 458.1 $ 63.1 +14 % Active Chemicals 177.0 152.7 24.3 +16 % Octane Additives 76.2 72.4 3.8 +5 % $ 774.4 $ 683.2 $ 91.2 +13 % Gross profit Fuel Specialties $ 149.3 $ 145.9 $ 3.4 +2 % Active Chemicals 40.6 33.3 7.3 +22 % Octane Additives 36.5 34.9 1.6 +5 % $ 226.4 $ 214.1 $ 12.3 +6 % Gross margin (%) Fuel Specialties 28.6 31.8 -3.2 Active Chemicals 22.9 21.8 1.1 Octane Additives 47.9 48.2 -0.3 Aggregate 29.2 31.3 -2.1 Operating expenses Fuel Specialties $ (67.6 ) $ (68.3 ) $ 0.7 -1 % Active Chemicals (18.0 ) (16.6 ) (1.4 ) +8 % Octane Additives (58.9 ) (9.1 ) (49.8 ) n/a Pension charge (0.5 ) (10.8 ) 10.3 -95 % Corporate costs (29.2 ) (26.3 ) (2.9 ) +11 % $ (174.2 ) $ (131.1 ) $ (43.1 ) +33 % Change (%) Americas EMEA ASPAC Avtel Total Volume -2 +7 -9 +13 +1 Price and product mix +11 +9 +13 +8 +11 Exchange rates 0 +5 +1 0 +2 +9 +21 +5 +21 +14 Table of Contents release offsets increases in operating expenses due to higher licensing costs and the adverse impact of foreign currency exchange rates on our European cost base denominated in European Union euro and British pound sterling. Active Chemicals Net sales: the table below details the components which comprise the year on year change in net sales spread across the markets in which we operate: Gross margin: the year on year increase of 1.1 percentage points reflected the continued improvement across the markets, especially our Polymers business, despite the competitive pressures on margins resulting from increased raw material costs. Operating expenses: the year on year increase of 8%, or $1.4 million, was less than the 16% growth in sales as we continued to leverage the infrastructure of this segment. Octane Additives Change (%) Americas EMEA ASPAC Total Volume -7 -2 +12 -2 Price and product mix +14 +15 +13 +14 Exchange rates +1 +6 +3 +4 +8 +19 +28 +16 Net sales: increased by 5% with increased volumes (up 4 percentage points) and an improved sales mix (up 3 percentage points) offset by reduced revenue from our environmental remediation business (down 2 percentage points). In both 2011 and 2010, sales were focused in the Middle East and Northern Africa. Gross margin: decreased marginally by 0.3 percentage points from 48.2% to 47.9%. Operating expenses: excluding the impacts of the $45.0 million NewMarket Corporation civil complaint settlement in 2011 and the $3.0 million adjustment to the settlement accrual related to OFFP and FCPA investigations in 2010, the year on year increase was $1.8 million, or 15%, primarily due to higher legal and other professional expenses. Other Income Statement Captions Pension charge: this non-cash charge decreased by $10.3 million to $0.5 million reflecting the reduction in the pension liability and the near elimination of the service cost since the Company closed the United Kingdom defined benefit pension plan to future service accrual with effect from March 31, 2010. Corporate costs: were $29.2 million, compared with $26.3 million a year ago. Excluding acquisition-related costs of $3.0 million in 2011 and a $3.9 million charge for the probable cost of the Company’s external compliance monitor in 2010, the year on year increase of $3.8 million primarily reflected higher accruals for share based compensation expense, driven by the substantial year on year rise in our stock price. 32 Table of Contents Restructuring charge: was comprised of the following: The Company closed its United Kingdom defined benefit pension plan to future service accrual with effect from March 31, 2010 and accordingly we recorded a non-cash curtailment loss of $8.2 million in the first quarter of 2010. Impairment of Octane Additives segment goodwill: was $2.0 million and $2.2 million in 2011 and 2010, respectively. Effective October 1, 2011, we updated the estimates used in the detailed forecast model to calculate impairment charges to reflect the Company’s extended estimate for the future life of our Octane Additives segment from December 31, 2012 to December 31, 2013, resulting in a lower charge. Profit on disposal, net: in 2010 the Company recognized $0.1 million profit following the disposal of surplus real estate. Other net income: of $6.3 million was comprised of $6.5 million of net foreign currency exchange gains and gains on translation of net assets denominated in non-functional currencies in our European businesses, and $0.2 million sundry other expenses. In 2010, other net income of $3.1 million related to net foreign currency exchange gains. Interest expense, net: the net interest expense, including amortization of deferred finance costs, has decreased from $4.6 million to $3.3 million due to the lower level of debt in 2011 and the deferred finance costs becoming fully amortized in the third quarter of 2011. Income taxes : the effective tax rate was 7.0% and (4.2)% in 2011 and 2010, respectively. The effective tax rate, once adjusted for the NewMarket Corporation civil complaint settlement, adjustment of income tax provisions and for the OFFP and FCPA settlement accrual, was 15.8% in 2011 compared with 13.6% in 2010. 33 (in millions) 2011 2010 Reduction in EMEA headcount $ 0.7 $ 0.5 Release of an accrual in respect of the relocation of a U.S. sales and administration facility (0.1 ) 0.0 Pension curtailment 0.0 8.2 $ 0.6 $ 8.7 (in millions, except ratios) 2011 2010 Income before income taxes $ 52.6 $ 70.7 Add back NewMarket Corporation civil complaint settlement 45.0 0.0 Add back OFFP/FCPA settlement accrual 0.0 (3.0 ) $ 97.6 $ 67.7 Income taxes $ 3.7 $ (3.0 ) Add back tax on NewMarket Corporation civil complaint settlement 15.7 0.0 Add back adjustment of income tax provisions (4.0 ) 12.2 $ 15.4 $ 9.2 Adjusted effective tax rate 15.8 % 13.6 % Table of Contents In addition to those mentioned above, the following factors had a significant impact on the Company’s effective tax rate as compared to the U.S. federal income tax rate of 35%: The impact on the effective tax rate from profits earned in foreign jurisdictions with lower tax rates varies as the geographical mix of the Company’s profits changes year on year. In 2011, the Company’s income tax expense benefited from a greater proportion of its overall profits arising in Switzerland than in 2010, primarily reflecting increased sales in our Octane Additives segment due to the timing of shipments to major customers. This resulted in an $8.9 million benefit in Switzerland (2010 – $6.5 million). In addition, there was a $0.1 million benefit in relation to the United Kingdom (2010 – $3.2 million) and a $0.9 million benefit in relation to Germany (2010 – $0.0 million). Foreign income inclusions arise each year from certain types of income earned overseas being taxable under U.S. tax regulations. These types of income include Subpart F income, principally from foreign based company sales in the United Kingdom, including the associated Section 78 tax gross up, and also from the income earned by certain overseas subsidiaries taxable under the U.S. tax regime. In 2011, the amount of Subpart F income and the associated Section 78 gross up amounted to $3.0 million (2010 – $2.1 million). The income earned by certain overseas subsidiaries taxable under the U.S. tax regime reduced to $2.0 million from $2.9 million in 2010. In addition, a dividend from an overseas subsidiary, remitted to the U.S., increased foreign income inclusions by $5.5 million during 2011 (2010 – $0.0 million). Foreign tax credits can fully or partially offset these incremental U.S. taxes from foreign income inclusions. The utilization of foreign tax credits varies year on year as this is dependent on a number of variable factors which are difficult to predict and may in certain years prevent any offset of foreign tax credits. During 2011, an additional $6.1 million of foreign tax credit carry forwards were generated, primarily due to the overseas dividend remitted to the U.S. in the year. This increase in foreign tax credit carry forwards and accompanying extension of expiration period has allowed the recognition of a further $9.4 million of foreign tax credit carry forwards as compared to $2.7 million in 2010. Following the United Kingdom’s 2% reduction in the corporation tax rate from 27% to 25% in April 2012, enacted in July 2011, the Company benefited from a net deferred tax credit of $2.5 million in the third quarter of 2011 primarily in respect of pension plan unrecognized actuarial net losses. Further details are given in Note 7 of the Notes to the Consolidated Financial Statements. 34 (in millions) 2011 2010 Foreign tax rate differential $ (9.9 ) $ (9.5 ) Foreign income inclusions 10.7 5.0 Foreign tax credits (13.5 ) (5.0 ) Tax deductibility of the OFFP/FCPA settlement accrual 0.0 (2.0 ) Deferred tax credit from United Kingdom income tax rate reduction $ (2.5 ) $ (1.1 ) Table of Contents Results of Operations – Fiscal 2010 compared to Fiscal 2009: Fuel Specialties Net sales: the table below details the components which comprise the year on year change in net sales spread across the markets in which we operate: Gross margin: the year on year decrease of 2.7 percentage points primarily reflected the competitive pressure on margins as raw material costs increased in 2010. This was partially offset by the impact of higher margins within our Avtel business from increased TEL manufacturing volumes on the fixed cost base on the TEL manufacturing site. 35 (in millions, except ratios) 2010 2009 Change Net sales Fuel Specialties $ 458.1 $ 422.7 $ 35.4 +8 % Active Chemicals 152.7 130.2 22.5 +17 % Octane Additives 72.4 45.6 26.8 +59 % $ 683.2 $ 598.5 $ 84.7 +14 % Gross profit Fuel Specialties $ 145.9 $ 146.0 $ (0.1 ) 0 % Active Chemicals 33.3 26.0 7.3 +28 % Octane Additives 34.9 14.2 20.7 +146 % $ 214.1 $ 186.2 $ 27.9 +15 % Gross margin (%) Fuel Specialties 31.8 34.5 -2.7 Active Chemicals 21.8 20.0 +1.8 Octane Additives 48.2 31.1 +17.1 Aggregate 31.3 31.1 +0.2 Operating expenses Fuel Specialties $ (68.3 ) $ (64.6 ) $ (3.7 ) +6 % Active Chemicals (16.6 ) (17.2 ) 0.6 -3 % Octane Additives (9.1 ) (59.0 ) 49.9 -85 % Pension charge (10.8 ) (6.4 ) (4.4 ) +69 % Corporate costs (26.3 ) (13.3 ) (13.0 ) +98 % $ (131.1 ) $ (160.5 ) $ 29.4 -18 % Change (%) Americas EMEA ASPAC Avtel Total Volume +6 +8 +75 +8 +15 Price and product mix -1 +2 -37 +4 -4 Exchange rates 0 -7 -1 0 -3 +5 +3 +37 +12 +8 Table of Contents Operating expenses: the year on year increase of 6% was less than the 8% growth in sales as we continued to leverage the infrastructure of this segment. In addition, there were 3% higher research and development expenses to support this developing segment and increased legal and other professional expenses. Active Chemicals Net sales: the table below details the components which comprise the year on year change in net sales spread across the markets in which we operate: Gross margin: the year on year increase of 1.8 percentage points reflected the improved performance from our Personal Care and Polymers businesses, which suffered from poor demand in 2009, despite the competitive pressures on margins as raw material costs increased in 2010. Operating expenses: the year on year reduction of 3% or $0.6 million was achieved despite the 17% sales growth and 28% increase in research and development expenses to support this developing segment, primarily due to the favorable impact of exchange rates on our European cost base and tight cost control. Octane Additives Net sales: increased by 59% due to increased volumes (up 45 percentage points), as a result of the timing of shipments to major customers, and an improved sales mix (up 14 percentage points). In both 2010 and 2009 sales were focused in the Middle East and Northern Africa. Gross margin: the year on year increase of 17.1 percentage points primarily reflected the increased TEL manufacturing volumes on the fixed cost base on the TEL manufacturing site. Operating expenses: excluding the impact of the $12.9 million OFFP and FCPA legal and other professional expenses and $40.2 million accrual for the OFFP and FCPA settlement in 2009, and $3.0 million adjustment to the related settlement accrual in 2010, the year on year increase in operating expenses was $6.2 million due to increased selling costs and higher legal and other professional expenses. Other Income Statement Captions Pension charge: this non-cash charge increased by $4.4 million to $10.8 million primarily reflecting the requirement in 2010 to amortize actuarial net losses, offset by the near elimination of the service cost since the Company closed the United Kingdom defined benefit pension plan to future service accrual with effect from March 31, 2010. 36 Change (%) Americas EMEA ASPAC Total Volume +19 -1 +7 +7 Price and product mix +7 +15 +17 +12 Exchange rates -1 -4 -2 -2 +25 +10 +22 +17 Table of Contents Corporate costs: increased by $13.0 million due to a $3.9 million charge in the first quarter of 2010 for probable future independent corporate compliance monitor expenses over the next three years. In 2009 corporate costs included a $2.4 million gain on stock options forfeited upon resignation of the Company’s former CEO and a $2.5 million benefit from a prior years’ United Kingdom sales tax settlement. Excluding these items, corporate costs were $22.4 million, compared with $18.2 million a year ago, reflecting the higher personnel-related costs, including retention bonuses, and the increased cost of alternative pension arrangements following the closure of the United Kingdom defined benefit pension plan to future service accrual with effect from March 31, 2010. Restructuring charge: was comprised of the following: The Company closed its United Kingdom defined benefit pension plan to future service accrual with effect from March 31, 2010 and accordingly we recorded a non-cash curtailment loss of $8.2 million in the first quarter of 2010. Impairment of Octane Additives segment goodwill: was $2.2 million in both 2010 and 2009. Profit on disposal: in 2010 the Company recognized $0.1 million profit following the disposal of surplus real estate. Other net income: of $3.1 million in 2010 related to net foreign currency exchange gains. In 2009 other net income of $3.6 million related to $3.5 million of net foreign currency exchange gains and $0.1 million of sundry other income. Interest expense, net: decreased from $6.0 million to $4.6 million due to the lower level of debt in 2010 and the accelerated write-off of $0.2 million of unamortized deferred finance costs in 2009. Income taxes: the effective tax rate was (4.2)% and 65.0% in 2010 and 2009 respectively. The effective tax rate, once adjusted for the OFFP and FCPA settlement accrual and adjustment of income tax provisions, was 13.6% in 2010 compared with 24.3% in 2009. 37 (in millions) 2010 2009 Pension curtailment $ 8.2 $ 0.0 Reduction in EMEA headcount 0.5 0.3 Separation agreement with the former CEO 0.0 1.3 Relocation of a U.S. sales and administration facility 0.0 0.7 Dissolution costs related to a non-trading foreign subsidiary 0.0 0.4 United Kingdom site clearance 0.0 0.1 $ 8.7 $ 2.8 Table of Contents In addition to those mentioned above, the following factors had a significant impact on the Company’s effective tax rate as compared to the U.S. federal income tax rate of 35%: The impact on the effective tax rate from profits earned in foreign jurisdictions with lower tax rates varies as the geographical mix of the Company’s profits changes year on year. In 2010, the Company’s income tax expense benefited from a greater proportion of its overall profits arising in Switzerland and the United Kingdom than in 2009, primarily reflecting substantially increased sales in our Octane Additives segment due to the timing of shipments to major customers. This resulted in a $6.5 million benefit in Switzerland (2009 – $1.2 million) and a $3.2 million benefit in the United Kingdom (2009 – $2.1 million). Foreign income inclusions arise each year from certain types of income earned overseas being taxable under U.S. tax regulations. These types of income include Subpart F income, principally from foreign based company sales in the United Kingdom, including the associated Section 78 tax gross up, and also from the income earned by certain overseas subsidiaries taxable under the U.S. tax regime. In 2010, the amount of Subpart F income and the associated Section 78 gross up amounted to $2.1 million (2009 – $2.5 million). The income for 2009 included a one-off recapture of Subpart F income from earlier years relating to the United Kingdom of $0.9 million; and income from the Isle of Man of $0.2 million which is not treated as Subpart F income from January 1, 2010 onwards. The income earned by certain overseas subsidiaries taxable under the U.S. tax regime increased to $2.9 million from $1.7 million in 2009. Foreign tax credits can fully or partially offset these incremental U.S. taxes from foreign income inclusions. The utilization of foreign tax credits varies year on year as this is dependent on a number of variable factors which are difficult to predict and may in certain 38 (in millions, except ratios) 2010 2009 Income before income taxes $ 70.7 $ 18.3 Add back OFFP/FCPA settlement accrual (3.0 ) 40.2 $ 67.7 $ 58.5 Income taxes $ (3.0 ) $ 11.9 Add back adjustment of income tax provisions 12.2 2.3 $ 9.2 $ 14.2 Adjusted effective tax rate 13.6 % 24.3 % (in millions) 2010 2009 Foreign tax rate differential $ (9.5 ) $ (3.4 ) Foreign income inclusions 5.0 4.2 Foreign tax credits (5.0 ) (3.4 ) Tax deductibility of the OFFP/FCPA settlement accrual (2.0 ) 0.0 Deferred tax credit from United Kingdom income tax rate reduction $ (1.1 ) $ 0.0 Table of Contents years prevent any offset of foreign tax credits. The principal reason for the increase in foreign tax credits in 2010 arises from the release of a $2.7 million valuation allowance against surplus foreign tax credits carried forward from 2009 and earlier years. In 2010 the Company benefited from the revised assumption that an element of the OFFP and FCPA settlement accrual should have been tax deductible. Following the United Kingdom’s 1% reduction in the corporation tax rate from 28% to 27% in April 2011, enacted in July 2010, the Company benefited from a net deferred tax credit in the third quarter of 2010 primarily in respect of pension plan unrecognized actuarial net losses. Further details are given in Note 7 of the Notes to the Consolidated Financial Statements. LIQUIDITY AND FINANCIAL CONDITION Working Capital The Company believes that adjusted working capital, a non-GAAP financial measure, provides useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, management uses this non-GAAP financial measure internally to allocate resources and evaluate the performance of the Company’s operations. In 2011 our adjusted working capital increased by $30.0 million (defined by the Company as trade and other accounts receivable, inventories, prepaid expenses, accounts payable and the current portion of accrued liabilities rather than total current assets less total current liabilities). The $15.2 million increase in trade and other accounts receivable was primarily due to increased trading. The $13.6 million increase in inventories was focused in our Fuel Specialties and Active Chemicals segments following the decision to build certain product inventories of strategic importance, offset by reductions in Octane Additives due to the timing of shipments. 39 (in millions) 2011 2010 Total current assets $ 320.3 $ 321.9 Total current liabilities (146.0 ) (158.9 ) Working capital 174.3 163.0 Less cash and cash equivalents (76.2 ) (107.1 ) Less short-term investments (4.8 ) (4.2 ) Add back accrued income taxes 2.0 6.1 Add back current portion of long-term debt 5.0 15.0 Add back current portion of plant closure provisions 4.1 3.9 Add back current portion of unrecognized tax benefits 3.2 2.2 Add back current portion of deferred income 1.4 0.1 Adjusted working capital $ 109.0 $ 79.0 Table of Contents Cash At December 31, 2011 and 2010 we had cash and cash equivalents of $76.2 million and $107.1 million, respectively, of which $74.1 million and $104.9 million, respectively, was held by non-U.S. subsidiaries principally in the United Kingdom. The Company is in a position to control whether or not to repatriate foreign earnings but does not need to and does not expect to make a further repatriation in the foreseeable future and hence has not provided for future income taxes on the cash held by foreign subsidiaries although we will continue to monitor this position. Short-term investments At December 31, 2011 and 2010 we had short-term investments of $4.8 million and $4.2 million, respectively. Debt On December 14, 2011, we entered into a five-year revolving credit facility which provides for borrowings by us of up to $100.0 million. The facility carries an interest rate based on U.S. LIBOR plus a margin of between 1.50% and 2.25% which is dependant on the Company’s ratio of net debt to EBITDA. EBITDA is a non-GAAP measure of liquidity defined in the finance facility. The facility can be drawn down until it expires on December 14, 2016 and may be drawn down in full in the U.S. We repaid the previous finance facility, which was due to expire on February 6, 2012, upon entering into the new facility. The Company’s finance facility contains restrictive clauses which may constrain our activities and limit our operational and financial flexibility. The facility obliges the lenders to comply with a request for utilization of finance unless there is an event of default outstanding. Events of default are defined in the finance facility and include a material adverse change to our assets, operations or financial condition. The facility contains a number of restrictions that limit our ability, amongst other things, and subject to certain limited exceptions, to incur additional indebtedness, pledge our assets as security, guarantee obligations of third parties, make investments, undergo a merger or consolidation, dispose of assets, or materially change our line of business. In addition, the facility also contains terms which, if breached, would result in it becoming repayable on demand. It requires, among other matters, compliance with two financial covenant ratios measured on a quarterly basis. These requirements are (1) the ratio of net debt to EBITDA shall not be greater than 2.5:1 and (2) the ratio of EBITDA to net interest shall not be less than 4.0:1. Management has determined that the Company has not breached these covenants throughout the period to December 31, 2011 and expects to not breach these covenants for the next 12 months. The finance facility is secured by a number of fixed and floating charges over certain assets which include key operating sites of the Company and its subsidiaries. As at December 31, 2011, the Company had $20.0 million of debt outstanding under its finance facility. 40 Table of Contents On September 13, 2011, the Company settled the NewMarket Corporation civil complaint. The settlement agreement included the Company issuing a $15.0 million promissory note to NewMarket Corporation payable in three equal annual installments (carrying simple interest at 1% per annum), the first installment of which is due on September 10, 2012. The debt maturity profile as at December 31, 2011 is set out below: Outlook At December 31, 2011, the Company had cash, cash equivalents and short-term investments of $81.0 million and debt of $35.0 million resulting in net cash of $46.0 million. The Company expects to fund its operations over at least the next 12 months from a combination of operating cash flows and its new revolving credit facility. Under the facility we have the ability to draw down up to $100.0 million, of which $20.0 million was drawn down at December 31, 2011, so long as we are in compliance with all financial covenants therein. Contractual Commitments The following represents contractual commitments at December 31, 2011 and the effect of those obligations on future cash flows: 41 (in millions) 2012 $ 5.0 2013 5.0 2014 5.0 2015 0.0 2016 20.0 35.0 Current portion of long-term debt (5.0 ) Long-term debt, net of current portion $ 30.0 (in millions) Total 2012 2013-14 2015-16 Thereafter Operating activities OFFP/FCPA payments $ 11.7 $ 8.3 $ 3.4 $ 0.0 $ 0.0 Compliance monitor 2.8 1.3 1.5 0.0 0.0 Planned funding of pension obligations 51.8 9.0 21.4 21.4 0.0 Remediation payments 27.1 3.6 8.1 1.9 13.5 Severance payments 1.5 0.5 1.0 0.0 0.0 Operating lease commitments 4.9 1.3 1.7 0.9 1.0 Raw material purchase obligations 12.5 5.0 7.5 0.0 0.0 Interest payments on debt 3.2 0.7 1.2 1.3 0.0 Investing activities Capital commitments 0.9 0.9 0.0 0.0 0.0 Financing activities Long-term debt obligations 35.0 5.0 10.0 20.0 0.0 Total $ 151.4 $ 35.6 $ 55.8 $ 45.5 $ 14.5 Table of Contents Operating activities Following resolution of certain government investigations and other matters, further details of which are given in Note 18 of the Notes to the Consolidated Financial Statements, the Company is committed to paying fines, penalties and disgorgements over a period of four years commencing 2010; and probable future compliance monitor expenses until 2013. The amounts related to the pension plan refer to the likely levels of Company funding of the United Kingdom defined benefit pension plan (the “Plan”). The Plan is closed to future service accrual but has a large number of deferred and current pensioners. The Company expects its annual cash contribution to be $9.0 million in 2012 and $10.7 million in 2013-16. It is not meaningful to predict an amount after five years since there are numerous uncertainties including future return on assets, pension increases and inflation. Remediation payments represent those cash flows that the Company is currently obligated to pay in respect of current and former facilities. It does not include any discretionary remediation costs that the Company may choose to incur. Severance payments represent those cash flows that the Company is currently obligated to pay in respect of severance costs associated with exit or disposal activities and post employment benefits. Operating lease commitments relate primarily to office space, motor vehicles and various items of computer and office equipment which are expected to be renewed and replaced in the normal course of business. Raw material purchase obligations relate to certain long-term raw material contracts which have been entered into by the Company that stipulate fixed or minimum quantities to be purchased; fixed, minimum, or variable cost provisions; and the approximate timing of the transaction. Purchase obligations exclude agreements that are cancelable without penalty. The Company uses interest rate swaps to hedge against the risk from variable interest rates on certain elements of its long-term debt. The estimated payments included in the table above reflect the variable interest charge on long-term debt obligations and the effect of the interest rate swaps. Estimated commitment fees are also included and interest income is excluded. Due to the uncertainty regarding the nature of tax audits, particularly those which are not currently underway, it is not meaningful to predict the outcome of obligations related to unrecognized tax benefits. Further disclosure is provided in Note 7 of the Notes to the Consolidated Financial Statements. Investing activities Capital commitments relate to certain capital projects that the Company has committed to undertake. 42 Table of Contents Financing activities On December 14, 2011, we entered into a five-year revolving credit facility which provides for borrowings by us of up to $100.0 million. The facility can be drawn down until it expires on December 14, 2016. At December 31, 2011, $20.0 million was drawn under the revolving credit facility. On September 13, 2011, the Company settled the NewMarket Corporation civil complaint. The settlement agreement included the Company issuing a $15.0 million promissory note to NewMarket Corporation payable in three equal annual installments (carrying simple interest at 1% per annum), the first installment of which is due on September 10, 2012. Environmental Matters and Plant Closures The Company is subject to environmental laws in all of the countries in which it operates. Under certain environmental laws the Company is responsible for the remediation of hazardous substances or wastes at currently or formerly owned or operated properties. Most of our manufacturing operations have been conducted outside the U.S. and, therefore, any liability pertaining to the investigation and remediation of contaminated properties is likely to be determined under non-U.S. law. We evaluate costs for remediation, decontamination and demolition projects on a regular basis. Full provision is made for those costs to which we are committed under environmental laws. Full provision has been made for the committed costs of $27.1 million at December 31, 2011. Expenditure against provisions was $3.1 million, $2.7 million and $1.5 million in the years 2011, 2010 and 2009, respectively. Total severance expenditure was $0.7 million, $0.4 million and $2.1 million in the years 2011, 2010 and 2009, respectively. 43 Table of Contents The Company uses floating rate debt to finance its global operations. The Company is subject to business risks inherent in non-U.S. activities, including political and economic uncertainty, import and export limitations, and market risk related to changes in interest rates and foreign currency exchange rates. The political and economic risks are mitigated by the stability of the countries in which the Company’s largest operations are located. Credit limits, ongoing credit evaluation and account monitoring procedures are used to minimize bad debt risk. Collateral is not generally required. The Company uses derivatives, including interest rate swaps, commodity swaps and foreign currency forward exchange contracts, in the normal course of business to manage market risks. The derivatives used in hedging activities are considered risk management tools and are not used for trading purposes. In addition, the Company enters into derivative instruments with a diversified group of major financial institutions in order to manage the exposure to non-performance of such instruments. The Company’s objective in managing the exposure to changes in interest rates is to limit the impact of such changes on earnings and cash flows and to lower overall borrowing costs. The Company’s objective in managing the exposure to changes in foreign currency exchange rates is to reduce volatility on earnings and cash flows associated with such changes. The Company offers fixed prices for some long-term sales contracts. As manufacturing and raw material costs are subject to variability the Company uses commodity swaps to hedge the cost of some raw materials thus reducing volatility on earnings and cash flows. The derivatives are considered risk management tools and are not used for trading purposes. The Company’s objective is to manage its exposure to fluctuating costs of raw materials. Interest Rate Risk The Company uses interest rate swaps to manage interest rate exposure. As at December 31, 2011 the Company had cash, cash equivalents and short-term investments of $81.0 million, no bank overdraft and long-term debt of $35.0 million (including current portion). Long-term debt comprises a new revolving credit facility which provides for borrowings by us of up to $100.0 million and a $15.0 million promissory note to NewMarket Corporation. The facility carries an interest rate based on U.S. LIBOR plus a margin of between 1.50% and 2.25% which is dependant on the Company’s ratio of net debt to EBITDA. EBITDA is a non-GAAP measure of liquidity defined in the finance facility. The promissory note carries simple interest at 1% per annum. At December 31, 2011, $20.0 million was drawn under the revolving credit facility. As management does not expect the facility to be drawn down in the long-term, the Company has not entered into interest rate swap agreements in relation to this. On the basis that interest on $15.0 million of the $35.0 million long-term debt (including current portion) is fixed and that the Company would receive interest on the $81.0 million positive cash balances and short-term investments, then the interest payable on unhedged debt 44 Item 7A Quantitative and Qualitative Disclosures About Market Risk Table of Contents is more than offset by the interest receivable on positive cash balances and short-term investments. On a gross basis, assuming no additional interest on the cash balances and short-term investments, a hypothetical absolute change of 1% in U.S. base interest rates on the unhedged debt of $20.0 million for a one-year period would impact net income and cash flows by approximately $0.2 million before tax. On a net basis, assuming additional interest on the cash balances and short-term investments, a hypothetical absolute change of 1% in U.S. base interest rates for a one-year period would impact net income and cash flows by approximately $0.6 million before tax. The above does not consider the effect of interest or exchange rate changes on overall activity nor management action to mitigate such changes. Exchange Rate Risk The Company generates an element of its revenues and incurs some operating costs in currencies other than the U.S. dollar. The reporting currency of the Company is the U.S. dollar. The Company evaluates the functional currency of each reporting unit according to the economic environment in which it operates. Several major subsidiaries of the Company operating outside of the U.S. have the U.S. dollar as their functional currency due to the nature of the markets in which they operate. In addition, the financial position and results of operations of some of our foreign subsidiaries are reported in the relevant local currency and then translated to U.S. dollars at the applicable currency exchange rate for inclusion in our consolidated financial statements. The primary foreign currencies in which we have exchange rate fluctuation exposure are the European Union euro, British pound sterling and Swiss franc. Changes in exchange rates between these foreign currencies and the U.S. dollar will affect the recorded levels of our assets and liabilities, to the extent that such figures reflect the inclusion of foreign assets and liabilities which are translated into U.S. dollars for presentation in our consolidated financial statements, as well as our results of operations. The Company’s objective in managing the exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes. Accordingly, the Company enters into various contracts that change in value as foreign currency exchange rates change to protect the U.S. dollar value of its existing foreign currency denominated assets, liabilities, commitments, and cash flows. The Company also uses foreign currency forward exchange contracts to offset a portion of the Company’s exposure to certain foreign currency denominated revenues so that gains and losses on these contracts offset changes in the U.S. dollar value of the related foreign currency denominated revenues. The objective of the hedging program is to reduce earnings and cash flow volatility related to changes in foreign currency exchange rates. The trading of our Fuel Specialties and Active Chemicals reporting segments is inherently naturally hedged and accordingly changes in exchange rates would not be material to our 45 Table of Contents earnings or financial position. The cost base of our Octane Additives reporting segment and corporate costs, however, are largely denominated in British pound sterling. A 5% strengthening in the U.S. dollar against British pound sterling would increase reported operating income by approximately $3.0 million for a one-year period excluding the impact of any foreign currency forward exchange contracts. Where a 5% strengthening of the U.S. dollar has been used as an illustration, a 5% weakening would be expected to have the opposite effect on operating income. Raw Material Cost Risk We use a variety of raw materials, chemicals and energy in our manufacturing and blending processes. Many of the raw materials that we use are derived from petrochemical-based feedstocks which can be subject to periods of rapid and significant cost instability. These fluctuations in cost can be caused by political instability in oil producing nations and elsewhere, or other factors influencing global supply and demand of these materials, over which we have no or little control. We use long-term contracts (generally with fixed costs or formula based costs) to help ensure availability and continuity of supply, and to manage the risk of cost increases. We have entered into hedging arrangements for certain raw materials, but do not typically enter into hedging arrangements for all raw materials, chemicals or energy costs. Should the costs of raw materials, chemicals or energy increase, and should we not be able to pass on these cost increases to our customers, then operating margins and cash flows from operating activities would be adversely impacted. Should raw material costs increase significantly, then the Company’s need for working capital could similarly increase. Any of these risks could adversely impact our results of operations, financial position and cash flows. 46 Table of Contents Report of Independent Registered Public Accounting Firm To the Board of Directors and Stockholders of Innospec Inc.: We have audited the accompanying consolidated balance sheet of Innospec Inc. and its subsidiaries (“Innospec”) as of December 31, 2011, and the related consolidated statements of income, comprehensive income/(loss) and accumulated other comprehensive loss, cash flows and stockholders’ equity for the year then ended. We also have audited Innospec’s internal control over financial reporting as of December 31, 2011, based on criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Innospec’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in “Management’s Report on Internal Control Over Financial Reporting” appearing in item 9A of the Form 10-K. Our responsibility is to express an opinion on these consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audit of the consolidated financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements. 47 Item 8 Financial Statements and Supplementary Data Table of Contents Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Innospec as of December 31, 2011, and the results of its operations and its cash flows for the year then ended, in conformity with U.S. generally accepted accounting principles. Also in our opinion, Innospec maintained, in all material respects, effective internal control over financial reporting as of December 31, 2011, based on criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. /s/ KPMG Audit Plc Manchester, United Kingdom February 17, 2012 48 Table of Contents Report of Independent Registered Public Accounting Firm To the Board of Directors and Stockholders of Innospec Inc.: In our opinion, the accompanying consolidated balance sheet as of December 31, 2010 and the related consolidated statements of income, stockholders’ equity, comprehensive income/(loss) and accumulated other comprehensive loss, and cash flows for each of two years in the period ended December 31, 2010 present fairly, in all material respects, the financial position of Innospec Inc. and its subsidiaries at December 31, 2010, and the results of their operations and their cash flows for each of the two years in the period ended December 31, 2010, in conformity with accounting principles generally accepted in the United States of America. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. /s/ PricewaterhouseCoopers LLP Manchester, United Kingdom February 18, 2011 49 Table of Contents CONSOLIDATED STATEMENTS OF INCOME ( in millions, except share and per share data ) The accompanying notes are an integral part of these statements. 50 Years ended December 31 2011 2010 2009 Net sales $ 774.4 $ 683.2 $ 598.5 Cost of goods sold (548.0 ) (469.1 ) (412.3 ) Gross profit 226.4 214.1 186.2 Operating expenses: Selling, general and administrative (155.9 ) (113.5 ) (144.1 ) Research and development (18.3 ) (17.6 ) (16.4 ) Restructuring charge (0.6 ) (8.7 ) (2.8 ) Impairment of Octane Additives segment goodwill (2.0 ) (2.2 ) (2.2 ) Profit on disposal, net 0.0 0.1 0.0 Total operating expenses (176.8 ) (141.9 ) (165.5 ) Operating income 49.6 72.2 20.7 Other net income 6.3 3.1 3.6 Interest expense (3.9 ) (5.1 ) (6.3 ) Interest income 0.6 0.5 0.3 Income before income taxes 52.6 70.7 18.3 Income taxes (3.7 ) 3.0 (11.9 ) Net income $ 48.9 $ 73.7 $ 6.4 Earnings per share: Basic $ 2.07 $ 3.10 $ 0.27 Diluted $ 1.99 $ 2.97 $ 0.26 Weighted average shares outstanding (in thousands): Basic 23,568 23,756 23,642 Diluted 24,520 24,814 24,714 Dividend declared per common share $ 0.00 $ 0.00 $ 0.05 Table of Contents CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS) ( in millions ) The accompanying notes are an integral part of these statements. 51 Total comprehensive income/(loss) for the years ended December 31 2011 2010 2009 Net income $ 48.9 $ 73.7 $ 6.4 Changes in cumulative translation adjustment (3.9 ) (15.6 ) 6.6 Changes in unrealized gains/(losses) on derivative instruments, net of tax of $0.3 million, $0.0 million and $(0.9) million, respectively (0.7 ) 0.0 2.3 Amortization of actuarial net losses, net of tax of $(0.1) million, $(1.4) million and $0.0 million, respectively 0.2 3.8 0.0 Gain on pension plan amendment, net of tax of $0.0 million, $(4.8) million and $0.0 million, respectively 0.0 12.3 0.0 Deferred taxes (2.6 ) (2.3 ) 0.0 Amortization of prior service credit, net of tax of $0.4 million, $0.3 million and $0.0 million, respectively (0.9 ) (0.6 ) 0.0 Actuarial net gains/(losses) arising during the year, net of tax of $(6.6) million, $(26.6) million and $35.0 million, respectively 19.5 71.9 (89.8 ) Total comprehensive income/(loss) $ 60.5 $ 143.2 $ (74.5 ) ACCUMULATED OTHER COMPREHENSIVE LOSS ( in millions ) Accumulated other comprehensive loss for the years ended December 31 2011 2010 2009 Cumulative translation adjustment $ (42.1 ) $ (38.2 ) $ (22.6 ) Unrealized gains on derivative instruments, net of tax of $0.0 million, $(0.3) million and $(0.3) million, respectively 0.2 0.9 0.9 Unrecognized actuarial net losses, net of tax of $26.0 million, $34.9 million and $69.7 million, respectively (78.1 ) (94.3 ) (179.4 ) Accumulated other comprehensive loss $ (120.0 ) $ (131.6 ) $ (201.1 ) (1) Impact on deferred taxes of a change in the associated tax rate on the unrecognized actuarial net losses of $164.6 million (net of deferred taxes of $64.1 million) previously recognized in other comprehensive loss. (2) Impact on deferred taxes of a change in the associated tax rate on the unrecognized actuarial net losses of $94.8 million (net of deferred taxes of $35.1 million) previously recognized in other comprehensive loss. (1), (2) Table of Contents CONSOLIDATED BALANCE SHEETS ( in millions, except share and per share data ) At December 31 2011 2010 Assets Current assets: Cash and cash equivalents $ 76.2 $ 107.1 Short-term investments 4.8 4.2 Trade and other accounts receivable (less allowances of $2.0 and $2.1, respectively) 99.4 84.2 Inventories (less allowances of $6.6 and $5.0, respectively): Finished goods 81.3 78.2 Work in progress 1.4 1.8 Raw materials 53.2 42.3 Total inventories 135.9 122.3 Prepaid expenses 4.0 4.1 Total current assets 320.3 321.9 Property, plant and equipment 45.9 48.7 Goodwill 141.5 143.6 Intangible assets 17.7 19.0 Deferred finance costs 1.7 0.5 Deferred tax assets 19.7 13.8 Pension asset 21.4 0.0 Other non-current assets 0.6 1.9 Total assets $ 568.8 $ 549.4 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 53.3 $ 45.9 Current portion of accrued liabilities 77.0 85.7 Accrued income taxes 2.0 6.1 Current portion of long-term debt 5.0 15.0 Current portion of plant closure provisions 4.1 3.9 Current portion of unrecognized tax benefits 3.2 2.2 Current portion of deferred income 1.4 0.1 Total current liabilities 146.0 158.9 Accrued liabilities, net of current portion 4.9 13.6 Long-term debt, net of current portion 30.0 32.0 Plant closure provisions, net of current portion 24.5 23.6 Unrecognized tax benefits, net of current portion 9.4 6.4 Deferred tax liabilities 2.9 1.1 Pension liability 6.3 11.7 Other non-current liabilities 0.8 0.5 Deferred income, net of current portion 0.9 0.9 Commitments and contingencies 0.0 0.0 Stockholders’ Equity Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares 0.3 0.3 Additional paid-in capital 291.5 286.3 Treasury stock (6,507,081 and 5,851,298 shares at cost, respectively) (88.1 ) (64.8 ) Retained earnings 259.4 210.5 Accumulated other comprehensive loss (120.0 ) (131.6 ) Total stockholders’ equity 343.1 300.7 Total liabilities and stockholders’ equity $ 568.8 $ 549.4 The accompanying notes are an integral part of these statements. 52 Table of Contents CONSOLIDATED STATEMENTS OF CASH FLOWS ( in millions ) Amortization of deferred finance costs of $0.5 million (2010 – $1.4 million, 2009 – $2.0 million) for the year are included in depreciation and amortization in the cash flow statement but in interest expense in the income statement. Cash payments/receipts in respect of income taxes and interest are disclosed in Note 7 and Note 13, respectively. Years ended December 31 2011 2010 2009 Cash Flows from Operating Activities Net income $ 48.9 $ 73.7 $ 6.4 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 14.4 15.4 18.4 Impairment of Octane Additives segment goodwill 2.0 2.2 2.2 Deferred taxes (4.0 ) (14.9 ) (2.4 ) Profit on disposal of property, plant and equipment, net 0.0 (0.1 ) 0.0 Non-cash issue of promissory note in civil complaint settlement 15.0 0.0 0.0 Non-cash issue of treasury stock in civil complaint settlement 5.0 0.0 0.0 Changes in working capital: Trade and other accounts receivable (15.3 ) 4.8 1.2 Inventories (14.3 ) (2.3 ) 18.9 Prepaid expenses 0.0 (0.2 ) 0.5 Accounts payable and accrued liabilities (13.7 ) (11.5 ) 53.1 Excess tax benefit from stock based payment arrangements (1.1 ) 0.0 (0.1 ) Accrued income taxes (4.1 ) (0.1 ) 16.5 Movement on plant closure provisions 1.1 (0.8 ) 1.5 Cash contributions to defined benefit pension plan (9.5 ) (15.6 ) (6.2 ) Non-cash expense of defined benefit pension plan 1.0 19.0 6.4 Stock option compensation 3.1 0.8 1.5 Movements on other non-current assets and liabilities 6.2 (12.2 ) (30.5 ) Net cash provided by operating activities 34.7 58.2 87.4 Cash Flows from Investing Activities Capital expenditures (7.0 ) (8.8 ) (7.2 ) Capitalization of internally developed software and other costs (3.1 ) 0.0 0.0 Proceeds on disposal of property, plant and equipment 0.0 0.2 0.0 Purchase of short-term investments (5.0 ) (7.5 ) 0.0 Sale of short-term investments 4.4 3.3 0.0 Net cash (used in) investing activities (10.7 ) (12.8 ) (7.2 ) Cash Flows from Financing Activities Net receipt/(repayment) of revolving credit facility 13.0 6.0 (17.0 ) Repayment of term loan (40.0 ) (10.0 ) (55.0 ) Receipt of term loan 0.0 0.0 50.0 Refinancing costs (1.7 ) 0.0 (3.7 ) Excess tax benefit from stock based payment arrangements 1.1 0.0 0.1 Dividend paid 0.0 0.0 (1.2 ) Issue of treasury stock 0.7 0.2 0.2 Repurchase of common stock (28.1 ) (2.7 ) 0.0 Net cash (used in) financing activities (55.0 ) (6.5 ) (26.6 ) Effect of foreign currency exchange rate changes on cash 0.1 (0.4 ) 1.1 Net change in cash and cash equivalents (30.9 ) 38.5 54.7 Cash and cash equivalents at beginning of year 107.1 68.6 13.9 Cash and cash equivalents at end of year $ 76.2 $ 107.1 $ 68.6 The accompanying notes are an integral part of these statements. 53 Table of Contents CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (in millions) Common Stock Additional Paid-In Capital Treasury Stock Retained Earnings Accumulated Other Comprehensive Loss Total Stockholders’ Equity Balance at December 31, 2008 $ 0.3 $ 282.5 $ (64.9 ) $ 131.6 $ (120.2 ) $ 229.3 Net income 6.4 6.4 Dividend ($0.05 per share) (1.2 ) (1.2 ) Changes in cumulative translation adjustment 6.6 6.6 Changes in unrealized gains/(losses) on derivative instruments, net of tax 2.3 2.3 Treasury stock re-issued (0.2 ) 0.7 0.5 Stock option compensation 3.5 3.5 Actuarial net losses arising during the year, net of tax (89.8 ) (89.8 ) Balance at December 31, 2009 $ 0.3 $ 285.8 $ (64.2 ) $ 136.8 $ (201.1 ) $ 157.6 Net income 73.7 73.7 Changes in cumulative translation adjustment (15.6 ) (15.6 ) Changes in unrealized gains/(losses) on derivative instruments, net of tax 0.0 0.0 Treasury stock re-issued 2.1 2.1 Treasury stock repurchased (2.7 ) (2.7 ) Stock option compensation 0.5 0.5 Amortization of actuarial net losses, net of tax 3.8 3.8 Gain on pension plan amendment, net of tax 12.3 12.3 Deferred taxes (2.3 ) (2.3 ) Amortization of prior service credit, net of tax (0.6 ) (0.6 ) Actuarial net gains arising during the year, net of tax 71.9 71.9 Balance at December 31, 2010 $ 0.3 $ 286.3 $ (64.8 ) $ 210.5 $ (131.6 ) $ 300.7 Net income 48.9 48.9 Changes in cumulative translation adjustment (3.9 ) (3.9 ) Changes in unrealized gains/(losses) on derivative instruments, net of tax (0.7 ) (0.7 ) Treasury stock re-issued 0.9 4.8 5.7 Treasury stock repurchased (28.1 ) (28.1 ) Stock option compensation 4.3 4.3 Amortization of actuarial net losses, net of tax 0.2 0.2 Deferred taxes (2.6 ) (2.6 ) Amortization of prior service credit, net of tax (0.9 ) (0.9 ) Actuarial net gains arising during the year, net of tax 19.5 19.5 Balance at December 31, 2011 $ 0.3 $ 291.5 $ (88.1 ) $ 259.4 $ (120.0 ) $ 343.1 (1) (2)  The accompanying notes are an integral part of these statements. 54 (1) Impact on deferred taxes of a change in the associated tax rate on the unrecognized actuarial net losses of $164.6 million (net of deferred taxes of $64.1 million) previously recognized in other comprehensive loss. (2) Impact on deferred taxes of a change in the associated tax rate on the unrecognized actuarial net losses of $94.8 million (net of deferred taxes of $35.1 million) previously recognized in other comprehensive loss. Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS Note 1. Nature of Operations Innospec develops, manufactures, blends and markets fuel additives, personal care and fragrance products and other specialty chemicals. Our products are sold primarily to oil refineries, personal care and fragrance companies, and other chemical and industrial companies throughout the world. Our fuel additives help improve fuel efficiency, boost engine performance and reduce harmful emissions. Our specialty chemicals provide effective technology-based solutions for our customers’ processes or products focused in the Personal Care; Household, Industrial & Institutional; and Fragrance Ingredients markets. Principal product lines and reportable segments are Fuel Specialties, Active Chemicals and Octane Additives. See Note 3 for financial information on the Company’s reportable segments. Certain revisions have been made, as of and for the year ended December 31, 2011, to the accounting and disclosure of our defined benefit pension plan covering a number of our German employees. These revisions have resulted in a $0.4 million benefit, net of tax of $0.2 million, to the income statement for the year ended December 31, 2011 in respect of actuarial net losses for the two years ended December 31, 2010 previously recognized in the income statement. Prior year comparatives have not been conformed to current year classifications. Note 2. Accounting Policies Basis of preparation: The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America and include all subsidiaries of the Company where the Company has a controlling financial interest. All significant intercompany accounts and balances have been eliminated upon consolidation. All acquisitions are accounted for as purchases and the results of operations of the acquired businesses are included in the consolidated financial statements from the date of acquisition. Use of estimates: The preparation of the consolidated financial statements, in accordance with generally accepted accounting principles in the United States of America, requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Cash equivalents: Investment securities with maturities of three months or less when purchased are considered to be cash equivalents. Short-term investments: Investment securities with maturities of more than 3 months and less than 12 months when purchased are considered to be short-term investments. Trade and other accounts receivable: The Company records trade and other accounts receivable at net realizable value and maintains allowances for customers not making required 55 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) payments. The Company determines the adequacy of allowances by periodically evaluating each customer receivable considering our customer’s financial condition, credit history and current economic conditions. Inventories: Inventories are stated at the lower of cost (FIFO method) or net realizable value. Cost includes materials, labor and an appropriate proportion of plant overheads. The Company accrues volume discounts where it is probable that the required volume will be attained and the amount can be reasonably estimated. The discounts are recorded as a reduction in the cost of materials based on projected purchases over the period of the agreement. Inventories are adjusted for estimated obsolescence and written down to net realizable value based on estimates of future demand and market conditions. Property, plant and equipment: Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is provided over the estimated useful lives of the assets using the straight-line method and is allocated between cost of goods sold and operating expenses. The cost of additions and improvements are capitalized. Maintenance and repairs are charged to expenses. When assets are sold or retired the associated cost and accumulated depreciation are removed from the consolidated financial statements and any related gain or loss is included in earnings. The estimated useful lives of the major classes of depreciable assets are as follows: Goodwill and other intangible assets : Goodwill and other intangible assets deemed to have indefinite lives are not amortized but are subject to at least annual impairment tests based on projected post-tax cash flows discounted at the Company’s weighted average cost of capital. The annual measurement date for impairment testing of the goodwill relating to the Fuel Specialties and Active Chemicals segments is December 31. At this date we performed annual impairment tests and concluded that there had been no impairment of goodwill in respect of those reporting segments. Octane Additives segment goodwill is tested for impairment at the end of each quarter. As expected the decline in the Octane Additives market has resulted in quarterly impairment charges being incurred from the first quarter of 2004 onwards. It is highly likely that further quarterly charges will be incurred in future years as the market continues to decline. The Company capitalizes software development costs, including licenses, subsequent to the establishment of technological feasibility. Other intangible assets deemed to have finite lives, including software development costs and licenses, are amortized using the straight-line method over their estimated useful lives and tested for any potential impairment when events occur or circumstances change which suggest that an impairment may have occurred. Deferred finance costs: The costs relating to debt financing are capitalized, separately disclosed in the consolidated balance sheets and amortized using the effective interest method over the expected life of the debt financing facility. 56 Buildings 7 to 25 years Equipment 3 to 10 years Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Impairment of long-lived assets : The Company reviews the carrying value of its long-lived assets, including buildings and equipment, whenever changes in circumstances suggest that the carrying values may be impaired. In order to facilitate this test the Company groups together assets at the lowest possible level for which cash flow information is available. Undiscounted future cash flows expected to result from the assets are compared with the carrying value of the assets and if they are lower an impairment loss may be recognized. The amount of the impairment loss is the difference between the fair value and the carrying value of the assets. Fair values are determined using post-tax cash flows discounted at the Company’s weighted average cost of capital. Derivative instruments: The Company uses various derivative instruments including forward currency contracts, options, interest rate swaps and commodity swaps to manage certain exposures. These instruments are entered into under the Company’s corporate risk management policy to minimize exposure and are not for speculative trading purposes. The Company recognizes all derivatives as either non-current assets or liabilities in the consolidated balance sheet and measures those instruments at fair value. Changes in the fair value of derivatives that are not designated as hedges, or do not meet the requirements for hedge accounting, are recognized in earnings. Derivatives which are designated as hedges are tested for effectiveness on a quarterly basis, and marked to market. The ineffective portion of the derivative’s change in value is recognized in earnings. The effective portion is recognized in other comprehensive income until the hedged item is recognized in earnings. Environmental compliance and remediation : Environmental compliance costs include ongoing maintenance, monitoring and similar costs. We recognize, at fair value, environmental liabilities when they are probable and costs can be reasonably estimated, and asset retirement obligations when there is a legal obligation and costs can be reasonably estimated. Such accruals are adjusted as further information develops or circumstances change. Costs of future obligations are discounted to their present values using the Company’s credit-adjusted risk-free rate. Revenue recognition: The Company supplies products to customers from its various manufacturing sites, and in some instances from containers held on customer sites, under a variety of standard shipping terms and conditions. In each case revenue is recognized when the transfer of legal title, which is defined and generally accepted in the standard terms and conditions, arises between the Company and the customer. Provisions for sales discounts and rebates to customers are based upon the terms of sales contracts and are recorded in the same period as the related sales as a deduction from revenue. The Company estimates the provision for sales discounts and rebates based on the terms of each agreement at the time of shipping. Components of net sales: All amounts billed to customers relating to shipping and handling are classified as net sales. Shipping and handling costs incurred by the Company are classified as cost of goods sold. 57 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Components of cost of goods sold: Cost of goods sold is comprised of raw material costs including inbound freight, duty and non-recoverable taxes, inbound handling costs associated with the receipt of raw materials, packaging materials, manufacturing costs including labor costs, maintenance and utility costs, plant and engineering overheads, amortization expense for certain intangible assets, warehousing and outbound shipping costs and handling costs. Inventory losses and provisions and the costs of customer claims are also recognized in the cost of goods line item. Components of selling, general and administrative expenses: Selling expenses comprise the costs of the direct sales force, and the sales management and customer service departments required to support them. It also comprises commission charges, the costs of sales conferences and trade shows, the cost of advertising and promotions, amortization expense for certain intangible assets, and the cost of bad and doubtful debts. General and administrative expenses comprise the cost of support functions including accounting, human resources, information technology and the cost of group functions including corporate management, finance, tax, treasury, investor relations and legal departments. Provision of management’s best estimate of legal and settlement costs for litigation in which the Company is involved is made and reported in the administrative expense line item. Research and development expenses: Research, development and testing costs are expensed to the income statement as incurred. Earnings per share : Basic earnings per share is based on the weighted average number of common shares outstanding during the period. Diluted earnings per share includes the effect of options that are dilutive and outstanding during the period. Foreign currencies: The Company’s policy is that exchange differences arising on the translation of the balance sheets of entities that have functional currencies other than the U.S. dollar are taken to a separate equity reserve, the cumulative translation adjustment. In entities where the U.S. dollar is the functional currency no gains or losses on translation occur. In these entities gains or losses on monetary assets relating to currencies other than the U.S. dollar are taken to the income statement. Gains or losses on foreign currency translations are included in other net income/(expense) in the income statement. Share based compensation plans: The Company accounts for employee stock options under the fair value method. Accordingly, share based compensation is measured at the grant date based on the fair value of the options. The Company uses the straight-line attribution method to recognize share based compensation costs over the service period of the option. Pension plans and other post-employment benefits: The Company recognizes the funded status of defined benefit post-retirement plans on the consolidated balance sheets, and changes in the funded status in comprehensive income. The measurement date of the plan’s funded status is the same as the Company’s fiscal year-end. 58 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Income taxes: The Company provides for income taxes by recognizing deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement carrying amounts and the relevant tax bases of the assets and liabilities. When appropriate, the Company evaluates the need for a valuation allowance to reduce deferred tax assets. The Company recognizes future tax benefits to the extent that realization of such benefits is more likely than not. The effect on deferred taxes of a change in tax rates is recognized in the period that includes the enactment date. Income tax positions must meet a more likely than not recognition criteria to be recognized. The Company recognizes accrued interest and penalties associated with uncertain tax positions as part of income taxes in our consolidated statements of income. Note 3. Segmental Reporting and Geographical Area Data Innospec divides its business into three segments for management and reporting purposes: Fuel Specialties, Active Chemicals and Octane Additives. The Fuel Specialties and Active Chemicals segments operate in markets where we actively seek growth opportunities but their end customers are different. The Octane Additives segment is generally characterized by volatile and declining demand. In 2011 the Company had a significant customer in the Fuel Specialties segment, Royal Dutch Shell plc and its affiliates (“Shell”), who accounted for $78.7 million (10%) of net group sales. In 2010 and 2009, Shell accounted for $67.8 million (10%) and $76.1 million (13%) of net group sales, respectively. 59 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) The Company evaluates the performance of its segments based on operating income. The following table analyzes sales and other financial information by the Company’s reportable segments: The pension charge relates to the United Kingdom defined benefit pension plan which is closed to future service accrual. The charges related to our other much smaller pension arrangements in the U.S. and overseas are included in the segment and income statement captions consistent with the related employees’ costs. The Company includes within the corporate costs line item the costs of: (in millions) 2011 2010 2009 Net sales Fuel Specialties $ 521.2 $ 458.1 $ 422.7 Active Chemicals 177.0 152.7 130.2 Octane Additives 76.2 72.4 45.6 $ 774.4 $ 683.2 $ 598.5 Gross profit Fuel Specialties $ 149.3 $ 145.9 $ 146.0 Active Chemicals 40.6 33.3 26.0 Octane Additives 36.5 34.9 14.2 $ 226.4 $ 214.1 $ 186.2 Operating income Fuel Specialties $ 81.7 $ 77.6 $ 81.4 Active Chemicals 22.6 16.7 8.8 Octane Additives (22.4 ) 25.8 (44.8 ) Pension charge (0.5 ) (10.8 ) (6.4 ) Corporate costs (29.2 ) (26.3 ) (13.3 ) Restructuring charge (0.6 ) (8.7 ) (2.8 ) Impairment of Octane Additives segment goodwill (2.0 ) (2.2 ) (2.2 ) Profit on disposal, net 0.0 0.1 0.0 Total operating income $ 49.6 $ 72.2 $ 20.7 Identifiable assets at year end Fuel Specialties $ 281.5 $ 260.4 $ 247.6 Active Chemicals 106.7 104.8 103.2 Octane Additives 51.5 65.9 79.5 Corporate 129.1 118.3 112.8 $ 568.8 $ 549.4 $ 543.1 60 • managing the Group as a company with securities listed on the NASDAQ and registered with the SEC; Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) • the President/CEO’s office, group finance, group human resources, group legal and compliance counsel, and investor relations; • running the corporate offices in the U.S. and Europe; • the corporate development function since they do not relate to the current trading activities of our other reporting segments; and Sales by geographic area are reported by source (where the transactions originate) and by destination (where the final sales to customers are made). Intercompany sales are priced to recover cost plus an appropriate mark-up for profit and are eliminated in the consolidated financial statements. Identifiable assets are those directly associated with the operations of the geographical area. Goodwill has not been allocated by geographical location on the grounds that it would be impracticable to do so. 61 • the corporate share of the information technology, accounting and human resources departments. (in millions) 2011 2010 2009 Net sales by source United States $ 265.6 $ 238.4 $ 217.0 United Kingdom 482.8 431.8 356.2 Rest of Europe 151.7 106.8 84.8 Other 0.9 0.7 0.3 Sales between areas (126.6 ) (94.5 ) (59.8 ) $ 774.4 $ 683.2 $ 598.5 Net sales by destination United States $ 248.2 $ 231.4 $ 222.0 United Kingdom 48.5 26.8 21.1 Rest of Europe 304.2 235.1 219.5 Other 173.5 189.9 135.9 $ 774.4 $ 683.2 $ 598.5 Income before income taxes United States $ (42.6 ) $ 11.1 $ (44.8 ) United Kingdom 39.0 25.5 52.4 Rest of Europe 58.2 36.6 12.8 Other 0.0 (0.3 ) 0.1 Impairment of Octane Additives segment goodwill (2.0 ) (2.2 ) (2.2 ) $ 52.6 $ 70.7 $ 18.3 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Note 4. Share Based Compensation Plans The Company has five active stock option plans, two of which provide for the grant of stock options to employees, one provides for the grant of stock options to non-employee directors, and another provides for the grant of stock options to key executives on a matching basis provided they use a proportion of their annual bonus to purchase common stock in the Company on the open market or from the Company. The fifth plan is a savings plan which provides for the grant of stock options to all Company employees provided they commit to make regular savings over a pre-defined period which can then be used to purchase common stock upon vesting of the options. The stock options have vesting periods ranging from 24 months to 6 years and in all cases stock options granted expire within 10 years of the date of grant. All grants are at the sole discretion of the Compensation Committee of the Board of Directors. Grants may be priced at market value or at a premium or discount. The aggregate number of shares of common stock reserved for issuance which can be granted under the plans is 2,640,000. The fair value of the options above is calculated using the Black-Scholes model. In some cases certain performance related options are dependent upon external factors such as the Company’s stock price. The fair value of these options is calculated using a Monte Carlo model. The following assumptions were used to determine the fair value of options calculated using the Black-Scholes model: 62 (in millions) 2011 2010 2009 Long-lived assets at year end United States $ 22.0 $ 16.7 $ 17.3 United Kingdom 32.4 40.1 47.6 Rest of Europe 10.9 11.6 11.4 $ 65.3 $ 68.4 $ 76.3 Identifiable assets at year end United States $ 123.2 $ 97.4 $ 112.8 United Kingdom 253.8 255.5 225.4 Rest of Europe 49.8 52.4 58.3 Other 0.5 0.5 0.6 Goodwill 141.5 143.6 146.0 $ 568.8 $ 549.4 $ 543.1 2011 2010 2009 Dividend yield 0.2 % 1.0 % 2.5 % Expected life 5 years 5 years 5 years Volatility 78.3 % 82.3 % 76.5 % Risk free interest rate 1.22 % 1.36 % 1.24 % Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) The following table summarizes the transactions of the Company’s stock option plans for the year ended December 31, 2011: The following table summarizes information about options outstanding at December 31, 2011: The aggregate intrinsic value of fully vested stock options was $0.6 million. Of the 109,430 stock options that are exercisable, 25,084 have performance conditions attached. The total compensation cost for 2011, 2010 and 2009 was $3.1 million, $3.1 million and $1.5 million, respectively. In 2009, this charge included a gain of $2.4 million related to the gain on stock options forfeited upon resignation of the Company’s former CEO. The total compensation cost related to non-vested stock options not yet recognized at December 31, 2011 was $3.6 million and this cost is expected to be recognized over the weighted-average period of 1.45 years. No stock options awards were modified in 2011 or 2010. On February 13, 2009, we extended the vesting period for 132,470 grants made under a key employee performance related stock option plan from February 13, 2009 to February 13, 2011, and modified the performance criteria to reflect the longer vesting period. Additional compensation cost of $0.2 million was required to be recognized for these modified stock options in the period February 13, 2009 to February 13, 2011. 63 Number of Shares Weighted Average Exercise Price Weighted Average Fair Value Options outstanding at December 31, 2010 1,517,481 $ 4.74 Granted – at discount 19,085 $ 0.00 $ 29.45 – at market value 9,680 $ 27.89 $ 17.72 Exercised (233,867 ) $ 3.01 Forfeitures (15,126 ) $ 3.94 Expired (68,033 ) $ 0.13 Options outstanding at December 31, 2011 1,229,220 $ 5.44 Range of Exercise Price Number Outstanding Weighted Average Remaining Life in Years Weighted Average Exercise Price Number Exercisable and Fully Vested Weighted Average Remaining Life in Years Weighted Average Exercise Price $0 - $5 751,826 7.55 $ 0.82 40,884 5.84 $ 0.00 $5 - $10 26,970 3.45 $ 9.66 26,970 3.45 $ 9.66 $10 - $15 399,168 3.07 $ 11.47 0 0.00 $ 0.00 $20 - $25 25,456 6.16 $ 20.38 25,456 6.16 $ 20.38 $25 - $30 24,420 6.51 $ 27.09 16,120 5.15 $ 27.09 $30 - $35 1,380 9.37 $ 32.60 0 0.00 $ 0.00 1,229,220 109,430 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) The total intrinsic value of options exercised in 2011, 2010 and 2009 was $2.2 million, $3.7 million and $0.4 million, respectively. The amount of cash received from the exercise of stock option awards in 2011, 2010 and 2009 was $0.7 million, $0.2 million and $0.2 million, respectively. The Company’s policy is to issue shares from treasury stock to holders of stock options who exercise those options. During 2011, 2010 and 2009 the new total fair value of shares vested was $2.9 million, $4.4 million and $1.1 million, respectively. The total options vested in 2011 were 290,363 (2010 – 174,298, 2009 – 176,848). An additional long-term incentive plan is in place to reward selected executives for delivering exceptional performance. Under this plan a discretionary bonus will be payable to eligible executives if the Innospec share performance out-performs that of competitors, as measured by the Russell 2000 Index, by a minimum of 10% over the five years from January 2008 to December 2012. The amount of bonus which can be earned will be a set cash amount for each one percentage point of out-performance. The maximum bonus under this plan will be payable for an out-performance versus the Russell 2000 Index of 30%. The maximum bonus under this plan, in respect of the current participants, is $8 million (2010 – $8 million, 2009 – $8 million). No bonus is payable under this plan if the Innospec stock price does not out-perform the Russell 2000 Index by more than 10% over the five year period, or the Russell 2000 Index falls in value over the same period. The fair value of these liability cash-settled stock appreciation rights is calculated on a quarterly basis using a Monte Carlo model and summarized as follows: The following assumptions were used in the Monte Carlo model: 64 (in millions) 2011 2010 2009 Balance at January 1 $ 0.8 $ 0.2 $ 0.1 Compensation charge 1.4 0.6 0.1 Balance at December 31 $ 2.2 $ 0.8 $ 0.2 2011 2010 2009 Dividend yield 0.0 % 0.5 % 1.0 % Volatility 53.5 % 69.0 % 82.2 % Risk free interest rate 0.36 % 1.05 % 1.65 % Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Note 5. Earnings Per Share Basic earnings per share is based on the weighted average number of common shares outstanding during the period. Diluted earnings per share includes the effect of options that are dilutive and outstanding during the period. Per share amounts are computed as follows: In 2011, 2010 and 2009 the average number of anti-dilutive options excluded from the calculation of diluted earnings per share were 690, 61,808 and 146,325 respectively. Note 6. Pension Plans The Company maintains a defined benefit pension plan (the “Plan”) covering a number of its current and former employees in the United Kingdom, although it does also have other much smaller pension arrangements in the U.S. and overseas. The Plan is closed to future service accrual but has a large number of deferred and current pensioners. The Projected Benefit Obligation (“PBO”) is based on final salary and years of credited service reduced by social security benefits according to a plan formula. Normal retirement age is 65 but provisions are made for early retirement. The Plan’s assets are invested by two investment management companies in funds holding United Kingdom and overseas equities, United Kingdom and overseas fixed interest securities, index linked securities, property unit trusts and cash or cash equivalents. The trustees’ investment policy is to seek to achieve specified objectives through investing in a suitable mixture of real and monetary assets. The trustees recognize that the returns on real assets, while expected to be greater over the long-term than those on monetary assets, are likely to be more volatile. A mixture across asset classes should nevertheless provide the level of returns required by the Plan to meet its liabilities at an acceptable level of risk for the trustees and an acceptable level of cost to the Company. The Company closed the Plan to future service accrual with effect from March 31, 2010 and accordingly we recorded a non-cash curtailment loss of $8.2 million in the first quarter of 2010. During the second quarter of 2010 the Company implemented a pension increase exchange (“PIE”) program for current pensioners, effective April 1, 2010, which reduced the 65 2011 2010 2009 Numerator (in millions): Net income available to common stockholders $ 48.9 $ 73.7 $ 6.4 Denominator (in thousands): Weighted average common shares outstanding 23,568 23,756 23,642 Dilutive effect of stock options and awards 952 1,058 1,072 Denominator for diluted earnings per share 24,520 24,814 24,714 Net income per share, basic: $ 2.07 $ 3.10 $ 0.27 Net income per share, diluted: $ 1.99 $ 2.97 $ 0.26 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) PBO by $17.1 million. This reduction in PBO resulted in a prior service credit which is being amortized using the straight-line method over the remaining life expectancy of Plan pensioners of 15 years commencing April 1, 2010. The PIE program provided pensioners with the option of receiving a one-off immediate increase to their pension in lieu of future non-statutory increases. During the fourth quarter of 2010 the Company implemented an enhanced transfer value (“ETV”) program for deferred pensioners which reduced the PBO by $15.7 million and resulted in a settlement loss of $1.1 million. The ETV program provided deferred pensioners with the option of transferring their existing pension entitlement from the Plan to another vehicle in exchange for an enhancement to the standard terms available for such a transfer. A full triennial actuarial valuation of the Plan was performed as at December 31, 2008 and an update performed as at December 31, 2011, the results of which are reflected in these consolidated financial statements. Since April 2010 the Company has been contributing £5.8 million (approximately $9 million) per calendar year to the Plan in accordance with a 10-year actuarial deficit recovery plan agreed with the trustees. Accordingly, the Company expects its annual cash contribution for 2012 to be approximately $9 million. The discount rate used represents the annualized yield based on a cash flow matched methodology with reference to an AA corporate bond spot curve and having regard to the duration of the Plan’s liabilities. The inflation rate is derived using a similar cash flow matched methodology as used for the discount rate but having regard to the difference between yields on fixed interest and index linked United Kingdom government gilts. The rate 66 ( in millions ) 2011 2010 2009 Plan net pension charge: Service cost $ 1.6 $ 1.6 $ 3.7 Interest cost on PBO 36.6 40.8 38.9 Expected return on plan assets (36.7 ) (35.9 ) (36.2 ) Amortization of prior service credit (1.3 ) (0.9 ) 0.0 Amortization of actuarial net losses 0.3 5.2 0.0 $ 0.5 $ 10.8 $ 6.4 Plan assumptions (%): Discount rate 4.75 5.40 5.60 Inflation rate 2.15 2.80 3.60 Rate of increase in compensation levels 0.00 0.00 3.60 Rate of return on plan assets – overall 4.85 5.45 5.75 Rate of return on plan assets – equity securities 7.70 7.70 7.20 Rate of return on plan assets – debt securities 3.60 4.50 5.80 Plan asset allocation by category (%): Equity securities 29 27 26 Debt securities 66 73 74 Cash 5 0 0 100 100 100 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) of increase in compensation levels is no longer relevant since the Company closed the Plan to future service accrual with effect from March 31, 2010. A 0.25% change in the discount rate assumption would change the PBO by approximately $20 million and the net pension charge for 2012 by approximately $0.5 million. A 0.25% change in the level of price inflation assumption would change the PBO by approximately $16 million and the net pension charge for 2012 by approximately $1.9 million. Following guidance issued by the United Kingdom government during 2010, and agreement from the Plan trustees, the Company changed the inflation rate measure from the Retail Prices Index to the Consumers Prices Index resulting in a reduction in actuarial net losses on an accounting basis of approximately $47 million. The current investment strategy of the Plan is to obtain an asset allocation of 69% debt securities and 31% equity securities in order to achieve a more predictable return on assets. As at December 31, 2011 and 2010, approximately 70% of the Plan’s assets were held in index-tracking funds with one investment management company. Approximately 35% of the Plan’s assets were invested in United Kingdom government gilts. No more than 5% of the Plan’s assets were invested in any one individual company’s investment funds. Movements in PBO and fair value of Plan assets are as follows: 67 (in millions) 2011 2010 Change in PBO Opening balance $ 684.0 $ 796.0 Interest cost 36.6 40.8 Service cost 1.6 1.6 Benefits paid (45.7 ) (60.0 ) Plan amendments 0.0 (17.1 ) Curtailment loss 0.0 8.2 Settlement loss 0.0 1.1 Actuarial losses/(gains) 16.3 (61.0 ) Exchange effect (5.4 ) (25.6 ) Closing balance $ 687.4 $ 684.0 Fair value of plan assets Opening balance $ 672.3 $ 671.8 Actual benefits paid (45.7 ) (60.0 ) Actual contributions by employer 9.8 15.5 Actual return on assets 78.9 65.3 Exchange effect (6.5 ) (20.3 ) Closing balance $ 708.8 $ 672.3 Plan assets excess/(deficit) over PBO $ 21.4 $ (11.7 ) Unrecognized net loss 103.1 150.6 Amortization of actuarial net losses (0.3 ) (5.2 ) Plan amendments 0.0 (17.1 ) Amortization of prior service credit 1.3 0.9 Amount recognized in other comprehensive loss (104.1 ) (129.2 ) Pension asset/(liability) $ 21.4 $ (11.7 ) Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) The accumulated benefit obligation for the Plan was $687.4 million and $684.0 million at December 31, 2011 and 2010, respectively. For the vast majority of assets, a market approach is adopted to assess the fair value of the assets, with the inputs being the quoted market prices for the actual securities held in the relevant fund. For assets in which there is no ready market and for which no indicative dealer prices are available, fund assets are independently evaluated, with the use of agreed upon procedures conducted by an audit firm to provide independent confirmation that proper valuation procedures are being followed. The fair values of pension assets by level of input were as follows: 68 (in millions) Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total At December 31, 2011 Fixed income securities: Debt securities issued by U.S. government and government agencies $ 0.9 $ $ $ 0.9 Debt securities issued by non-U.S. governments and government agencies 221.0 221.0 Corporate debt securities 254.2 254.2 Residential mortgage-backed securities 0.2 0.2 Other asset-backed securities 2.2 2.2 Equity securities: Equity securities held for proprietary investment purposes 114.1 114.1 Real estate 26.1 26.1 Other assets 15.5 13.7 28.1 57.3 Total assets at fair value 634.2 13.7 28.1 676.0 Cash 32.8 32.8 Total plan assets $ 667.0 $ 13.7 $ 28.1 $ 708.8 At December 31, 2010 Fixed income securities: Debt securities issued by U.S. government and government agencies $ 1.7 $ $ $ 1.7 Debt securities issued by non-U.S. governments and government agencies 240.5 240.5 Corporate debt securities 248.9 248.9 Residential mortgage-backed securities 0.6 0.6 Commercial mortgage-backed securities 0.3 0.3 Other asset-backed securities 6.1 6.1 Equity securities: Equity securities held for proprietary investment purposes 108.2 108.2 Real estate 28.7 28.7 Other assets 11.3 23.3 34.6 Total assets at fair value 635.0 11.3 23.3 669.6 Cash 2.7 2.7 Total plan assets $ 637.7 $ 11.3 $ 23.3 $ 672.3 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) The reconciliation of the fair value of the Plan assets using significant unobservable inputs (Level 3) was as follows: The projected net pension credit for the year ending December 31, 2012 is as follows: The following benefit payments are expected to be made: 69 (in millions) Debt Securities Issued by Non-U.S. Government and Government Agencies Other Assets Total Balance at December 31, 2009 $ 3.4 $ 18.0 $ 21.4 Realized/unrealized (losses)/gains: Relating to assets still held at the reporting date (3.4 ) 2.9 (0.5 ) Purchases, issuances and settlements 5.3 5.3 Transfers in/(out) of Level 3 (2.2 ) (2.2 ) Exchange effect (0.7 ) (0.7 ) Balance at December 31, 2010 0.0 23.3 23.3 Realized/unrealized (losses)/gains: Relating to assets still held at the reporting date 1.0 1.0 Relating to assets sold during the period (0.5 ) (0.5 ) Purchases, issuances and settlements 4.5 4.5 Exchange effect (0.2 ) (0.2 ) Balance at December 31, 2011 $ 0.0 $ 28.1 $ 28.1 (in millions) Service cost $ 1.6 Interest cost on PBO 31.5 Expected return on plan assets (33.4 ) Amortization of prior service credit (1.2 ) Amortization of actuarial net losses 1.2 $ (0.3 ) (in millions) 2012 $ 43.4 2013 $ 44.0 2014 $ 44.8 2015 $ 45.5 2016 $ 46.3 2017 – 2021 $ 243.7 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) The Company also maintains a unfunded defined benefit pension plan covering a number of its current and former employees in Germany (the “German Plan”). The German Plan is closed to new entrants and has no assets. Movements in PBO of the German Plan are as follows: Company contributions to defined contribution schemes during 2011 were $6.6 million (2010 – $5.5 million). 70 (in millions) 2011 2010 2009 German Plan net pension charge: Service cost $ 0.2 $ 0.1 $ 0.1 Interest cost on PBO 0.3 0.3 0.3 $ 0.5 $ 0.4 $ 0.4 German Plan assumptions (%): Discount rate 5.00 5.00 5.50 Inflation rate 2.00 2.00 2.00 Rate of increase in compensation levels 2.75 2.75 2.75 (in millions) 2011 2010 Change in PBO Opening balance $ 6.3 $ 5.7 Service cost 0.2 0.1 Interest cost 0.3 0.3 Benefits paid (0.2 ) (0.1 ) Actuarial losses 0.0 0.6 Exchange effect (0.3 ) (0.3 ) Closing balance $ 6.3 $ 6.3 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Note 7. Income Taxes A roll-forward of unrecognized tax benefits and associated accrued interest and penalties is as follows: All of the $12.6 million of unrecognized tax benefits, and interest and penalties, would impact our effective tax rate if recognized. We recognize accrued interest and penalties associated with uncertain tax positions as part of income taxes in our consolidated statements of income. The Company determined that a portion of the NewMarket Corporation civil complaint settlement (see Note 18), and associated legal and other professional expenses, would be tax 71 (in millions) Interest and Penalties Unrecognized Tax Benefits Total Opening balance at January 1, 2009 $ 3.5 $ 31.3 $ 34.8 Additions related to tax positions taken in the current period 2.5 6.9 9.4 Additions for tax positions of prior periods 0.4 0.0 0.4 Exchange effect 0.2 1.2 1.4 Settlements (2.8 ) (23.8 ) (26.6 ) Closing balance at December 31, 2009 3.8 15.6 19.4 Current (1.0 ) (4.0 ) (5.0 ) Non-current $ 2.8 $ 11.6 $ 14.4 Opening balance at January 1, 2010 $ 3.8 $ 15.6 $ 19.4 Additions related to tax positions taken in the current period 0.0 0.0 0.0 Additions for tax positions of prior periods 0.1 2.0 2.1 Settlements (3.6 ) (9.3 ) (12.9 ) Closing balance at December 31, 2010 0.3 8.3 8.6 Current (0.2 ) (2.0 ) (2.2 ) Non-current $ 0.1 $ 6.3 $ 6.4 Opening balance at January 1, 2011 $ 0.3 $ 8.3 $ 8.6 Additions related to tax positions taken in the current period 0.0 5.2 5.2 Additions for tax positions of prior periods 0.2 0.5 0.7 Reductions for tax positions of prior periods (0.1 ) (1.8 ) (1.9 ) Closing balance at December 31, 2011 0.4 12.2 12.6 Current (0.3 ) (2.9 ) (3.2 ) Non-current $ 0.1 $ 9.3 $ 9.4 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) deductible and accordingly recorded a $5.0 million addition to unrecognized tax benefits. During the third quarter of 2011, an additional $0.2 million was recorded in respect of acquisition-related costs; and there was a $1.8 million reduction in unrecognized tax benefits, and $0.1 million for associated interest and penalties, due to the expiration of applicable statutes of limitations for certain tax years. In the fourth quarter of 2011, the Company recorded a further $0.6 million addition for tax positions of prior periods in relation to U.S. state taxes and accrued interest. The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction, and various state and foreign jurisdictions. As at December 31, 2011, the Company’s subsidiaries in the U.S. are subject to state tax audits in various states and the Company’s German subsidiaries are subject to tax audits in Germany. The Company does not currently anticipate that adjustments, if any, arising out of these tax audits would result in a material change to its financial position as at December 31, 2011. The Company and its U.S. subsidiaries remain open to examination by the IRS for years 1998 to 2004 and 2007 onwards due to the net operating losses in the period 1998 to 2002, although no examination is currently underway. The Company’s subsidiaries in foreign tax jurisdictions are open to examination including France (2009 onwards), Germany (2006 onwards), Switzerland (2010 onwards) and the United Kingdom (2008 onwards). The sources of income before income taxes were as follows: The components of income tax charges are summarized as follows: Cash payments for income taxes were $18.1 million, $22.9 million and $8.6 million during 2011, 2010 and 2009, respectively. 72 (in millions) 2011 2010 2009 Domestic $ (42.6 ) $ 11.1 $ 8.3 Foreign 95.2 59.6 10.0 $ 52.6 $ 70.7 $ 18.3 (in millions) 2011 2010 2009 Current: Federal $ 5.4 $ 7.2 $ 2.0 Foreign 13.6 4.0 10.4 19.0 11.2 12.4 Deferred: Federal (12.8 ) (9.0 ) 0.3 Foreign (2.5 ) (5.2 ) (0.8 ) (15.3 ) (14.2 ) (0.5 ) $ 3.7 $ (3.0 ) $ 11.9 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) The effective tax rate varies from the U.S. federal statutory rate because of the factors indicated below: Significant factors affecting the variation to statutory rate are set out above and include foreign income inclusions net of foreign tax credits. There was an unfavorable impact from an increase in the Company’s unrecognized tax benefits position primarily in respect of the NewMarket Corporation civil complaint settlement. There was a favorable impact from the 2% reduction in the United Kingdom’s corporate tax rate primarily in respect of the unrecognized actuarial net losses associated with the United Kingdom defined benefit pension plan. The mix of taxable profits generated in the different geographical localities in which the Group operates had a significant positive impact on the effective tax rate in 2011. 73 2011 2010 2009 Statutory rate 35.0 % 35.0 % 35.0 % Foreign income inclusions 20.5 7.1 23.0 Impairment of Octane Additives segment goodwill 1.3 1.1 4.3 Foreign tax credits (25.8 ) (7.1 ) (18.8 ) Pension charge (8.9 ) 0.5 (8.0 ) Foreign tax rate differential (19.1 ) (13.5 ) (18.8 ) Unrecognized net operating losses 0.0 0.0 (10.5 ) Permanent tax adjustments 0.3 (2.1 ) 5.8 Amortization 0.7 1.7 (0.2 ) Tax (credit)/charge from previous years (1.9 ) (2.9 ) 65.1 Net charge/(credit) from unrecognized tax benefits 7.7 (15.3 ) (92.1 ) OFFP/FCPA settlement accrual 0.0 (5.6 ) 76.7 United Kingdom income tax rate reduction (4.8 ) (1.6 ) 0.0 Other items and adjustments, net 2.0 (1.5 ) 3.5 7.0 % (4.2 )% 65.0 % Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Details of deferred tax assets and liabilities are as follows: Details of the deferred tax asset valuation allowance are as follows: As a result of the Company’s assessment of its net deferred tax assets at December 31, 2011, the Company considers it more likely than not that no valuation allowance is required for $0.8 million (2010 – $0.6 million) of its net operating loss carry forwards and that a partial valuation allowance is required against its foreign tax credit carry forwards. 74 (in millions) 2011 2010 Deferred tax assets: Foreign tax credits $ 19.6 $ 13.5 Accrued expenses 8.8 7.7 Stock options 4.0 3.5 Excess of tax over book basis in property, plant and equipment 1.2 2.6 Net operating loss carry forwards 0.8 0.6 Pension liability 0.0 4.3 Other 5.5 5.3 39.9 37.5 Valuation allowance (7.5 ) (10.8 ) Total deferred tax assets 32.4 26.7 Deferred tax liabilities: Goodwill amortization (6.5 ) (4.7 ) Pension asset (5.4 ) 0.0 Intangible assets (1.5 ) (3.5 ) Other (2.2 ) (5.8 ) Total deferred tax liabilities (15.6 ) (14.0 ) Total net deferred tax asset $ 16.8 $ 12.7 Deferred taxes are included within the consolidated balance sheets as follows: Deferred tax assets $ 19.7 $ 13.8 Deferred tax liabilities (2.9 ) (1.1 ) $ 16.8 $ 12.7 (in millions) 2011 2010 2009 At January 1 $ (10.8 ) $ (4.4 ) $ (7.3 ) Change in foreign tax credits 3.3 (6.4 ) 1.0 Change in net operating loss carry forwards 0.0 0.0 1.9 At December 31 $ (7.5 ) $ (10.8 ) $ (4.4 ) Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) The net operating loss carry forwards arose in the U.S. in the current period and prior periods as a result of trading and state tax losses. It is expected that sufficient taxable profits will be generated against which these net operating loss carry forwards can be relieved. The foreign tax credit carry forwards arose in the U.S. in the current period and in prior periods. The Company has determined that future foreign income inclusions will be sufficient to utilize approximately $12.1 million (2010 – $2.7 million) of the foreign tax credit carry forwards prior to their expiration and therefore only a partial valuation allowance is required. Should it be determined in the future that it is no longer more likely than not that these assets will be realized, an additional valuation allowance would be required, and the Company’s operating results would be adversely affected during the period in which such a determination would be made. During 2011 a dividend of $40.5 million was remitted from the Company’s overseas subsidiaries to the U.S.. The dividend was one-off in nature and no future remittances are expected to be made. The Company is in a position to control whether or not to repatriate foreign earnings. No taxes have been provided for the unremitted earnings of our overseas subsidiaries as any tax basis differences relating to investments in these overseas subsidiaries are considered to be permanent in duration. The amount of unremitted earnings at December 31, 2011 and 2010 was approximately $665 million and $637 million, respectively. 75 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Note 8. Goodwill Goodwill comprises the following: (in millions) Fuel Specialties Active Chemicals Octane Additives Total At January 1, 2010 Gross cost $ 117.8 $ 30.4 $ 526.1 $ 674.3 Accumulated Octane Additives segment goodwill impairment losses 0.0 0.0 (229.8 ) (229.8 ) 117.8 30.4 296.3 444.5 Exchange effect (0.2 ) 0.0 0.0 (0.2 ) Impairment of Octane Additives segment goodwill 0.0 0.0 (2.2 ) (2.2 ) At December 31, 2010 117.6 30.4 294.1 442.1 Gross cost 117.6 30.4 526.1 674.1 Accumulated Octane Additives segment goodwill impairment losses 0.0 0.0 (232.0 ) (232.0 ) 117.6 30.4 294.1 442.1 Accumulated amortization – at January 1, 2010 (8.7 ) (0.3 ) (289.5 ) (298.5 ) Exchange effect 0.0 0.0 0.0 0.0 Accumulated amortization – at December 31, 2010 (8.7 ) (0.3 ) (289.5 ) (298.5 ) Net book amount – at December 31, 2010 $ 108.9 $ 30.1 $ 4.6 $ 143.6 At January 1, 2011 Gross cost $ 117.6 $ 30.4 $ 526.1 $ 674.1 Accumulated Octane Additives segment goodwill impairment losses 0.0 0.0 (232.0 ) (232.0 ) 117.6 30.4 294.1 442.1 Exchange effect (0.1 ) 0.0 0.0 (0.1 ) Impairment of Octane Additives segment goodwill 0.0 0.0 (2.0 ) (2.0 ) At December 31, 2011 117.5 30.4 292.1 440.0 Gross cost 117.5 30.4 526.1 674.0 Accumulated Octane Additives segment goodwill impairment losses 0.0 0.0 (234.0 ) (234.0 ) 117.5 30.4 292.1 440.0 Accumulated amortization – at January 1, 2011 (8.7 ) (0.3 ) (289.5 ) (298.5 ) Exchange effect 0.0 0.0 0.0 0.0 Accumulated amortization – at December 31, 2011 (8.7 ) (0.3 ) (289.5 ) (298.5 ) Net book amount – at December 31, 2011 $ 108.8 $ 30.1 $ 2.6 $ 141.5  76 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) The Company’s reporting units, the level at which goodwill is tested for impairment, are consistent with the reportable segments identified in Note 3: Fuel Specialties, Active Chemicals and Octane Additives. All of the components in each segment (including products, markets and competitors) have similar economic characteristics and therefore the segments reflect the lowest level at which operations and cash flows can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the Company. The Company tests goodwill annually for impairment, or between years if events occur or circumstances change which suggest that an impairment may have occurred. To determine the fair value of each of our segments we utilize a discounted cash flow methodology based on the forecasted future after-tax cash flows from operations for each since we believe this provides the best approximation of fair value. This methodology requires us to make assumptions and estimates including those in respect of future revenue growth and gross margins, which are based upon our long range plans, and the Company’s weighted average cost of capital. Our long range plans are regularly updated as part of our planning processes and are reviewed and approved by management and our Board of Directors. We assume terminal values for the Fuel Specialties and Active Chemicals reporting units which are added to the present value of the relevant forecasted future cash flows. We assume no terminal value for the Octane Additives reporting unit beyond its estimated future life. The discounted cash flow methodology does not assume a control premium. We use a discount rate equivalent to the Company’s weighted average cost of capital which is estimated by reference to the overall after-tax rate of return required by equity and debt market participants in the Company. We assign assets and liabilities, including deferred taxes and goodwill, to our reporting units if the asset or liability relates to the operations of that reporting unit and is included in determining the fair value of the reporting unit. Cash and debt obligations are excluded from the carrying value of our reporting units. In 2011 some of the assumptions and estimates underpinning our discounted cash flows were revised as part of our planning processes although the methodology was unchanged. The most significant revisions were that the Company’s weighted average cost of capital was changed to reflect the changing proportion of debt to equity funding of the Company and effective October 1, 2011, the Company extended its estimate for the future life of the Octane Additives segment from December 31, 2012 to December 31, 2013. The Company elected to perform its annual tests in respect of Fuel Specialties and Active Chemicals goodwill as at December 31 each year. At December 31, 2011 we had $108.8 million and $30.1 million of goodwill relating to our Fuel Specialties and Active Chemicals segments, respectively. At this date we performed annual impairment tests and concluded that there had been no impairment of goodwill in respect of those reporting segments. In light of the continuing decline in the Octane Additives market globally, as the Company makes sales of Octane Additives in each quarter, the remaining sales and corresponding cash flows that can be derived from the Octane Additives segment are reduced, and accordingly the fair value of the Octane Additives reporting unit is reduced. As a result, the Company determined that quarterly 77 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) impairment tests be performed from January 1, 2004 and any impairment charge arising be recognized in the relevant quarter. As a result of the Octane Additives impairment tests performed during 2011, 2010 and 2009 impairment charges of $2.0 million, $2.2 million and $2.2 million, respectively, have been recognized. These charges are non-cash in nature and have no impact on taxation. There is $2.6 million of goodwill remaining at December 31, 2011 which relates to the Octane Additives segment. Given the quantum and predictability of the remaining future cash flows from the Octane Additives segment, the Company expects goodwill impairment charges to be recognized in the income statement on an approximate straight-line basis to December 31, 2013. The table below presents the impact a change in the following significant assumptions would have had on our impairment charge recognized at December 31, 2011 (in respect of goodwill, other intangibles and property, plant and equipment) assuming all other assumptions and factors remained constant: We believe that the assumptions used in our annual and quarterly impairment tests are reasonable, but that they are judgmental, and variations in any of the assumptions may result in materially different calculations of impairment charges, if any. Note 9. Intangible Assets Intangible assets comprise the following: (in millions) Approximate Increase/(Decrease) to Impairment Charge Change Fuel Specialties Active Chemicals Octane Additives Credit-adjusted risk-free rate +10 % $ 0.0 $ 0.0 $ 0.5 Credit-adjusted risk-free rate -10 % 0.0 0.0 (0.5 ) After-tax cash flows +10 % 0.0 0.0 (4.7 ) After-tax cash flows -10 % $ 0.0 $ 0.0 $ 4.7 (in millions) 2011 2010 Gross cost – Ethyl $ 22.1 $ 22.1 – Technology 7.1 7.1 – Customer relationships 16.0 16.0 – Patents 2.9 2.9 – Internally developed software and other costs 3.1 0.0 51.2 48.1 Accumulated amortization – Ethyl (15.0 ) (13.1 ) – Technology (5.3 ) (4.6 ) – Customer relationships (11.2 ) (9.7 ) – Patents (2.0 ) (1.7 ) – Internally developed software and other costs 0.0 0.0 (33.5 ) (29.1 ) $ 17.7 $ 19.0 78 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Ethyl An intangible asset of $28.4 million was recognized in the second quarter of 2007 in respect of Ethyl foregoing their entitlement effective April 1, 2007 to a share of the future income stream under the sales and marketing agreements to market and sell TEL. In 2008, contract provisions no longer deemed necessary of $6.3 million were offset against the intangible asset. The amount attributed to the Octane Additives reporting segment was being amortized straight-line to December 31, 2012 and the amount attributed to the Fuel Specialties reporting segment is being amortized straight-line to December 31, 2017. Effective October 1, 2011, the Company extended its estimate for the future life of the Octane Additives segment from December 31, 2012 to December 31, 2013 and therefore prospectively adjusted the amortization period for the amount attributed to the Octane Additives segment. An amortization expense of $1.9 million was recognized in 2011 (2010 – $2.1 million) in cost of goods sold. Technology Following the acquisition of the remaining 50% of Innospec Fuel Specialties LLC on July 8, 2004, the Company recognized an intangible asset of $2.3 million in respect of various technological approvals the business has received from certain military and civilian authorities. The approvals act as a barrier to entry to any potential competitor in the market who would wish to supply these products. An intangible asset of $4.8 million was recognized in respect of a number of specialized manufacturing processes carried out by Innospec Widnes Limited following the acquisition of that entity in August 2004. Both of these assets have an expected life of 10 years and are being amortized on a straight-line basis over this period. No residual value is anticipated. An amortization expense of $0.7 million was recognized in 2011 (2010 – $0.7 million) in cost of goods sold. Customer relationships Following the acquisition of Finetex (now merged into Innospec Active Chemicals LLC) in January 2005, the Company recognized an intangible asset totaling $7.1 million, $4.2 million of which was in relation to customer lists acquired. This asset has an expected life of 13 years and is being amortized on a straight-line basis over this period. No residual value is anticipated. Intangible assets were recognized in 2004 in respect of both the Innospec Fuel Specialties LLC ($9.0 million) and Innospec Widnes Limited ($2.8 million) acquisitions, and relate to ongoing customer relationships. These have an expected life of 10 years and are being amortized on a straight-line basis over that period. No residual value is anticipated. An amortization expense of $1.5 million was recognized in 2011 (2010 – $1.6 million) in selling, general and administrative expenses. 79 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Patents Following the acquisition of Finetex, the Company recognized an intangible asset of $2.9 million in respect of patents and trademarks. These have an expected life of 10 years and are being amortized on a straight-line basis over that period. An amortization expense of $0.3 million was recognized in 2011 (2010 – $0.3 million) in cost of goods sold. The aggregate intangible asset amortization expense was $4.4 million, $4.7 million and $4.7 million in 2011, 2010 and 2009, respectively, of which $2.9 million, $3.1 million and $3.1 million, respectively, was recognized in cost of goods sold, and the remainder was recognized in selling, general and administrative expenses. Future amortization expense is estimated to be $4.1 million per annum for 2012 and 2013, and $3.0 million per annum for 2014. Internally developed software and other costs We are continuing with the implementation of a new, company-wide, information system platform. The platform provider is well established in the market. The implementation will be a phased, risk-managed, site deployment and follow a multistage user acceptance program with the existing platform providing a fallback position. Internally developed software and other costs capitalized at December 31, 2011 were $3.1 million (2010 – $0.0 million). No amortization was recognized in 2011 (2010 – $0.0 million). Note 10. Deferred Finance Costs On December 14, 2011, we entered into a new five-year revolving credit facility and $1.7 million of refinancing costs were capitalized. These are being amortized over the expected life of the revolving credit facility using the effective interest method. Deferred finance costs associated with the previous finance facility became fully amortized in the third quarter of 2011. Amortization expense was $0.5 million, $1.4 million and $2.0 million in 2011, 2010 and 2009, respectively. The charge is included in interest expense (see Note 2). 80 (in millions) 2011 2010 Gross cost $ 1.7 $ 3.9 Accumulated amortization 0.0 (3.4 ) $ 1.7 $ 0.5 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Note 11. Property, Plant and Equipment Property, plant and equipment consists of the following: Of the total net book value of equipment at December 31, 2011 and 2010 no amounts are in respect of assets held under capital leases. Depreciation charges were $9.2 million, $9.3 million and $11.7 million in 2011, 2010 and 2009, respectively. The estimated additional cost to complete work in progress is $0.9 million (2010 – $1.4 million). 81 (in millions) 2011 2010 Land $ 7.1 $ 7.1 Buildings 5.1 4.7 Equipment 113.3 110.7 Work in progress 8.2 5.8 133.7 128.3 Less accumulated depreciation (87.8 ) (79.6 ) $ 45.9 $ 48.7 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Note 12. Plant Closure Provisions The principal site giving rise to environmental remediation liabilities is the Octane Additives manufacturing site at Ellesmere Port in the United Kingdom, which management believes is the last ongoing manufacturer of TEL. There are also environmental remediation liabilities on a much smaller scale in respect of our other manufacturing sites in the U.S. and Europe. The liability for estimated closure costs of Innospec’s Octane Additives manufacturing facilities includes costs for decontamination and environmental remediation activities (remediation) when demand for TEL diminishes. Severance provisions have been made in relation to Corporate personnel and personnel in each of the three reporting segments. Movements in the provisions are summarized as follows: Amounts due within one year refer to provisions where expenditure is expected to arise within one year of the balance sheet date. Severance charges are recognized in the income statement as restructuring costs along with other restructuring costs. Remediation costs are recognized in cost of goods sold. 82 (in millions) Severance Other Restructuring Remediation Total Total at January 1, 2009 $ 1.6 $ 0.2 $ 25.1 $ 26.9 Charge for the period 1.8 1.0 2.0 4.8 Expenditure (2.1 ) (0.2 ) (1.5 ) (3.8 ) Exchange effect 0.0 0.0 0.5 0.5 Total at December 31, 2009 1.3 1.0 26.1 28.4 Due within one year (0.2 ) (1.0 ) (2.7 ) (3.9 ) Balance at December 31, 2009 $ 1.1 $ 0.0 $ 23.4 $ 24.5 Total at January 1, 2010 $ 1.3 $ 1.0 $ 26.1 $ 28.4 Charge for the period 0.5 0.0 2.5 3.0 Expenditure (0.4 ) (0.8 ) (2.7 ) (3.9 ) Exchange effect 0.1 (0.1 ) 0.0 0.0 Total at December 31, 2010 1.5 0.1 25.9 27.5 Due within one year (0.5 ) (0.1 ) (3.3 ) (3.9 ) Balance at December 31, 2010 $ 1.0 $ 0.0 $ 22.6 $ 23.6 Total at January 1, 2011 $ 1.5 $ 0.1 $ 25.9 $ 27.5 Charge for the period 0.7 (0.1 ) 4.5 5.1 Expenditure (0.7 ) 0.0 (3.1 ) (3.8 ) Exchange effect 0.0 0.0 (0.2 ) (0.2 ) Total at December 31, 2011 1.5 0.0 27.1 28.6 Due within one year (0.5 ) 0.0 (3.6 ) (4.1 ) Balance at December 31, 2011 $ 1.0 $ 0.0 $ 23.5 $ 24.5 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Severance A charge of $0.7 million was recognized in respect of a reduction in EMEA headcount. Other restructuring A residual accrual of $0.1 million, in respect of the relocation of a U.S. sales and administration facility, was released in 2011. Remediation The remediation provision represents the fair value of the Company’s liability for environmental liabilities and asset retirement obligations. The accretion expense recognized in 2011 was $2.4 million. The remediation charge also included a further $2.1 million primarily in respect of changes in the scope of future remediation activities. We recognize, at fair value, environmental liabilities when they are probable and costs can be reasonably estimated, and asset retirement obligations when there is a legal obligation and costs can be reasonably estimated. The Company has to anticipate the program of work required and the associated future expected costs, and has to comply with environmental legislation in the relevant countries in which it operates or has operated in. The Company views the costs of vacating our Ellesmere Port site as a contingent liability because there is no present intention to exit the site. The Company has further determined that, due to the uncertain product life of TEL, particularly in the market for aviation gasoline, there exists such uncertainty as to the probability and timing of such cash flows that it is not possible to estimate them sufficiently reliably to recognize a provision. Remediation expenditure against provisions was $3.1 million, $2.7 million and $1.5 million in 2011, 2010 and 2009, respectively. Note 13. Long-Term Debt Long-term debt consists of the following: On December 14, 2011, we entered into a five-year revolving credit facility which provides for borrowings by us of up to $100.0 million. The facility carries an interest rate based on 83 (in millions) 2011 2010 Senior term loan $ 0.0 $ 40.0 Revolving credit 20.0 7.0 Promissory note 15.0 0.0 35.0 47.0 Less current portion (5.0 ) (15.0 ) $ 30.0 $ 32.0 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) U.S. LIBOR plus a margin of between 1.50% and 2.25% which is dependant on the Company’s ratio of net debt to EBITDA. EBITDA is a non-GAAP measure of liquidity defined in the finance facility. The facility can be drawn down until it expires on December 14, 2016. We repaid the previous finance facility, which was due to expire on February 6, 2012, upon entering into the new facility. The Company’s finance facility contains restrictive clauses which may constrain our activities and limit our operational and financial flexibility. The facility obliges the lenders to comply with a request for utilization of finance unless there is an event of default outstanding. Events of default are defined in the finance facility and include a material adverse change to our assets, operations or financial condition. The facility contains a number of restrictions that limit our ability, amongst other things, and subject to certain limited exceptions, to incur additional indebtedness, pledge our assets as security, guarantee obligations of third parties, make investments, undergo a merger or consolidation, dispose of assets, or materially change our line of business. In addition, the facility also contains terms which, if breached, would result in it becoming repayable on demand. It requires, among other matters, compliance with two financial covenant ratios measured on a quarterly basis. These requirements are (1) the ratio of net debt to EBITDA shall not be greater than 2.5:1 and (2) the ratio of EBITDA to net interest shall not be less than 4.0:1. Management has determined that the Company has not breached these covenants throughout the period to December 31, 2011 and expects to not breach these covenants for the next 12 months. The finance facility is secured by a number of fixed and floating charges over certain assets which include key operating sites of the Company and its subsidiaries. On September 13, 2011, the Company settled the NewMarket Corporation civil complaint. The settlement agreement included the Company issuing a $15.0 million promissory note to NewMarket Corporation payable in three equal annual installments (carrying simple interest at 1% per annum), the first installment of which is due on September 10, 2012. The weighted average rate of interest on borrowings was 3.4% at December 31, 2011 and 4.1% at December 31, 2010. Payments of interest on long-term debt were $1.8 million, $2.0 million and $2.9 million in 2011, 2010 and 2009, respectively. The net cash outflows in respect of refinancing costs were $1.7 million, $0.0 million and $3.7 million in 2011, 2010 and 2009, respectively. Note 14. Deferred Income Deferred income consists of: 84 (in millions) 2011 2010 Deferred income $ 2.3 $ 1.0 Less current portion (1.4 ) (0.1 ) $ 0.9 $ 0.9 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) In April 2011, the Company received a purchase order from the Iraqi Ministry of Oil (“MOO”) for 2,000 tonnes of tetra ethyl lead (“TEL”). Upon completion of the order, 160.5 tonnes of free issue TEL is to be supplied to the MOO in full and final settlement of any claims the Republic of Iraq may have against the Company concerning claims on certain payments totaling approximately €2.0 million that had been claimed by the MOO in connection with two contracts dating back to 2003. Signed acceptance of the terms was received from the MOO on June 13, 2011. The free issue TEL is contingent on delivery and payment for the full 2,000 tonnes. Income of $1.3 million, relating to an initial shipment of 1,000 tonnes, has been deferred until the MOO take delivery of the free product. Deferred income of $1.0 million relates to post acquisition government grants received by Innospec Leuna GmbH. Note 15. Stockholders’ Equity At December 31, 2011, the Company had authorized common stock of 40,000,000 shares (2010 – 40,000,000). Issued shares at December 31, 2011, were 29,554,500 (2010 – 29,554,500) and treasury stock amounted to 6,507,081 shares (2010 – 5,851,298). Note 16. Fair Value Measurements Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes a mid-market pricing convention for valuing the majority of its assets and liabilities measured and reported at fair value. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated or generally unobservable. The Company primarily applies the market approach for recurring fair value measurements and endeavors to utilize the best available information. Accordingly, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. The Company is able to classify fair value balances based on the observability of those inputs. The Company gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest 85 Common Stock Treasury Stock (number of shares in thousands) 2011 2010 2009 2011 2010 2009 At January 1 29,555 29,555 29,555 5,851 5,890 5,956 Exercise of options 0 0 0 (236 ) (186 ) (68 ) Stock purchases 0 0 0 1,087 147 2 Settlement of NewMarket Corporation civil complaint 0 0 0 (195 ) 0 0 At December 31 29,555 29,555 29,555 6,507 5,851 5,890 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) priority to unobservable inputs (Level 3 measurement). Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy Levels. In 2011, the Company evaluated the fair value hierarchy levels assigned to its assets and liabilities, and concluded that there should be no transfers into or out of Levels 1, 2 and 3. The following table presents the carrying amount and fair values of the Company’s assets and liabilities measured on a recurring basis: The following methods and assumptions were used to estimate the fair values of financial instruments: Cash and cash equivalents, and short-term investments: The carrying amount approximates fair value because of the short-term maturities of such instruments. Long-term debt: Long-term debt comprises the new revolving credit facility and the promissory note, which were entered into in December 2011 and September 2011, respectively. The carrying amount of long-term debt approximates fair value. 86 December 31, 2011 December 31, 2010 (in millions) Carrying Amount Fair Value Carrying Amount Fair Value Assets Non-derivatives: Cash and cash equivalents $ 76.2 $ 76.2 $ 107.1 $ 107.1 Short-term investments 4.8 4.8 4.2 4.2 Non-financial assets (Level 3 measurement): Goodwill – Octane Additives 2.6 2.6 4.6 4.6 Derivatives (Level 1 measurement): Other non-current assets: Commodity swaps 0.2 0.2 1.7 1.7 Foreign currency forward exchange contracts 0.0 0.0 0.7 0.7 Liabilities Non-derivatives: Long-term debt (including current portion) 35.0 35.0 47.0 47.0 Non-financial liabilities (Level 3 measurement): Plant closure provisions – remediation 27.1 27.1 25.9 25.9 Derivatives (Level 1 measurement): Other non-current liabilities: Interest rate swaps 0.1 0.1 0.5 0.5 Foreign currency forward exchange contracts $ 0.5 $ 0.5 $ 0.0 $ 0.0 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Plant closure provisions – remediation: The remediation provision represents the fair value of the Company’s liability for environmental liabilities and asset retirement obligations. Derivatives: The fair value of derivatives relating to interest rate swaps, foreign currency forward exchange contracts and commodity swaps are derived from current settlement prices and comparable contracts using current assumptions. The cumulative gains and losses on the interest rate swaps and commodity swaps are summarized as follows: On June 12, 2009, the Company entered into $50.0 million of interest rate swaps which amortize and mature between February 2010 and February 2012 in line with the long-term debt maturity profile of our previous finance facility. We repaid the previous finance facility upon entering into the new facility in December 2011, at which point the remaining interest rate swaps were rendered ineffective and the associated fair value recognized in earnings. The interest rate swaps qualified for hedge accounting until this point and throughout the year ended December 31, 2010. The commodity swaps are used to manage the Company’s cash flow exposure to raw material cost volatility. They have been designated as cash flow hedges and all the commodity swaps qualify for hedge accounting throughout the years ended December 31, 2011 and 2010. At December 31, 2011, the commodity hedges were determined to be effective and consequently an unrealized gain of $0.2 million was recorded in other comprehensive income. The interest rate swaps were ineffective because our previous finance facility, which carried the corresponding floating rate debt obligations, had been repaid, and accordingly a loss of $0.1 million has been recognized in earnings. At December 31, 2010, both interest rate and commodity hedges were determined to be effective and consequently a net unrealized gain of $1.2 million was recorded in other comprehensive income. Ineffectiveness was determined to be immaterial in 2010 and 2009 and accordingly no gain or loss was recognized in earnings in these periods. Based on the valuations as at December 31, 2011 the Company expects the unrealized gain of $0.2 million to be reclassified into earnings in the next 12 months. Foreign currency forward exchange contracts primarily relate to contracts entered into to hedge future known transactions or hedge balance sheet net cash positions. The movements in the carrying amounts and fair values of these contracts are largely due to changes in exchange rates against the U.S. dollar. 87 (in millions) 2011 2010 Balance at January 1 $ 1.2 $ 1.2 Change in fair value (1.1 ) 0.0 Balance at December 31 $ 0.1 $ 1.2 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Note 17. Derivative Instruments and Risk Management The Company has limited involvement with derivative instruments and does not trade them. The Company does use derivatives to manage certain interest rate, foreign currency exchange rate and raw material cost exposures. The Company uses interest rate swaps, floors, collar and cap agreements to reduce the impact of changes in interest rates on its floating rate debt. The swap agreements are contracts to exchange floating rate for fixed interest payments periodically over the life of the agreements without the exchange of the underlying notional amounts. The notional amounts are used to calculate interest to be paid or received and do not represent the amount of exposure to credit loss. As at December 31, 2011 the Company had no interest rate instruments designated as effective hedges. At December 31, 2010 the following were in effect: The interest rate swaps with expiry dates of February 6, 2012 were ineffective at December 31, 2011 because the Company’s previous finance facility, which carried the corresponding floating rate debt obligations, had been repaid. Accordingly, a loss of $0.1 million has been recognized in earnings in 2011. The Company has hedged the cost of certain raw materials with commodity swaps which are summarized as follows: The impact on the income statement for the last 12 months is summarized below: 88 (in millions) Notional Amount Strike Rate Expiry date Interest rate swap $ 7.5 1.4435 % February 7, 2011 $ 7.5 1.4500 % February 7, 2011 $ 15.0 1.8250 % February 6, 2012 $ 10.0 1.8700 % February 6, 2012 December 31, 2011 December 31, 2010 (in millions) Carrying Amount Fair Value Carrying Amount Fair Value Notional quantity – 2,950 tonnes $ 1.7 $ 1.7 Notional quantity – 2,075 tonnes $ 0.2 $ 0.2 (in millions) Gain/(Loss) Recognized in OCI on Derivative Location of Gain/(Loss) Reclassified from Accumulated OCI into Income Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income Interest rate contracts $ 0.0 Interest income/(expense) $ (0.5 ) Commodity contracts (0.3 ) Cost of goods sold 1.2 (0.3 ) 0.7 Taxation 0.1 Income taxes (0.2 ) $ (0.2 ) $ 0.5 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) We enter into various foreign currency forward exchange contracts to minimize currency exposure from expected future cash flows. The contracts have maturity dates of up to four years at the date of inception. These foreign currency forward exchange contracts have not been designated as hedging instruments, and their impact on the income statement in 2011, 2010 and 2009 is summarized below: The Company sells a range of Fuel Specialties, Active Chemicals and Octane Additives to major oil refineries and chemical companies throughout the world. Credit limits, ongoing credit evaluation and account monitoring procedures are used to minimize bad debt risk. Collateral is not generally required. Note 18. Commitments and Contingencies Operating Leases The Company has commitments under operating leases primarily for office space, motor vehicles and various items of computer and office equipment. The leases are expected to be renewed and replaced in the normal course of business. Rental expense was $2.6 million in 2011, $2.8 million in 2010 and $2.6 million in 2009. Future commitments under non-cancelable operating leases are as follows: Commitments in respect of environmental remediation obligations are disclosed in Note 12. Contingencies Resolution of certain government investigations and other matters As we have previously disclosed, the Company reached a $40.2 million settlement to resolve all matters in respect of investigations by U.S. and United Kingdom government authorities 89 Location of Gain/(Loss) Recognized in Income Amount of Gain/(Loss) Recognized in Income (in millions) 2011 2010 2009 Foreign currency forward exchange contracts Other income/(expense) $ 1.3 $ 0.9 $ 12.0 (in millions) 2012 $ 1.3 2013 1.0 2014 0.7 2015 0.5 2016 0.4 Thereafter 1.0 $ 4.9 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) into certain legacy transactions conducted by the Company and its subsidiaries under the United Nations Oil for Food Program (“OFFP”), the U.S. Foreign Corrupt Practices Act (“FCPA”), the U.S. Cuban Assets Control Regulations (“CACR”) and United Kingdom anti-bribery laws. The settlement consists of fines, penalties and disgorgements which are payable over a period of four years commencing 2010. As at December 31, 2011, the expected schedule of payments was as follows: For accounting purposes only we are required under GAAP, in accordance with our accounting policy, to discount elements of the fines, penalties and disgorgements to their net present value. Settlement of NewMarket Corporation civil complaint (in millions) Government Authorities Compliance Monitor Total Fines, penalties and disgorgements $ 40.2 $ 0.0 $ 40.2 Probable future expenses 0.0 3.9 3.9 Less discounting to net present value (0.4 ) 0.0 (0.4 ) 39.8 3.9 43.7 Amounts paid: – fixed (23.2 ) (1.1 ) (24.3 ) – contingent on future trading (5.0 ) 0.0 (5.0 ) Exchange effect 0.1 0.0 0.1 11.7 2.8 14.5 Due within one year (8.3 ) (1.3 ) (9.6 ) $ 3.4 $ 1.5 $ 4.9 As we have previously disclosed, the Company and its subsidiaries, Alcor Chemie Vertriebs GmbH and Innospec Limited, were the subject of two civil actions brought by NewMarket Corporation and its subsidiary, Afton Chemical Corporation (collectively, “NewMarket”). NewMarket and the Company agreed to settle these actions pursuant to the terms of a settlement agreement between them signed on September 13, 2011 which provided for mutual releases of the parties and dismissal of the actions with prejudice. Under the settlement agreement, the Company will pay NewMarket an aggregate amount of approximately $45.0 million, payable in a combination of cash, a promissory note and stock, of which $25.0 million was paid in cash in September 2011, $15.0 million is payable in three equal annual installments under the promissory note (carrying simple interest at 1% per annum) the first installment of which is due on September 10, 2012, and approximately $5.0 million was paid in the form of 195,313 shares of the Company’s common stock transferred to NewMarket in September 2011. 90 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Other Legal Matters While we are involved from time to time in claims and legal proceedings that result from, and are incidental to, the conduct of our business including business and commercial litigation, employee and product liability claims, there are no other material pending legal proceedings to which the Company or any of its subsidiaries is a party, or of which any of their property is subject, although an adverse resolution of an unexpectedly large number of these individual items could in the aggregate have a material adverse effect on results of operations for a particular year or quarter. Guarantees The Company and certain of the Company’s consolidated subsidiaries are contingently liable for certain obligations of affiliated companies primarily in the form of guarantees of debt and performance under contracts entered into as a normal business practice. This includes guarantees of non-U.S. excise taxes and customs duties. As at December 31, 2011, such contingent liabilities amounted to $5.4 million. Under the terms of the guarantee arrangements, generally the Company would be required to perform should the affiliated company fail to fulfill its obligations under the arrangements. In some cases, the guarantee arrangements have recourse provisions that would enable the Company to recover any payments made under the terms of the guarantees from securities held of the guaranteed parties’ assets. The Company and its affiliates have numerous long-term sales and purchase commitments in their various business activities, which are expected to be fulfilled with no adverse consequences material to the Company. Note 19. Profit on Disposal, net In April 2010, the Company recognized a $0.2 million profit following the disposal of surplus real estate. The loss on disposal of the surplus U.S. real estate relates to the sale of the Company’s former manufacturing site in Elmwood Park, New Jersey. Note 20. Recently Issued Accounting Pronouncements In December 2011, the FASB issued ASU 2011-12, Comprehensive Income (Topic 220): Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of 91 (in millions) 2011 2010 2009 Profit on disposal of surplus United Kingdom real estate $ 0.0 $ 0.2 $ 0.0 Loss on disposal of surplus U.S. real estate 0.0 (0.1 ) 0.0 $ 0.0 $ 0.1 $ 0.0 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Items Out of Accumulated Other Comprehensive Income in ASU 2011-05 . This was the FASB’s response to concerns that the new presentation requirements about reclassifications of items out of accumulated other comprehensive income would be difficult for preparers and may add unnecessary complexity to financial statements. The amendments to the update are effective at the same time as the amendments in Update 2011-05, that is for fiscal years, and interim periods within those years, beginning after December 15, 2011. The Company has adopted this guidance and it has not had a material effect on its consolidated financial statements. In December 2011, the FASB issued ASU 2011-11, Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities . The objective of ASU 2011-11 is to facilitate convergence of U.S. GAAP and International Financial Reporting Standards and improve the comparability of statements of financial position. Entities are required to disclose both gross information and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. This scope would include derivatives, sale and repurchase agreements, and securities borrowing and securities lending arrangements. This guidance is effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. Entities should provide the disclosures required by these amendments retrospectively for all comparative periods presented. The Company is currently evaluating the potential impact that the adoption of this statement will have on its consolidated financial statements. In September 2011, the FASB issued ASU 2011-08, Intangibles – Goodwill and Other (Topic 350): Testing Goodwill for Impairment , which amended its guidance on the testing of goodwill impairment to allow an entity the option to first assess qualitative factors to determine whether performing the current two-step process is necessary. Under the new option, the calculation of the reporting unit’s fair value is not required unless as a result of the qualitative assessment, it is more likely than not that the fair value of the reporting unit is less than the unit’s carrying amount. This guidance is effective for fiscal years and interim periods beginning after December 15, 2011, with early adoption permitted. The Company has adopted this guidance and it has not had a material effect on its consolidated financial statements. In June 2011, the FASB issued ASU 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income . The objective of ASU 2011-05 is to improve the comparability, consistency, and transparency of financial reporting, to increase the prominence of items reported in other comprehensive income, and to facilitate convergence of U.S. GAAP and International Financial Reporting Standards. To achieve this, the FASB decided to eliminate the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity. The amendments in ASU 2011-05 require that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In the two-statement approach, the first statement should present total net income and its 92 Table of Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) components followed consecutively by a second statement that should present total other comprehensive income, the components of other comprehensive income, and the total of comprehensive income. Finally, current GAAP does not require an entity to present reclassification adjustments on the face of the financial statements from other comprehensive income to net income, which is required by the guidance in ASU 2011-05. For public entities, the amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. Early adoption is permitted, because compliance with the amendments is already permitted. The amendments do not require any transition disclosures. The Company is in compliance with the provisions of this update, with the exception of the reclassification adjustments as per the guidance in ASU 2011-12. In May 2011, the FASB issued ASU 2011-04, Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs . ASU 2011-04 results in common fair value measurement, as well as disclosure requirements, under U.S. GAAP and International Financial Reporting Standards. The amendments clarify guidance on measuring fair value but do not require any additional fair value measurements. This guidance is effective for fiscal years and interim periods beginning after December 15, 2011, with early adoption permitted. The Company has adopted this guidance and it has not had a material effect on its consolidated financial statements. Note 21. Related Party Transactions Mr. Robert I. Paller has been a non-executive director of the Company since November 1, 2009. The Company has retained and continues to retain Smith, Gambrell & Russell, LLP (“SGR”), a law firm with which Mr. Paller holds a position. In 2011, 2010 and 2009 the Company incurred fees payable to SGR of $6.5 million, $1.1 million and $0.1 million, respectively. As at December 31, 2011, the amount due to SGR from the Company was $0.1 million. Note 22. Subsequent Events The Company has evaluated subsequent events through the date that the consolidated financial statements were issued, and has concluded that no additional disclosures are required in relation to events subsequent to the balance sheet date. 93 Table of Contents None. Evaluation of Disclosure Controls and Procedures As of the end of the period covered by this report the Company carried out an evaluation under the supervision and with the participation of our management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended). Based upon this evaluation of disclosure controls and procedures, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective as of December 31, 2011. Management’s Report on Internal Control Over Financial Reporting The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting. The Company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. The Company’s management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2011. In making this assessment, management used the criteria in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on the evaluation the Company concluded that the Company maintained effective internal control over financial reporting as of December 31, 2011, based on criteria in the Internal Control – Integrated Framework issued by the COSO. The effectiveness of the Company’s internal control over financial reporting as of December 31, 2011 has been audited by KPMG Audit Plc, an independent registered public accounting firm, as stated in their report which is included in Item 8 of this Annual Report on Form 10-K. 94 Item 9 Changes in and Disagreements with Accountants on Accounting and Financial Disclosure Item 9A Controls and Procedures Table of Contents Changes in Internal Controls over Financial Reporting The Company is continuously seeking to improve the efficiency and effectiveness of its operations and of its internal controls. This results in refinements to processes throughout the Company. However, there has been no change in the Company’s internal control over financial reporting during the most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. None. Item 9B Other Information 95 Table of Contents PART III Information under the headings “Election of a Director”, “Re-Election of Two Directors”, “Information about the Board of Directors,” “Information about the Executive Officers” and “Section 16(a) Beneficial Ownership Reporting Compliance” set out in the Proxy Statement for the Annual Meeting of Stockholders to be held on May 9, 2012 (“the Proxy Statement”) is incorporated herein by reference. The Board of Directors has formally adopted a Code of Ethics. Any stockholder who requires a copy of the Code of Ethics, Corporate Governance Guidelines or any of the Board Committee Charters may obtain one by writing to the General Counsel and Chief Compliance Officer, Innospec Inc., 8375 South Willow Street, Littleton, Colorado, 80124, e-mail investor@innospecinc.com. These documents can also be accessed via the Company’s web site, www.innospecinc.com. The Company intends to disclose on its internet site any amendments to, or waivers from, its Code of Conduct that are required to be publicly disclosed pursuant to the rules of the SEC or NASDAQ. Information regarding the composition and the workings of the Audit Committee is included under the headings “Corporate Governance – Board Committees – Audit Committee” and “Audit Committee Report” in the Proxy Statement and is incorporated herein by reference. Information regarding the procedures by which stockholders may recommend nominees to the Board of Directors is included under the heading “Corporate Governance – Board Committees – Nominating and Governance Committee” in the Proxy Statement and is incorporated herein by reference. The information under the headings “Executive Compensation,” “Corporate Governance – Board Committees – Compensation Committee – Compensation Committee Interlocks and Insider Participation” and “Compensation Committee Report” in the Proxy Statement is incorporated herein by reference. The information under the heading “Information About our Common Stock Ownership” in the Proxy Statement is incorporated herein by reference. Shares Authorized for Issuance Under Equity Compensation Plans The information contained in the table under the heading “Equity Compensation Plans” in the Proxy Statement is incorporated herein by reference. 96 Item 10 Directors, Executive Officers and Corporate Governance Item 11 Executive Compensation Item 12 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters Table of Contents The information under the headings “Transactions with Executives, Officers, Directors and Others”, “Certain Other Transactions and Relationships” and “Corporate Governance – Director Independence” in the Proxy Statement is incorporated herein by reference. Information with respect to fees and services related to the Company’s independent registered public accounting firm, KPMG Audit Plc, is contained under the heading “Principal Accountant Fees and Services” in the Proxy Statement and is incorporated herein by reference. Information with respect to the Audit Committee’s pre-approval policies and procedures is contained under the heading “Audit Committee Pre-approval Policies and Procedures” in the Proxy Statement and is incorporated herein by reference. 97 Item 13 Certain Relationships and Related Transactions, and Director Independence Item 14 Principal Accountant Fees and Services Table of Contents PART IV 98 Item 15 Exhibits and Financial Statement Schedules (a) (1) Financial Statements The Consolidated Financial Statements of Innospec Inc. and its subsidiaries and related notes thereto, together with the report thereon of KPMG Audit Plc dated February 17, 2012, appear on pages 47 through 93 of the 2011 Form 10-K to stockholders, are incorporated in Item 8. (2) Financial Statement Schedules All financial statement schedules have been omitted since the information required to be submitted has been included in the financial statements or because they are either not applicable or not required under the Rules of Regulations S-X. (3) Exhibits 3.1 Amended and Restated By-laws of the Registrant. (1) 4 Rights Agreement dated June 12, 2009. (12) 10.1 Employment offer letter from The Associated Octel Company Limited to Philip J Boon, (2) and Executive Service Agreement dated June 1, 2009. (11) * 10.2 Contract of Employment, Ian McRobbie. (3) * 10.3 Contract of Employment, Dr. Catherine Hessner. (5) * 10.4 Contract of Employment, Patrick Williams, dated October 11, 2005, (6) and Executive Service Agreement dated April 2, 2009. (10) * 10.5 Contract of Employment, Ian Cleminson, dated June 30, 2006. (7) * 10.6 Innospec Inc. Performance Related Stock Option Plan 2008. (8) * 10.7 Innospec Inc. Company Share Option Plan 2008. (8) * 10.8 Innospec Inc. Non Employee Directors’ Stock Option Plan 2008. (8) * 10.9 Innospec Inc. Sharesave Plan 2008. (8) * 10.10 Innospec Inc. Executive Co-Investment Stock Plan 2004, as amended by the First Amendment (filed herewith). 10.11 Multicurrency Revolving Facility Agreement dated December 14, 2011 with Lloyds TSB Bank plc as agent and security agent which provides for a five year, $100,000,000, revolving loan. (9) Table of Contents 99 10.12 Contract of Employment, David E. Williams, dated September 17, 2009. (13) * 10.13 Letter dated December 1, 2010 from the Board of Directors to Patrick S. Williams regarding a one off bonus payment. (14) * 10.14 Letter dated December 1, 2010 from the Board of Directors to Ian P. Cleminson regarding a one off bonus payment. (14) * 10.15 Letter dated December 1, 2010 from the Board of Directors to Philip J. Boon regarding a one off bonus payment. (14) * 10.16 Letter dated December 1, 2010 from the Board of Directors to Ian McRobbie regarding a one off bonus payment. (14) * 10.17 Letter dated December 1, 2010 from the Board of Directors to Brian Watt regarding a one off bonus payment. (14) * 10.18 Contract of Employment, Andrew Hartley dated July 23, 2004. (15) * 10.19 Compromise Agreement, Andrew Hartley dated December 21, 2011 (filed herewith). * 12.1 Statement Regarding Computation of Financial Ratios (filed herewith). 14 The Innospec Inc. Code of Ethics (as updated) (filed herewith). 16 Letter regarding change in certifying accountant dated June 17, 2011. (16) 21.1 Principal Subsidiaries of the Registrant (filed herewith). 23.1 Consent of Independent Registered Public Accounting Firm, KPMG Audit Plc (filed herewith). 23.2 Consent of Independent Registered Public Accounting Firm, PricewaterhouseCoopers LLP (filed herewith). 31.1 Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith). 31.2 Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith). 32.1 Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith). 32.2 Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith). 101 XBRL Instance Document and Related Items. Table of Contents Notes 100 (1) Incorporated by reference to the Company’s amendment dated April 21, 1998, to a previously filed Form 10-12B/A. (2) Filed with the Company’s Form 10-K on March 26, 2001. (3) Filed with the Company’s Form 10-K on March 28, 2003. (4) Filed with the Company’s Proxy Statement on March 15, 2004. (5) Filed with the Company’s Form 10-K on March 31, 2005. (6) Filed with the Company’s Form 8-K on October 12, 2005. (7) Filed with the Company’s Form 8-K on June 30, 2006. (8) Filed with the Company’s Proxy Statement on March 31, 2008. (9) Filed with the Company’s 8-K on December 19, 2011. (10) Filed with the Company’s 8-K on April 3, 2009. (11) Filed with the Company’s 8-K on May 27, 2009. (12) Filed with the Company’s 8-K on June 12, 2009. (13) Filed with the Company’s 8-K on September 14, 2009. (14) Filed with the Company’s 10-K on February 18, 2011. (15) Filed with the Company’s 10-K on March 31, 2005. (16) Filed with the Company’s 8-K on June 17, 2011. * Management contract or compensatory plan. Table of Contents SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated as of February 17, 2012: 101 INNOSPEC INC. By: /s/ PATRICK S. WILLIAMS (Registrant) Patrick S. Williams Date: President and Chief Executive Officer February 17, 2012 /s/ ROBERT E. BEW Dr Robert E. Bew Chairman and Director /s/ IAN P. CLEMINSON Ian P. Cleminson Executive Vice President and Chief Financial Officer /s/ MARK A. BRACEWELL Mark A. Bracewell Group Financial Controller (Principal Accounting Officer) /s/ HUGH G. C. ALDOUS Hugh G. C. Aldous Director /s/ MILTON C. BLACKMORE Milton C. Blackmore Director /s/ MARTIN M. HALE Martin M. Hale Director /s/ ROBERT I. PALLER Robert I. Paller Director /s/ JOACHIM ROESER Joachim Roeser Director Exhibit 10.10 RULES of the 2004 INNOSPEC INC. EXECUTIVE CO-INVESTMENT PLAN CONTENTS i 1. PURPOSE AND DEFINITIONS 2 1.1. Purpose 2 1.2. Definitions 2 2. PROCEDURE FOR SHARE MATCHING 3 2.1. Purchase of Shares with Bonus 3 2.2. Purchase of Shares When Target Bonus is Exceeded 4 2.3. Procedure for Share Matching 4 3. CONDITIONS RELATING TO MATCHING SHARES 4 3.1. Requirement to Remain in Employment 4 3.2. Forfeit of Matching Shares 4 4. RESTRICTIONS ON MATCHING SHARES 4 4.1. Maximum Aggregate Number of Matching Shares 4 4.2. Matching Shares may not be sold or transferred 5 4.3. No Rights Under Matching Shares 5 4.4. Right to Matching Shares Prematurely 5 4.5. Admission to NASDAQ 5 4.6. Ranking of Matching Shares 5 5. TAKE-OVER, RECONSTRUCTION AND AMALGAMATION AND LIQUIDATION 5 5.1. Take-over pursuant to General Offer 5 5.2. Voluntary Winding Up of the Company 6 6. ADMINISTRATION 6 6.1. Maintenance of Unissued Share Capital 6 6.2. The Committee’s Power to Administer Plan 6 6.3. The Committee’s Decision is Final and Conclusive 6 6.4. Costs of Administering Plan 6 7. ALTERATIONS 6 7.1. Power to alter Rules 6 7.2. Alterations which affect subsisting rights of former or current Eligible Employees 6 8. GENERAL 6 8.1. Effective Date 6 8.2. Termination of the Plan 6 8.3. Governing Law 6  The 2004 Innospec Inc. Executive Co-Investment Stock Plan, adopted by the Board of Directors of the Company on 24 February 2004, for certain senior executives of the Company, is intended to align the interests of such persons with the Company by allowing such senior executives to elect to utilize a portion of his or her Bonus for the purchase of Shares and provisionally receive certain Matching Shares provided by the Company, to facilitate the shareholding requirement for senior management as set out by the Committee. In this Plan, the following words and expressions shall, where the context so permits, have the meanings set forth below: “the Act” the Income and Corporation Taxes Act 1988; “Acquiring Company” the person mentioned in Section 5.1, being a company within the meaning of Section 8.32 of the Act; “Board of Directors” the board of directors of the Company; “Bonus” the net amount of bonus compensation, after the deduction of all applicable income tax and social security liabilities, as determined by the Committee, awarded to an Eligible Employee in addition to such person’s base salary; “Bonus Notification Date” the date on which the Company notifies each Eligible Employee of his Bonus amount; “the Code” the United States Internal Revenue Code of 1986 (as amended); “the Committee” the Innospec Inc. Compensation Committee; “the Company” Innospec Inc., a Delaware Corporation; “Control” the meaning ascribed by Section 840 of the Act; “Election Date” the date on which an Eligible Employee elects to utilize a portion of his Bonus pursuant to Sections 2.1(a) and 2.2(a); “Eligible Employee” the senior executives of the Group designated as participants in the Plan, as determined by the Committee, whether annually or otherwise, who are employed by the Company or any of its Subsidiaries; “Fair Market Value” in relation to a Share on any day, either: 2 1. PURPOSE AND DEFINITIONS 1.1. Purpose 1.2. Definitions (1) if and for so long as the Shares are listed on NASDAQ, the reported closing price of shares of Innospec Inc. common stock on NASDAQ for that day, or the last preceding trading day if that day is not a day that NASDAQ is open for business; or (2) its fair market value as determined by the Board of Directors; “Group” the Company and each of its Subsidiaries; “Matching Shares” the matching Shares provisionally issued by the Company to the Eligible Employees pursuant to Sections 2.3(a) and 2.3(b). “NASDAQ” The Nasdaq Stock Market, including its three market ties: NASDAQ Global Select Market, NASDAQ Global Market and NASDAQ Capital Market or their successors; “Parent” any company which is a parent corporation of the Company within the meaning of Section 424(e) of the Code; “Purchase Period” the next available trading opportunity in accordance with the Company’s trading policy; “the Plan” the 2004 Innospec Inc. Executive Co-Investment Stock Plan (as amended on July 1, 2006) in its present form, or as from time to time altered in accordance with the Rules; “Rules” the Rules of the Plan and “Rule” shall be construed accordingly; “Share” a share of common stock, par value $0.01 per share, in the Company; “Share Price” the price paid for a Share during the Purchase Period; “Subsidiary” any company which is a subsidiary corporation within the meaning of Section 424(f) of the Code; “Target Bonus” a target amount, set annually at the absolute discretion of the Board of Directors, for each Eligible Employee regarding his Bonus. References to any statutory provision are to that provision as amended or re-enacted from time to time, and, unless the context otherwise requires, words in the singular shall include the plural (and vice versa) and words importing the masculine the feminine (and vice versa). 2. PROCEDURE FOR SHARE MATCHING 2.1. Purchase of Shares with Bonus (a) Within 21 days after each Bonus Notification Date, each Eligible Employee may elect to utilize a minimum of zero and a maximum of fifty percent of his Bonus earned for the purchase of Shares in the Company during the following Purchase Period. (b) During the Purchase Period, each Eligible Employee shall purchase a number of Shares equal to the quotient of the amount determined in Section 2.1(a) and the Share Price, rounded down to the nearest whole number. 3 (c) In the event that an Eligible Employee does not make an election pursuant to Section 2.1(a) within 21 days after the relevant Bonus Notification Date, then such Eligible Employee shall not receive any Matching Shares granted pursuant to Section 2.3(a).  2.2. Purchase of Shares When Target Bonus is Exceeded (a) If the Committee has awarded an Eligible Employee a bonus in an amount that exceeds the aggregate Target Bonus for such Eligible Employee, then in addition to the Shares purchased pursuant to Section 2.1 above, such Eligible Employee must utilize at least one-third of the amount in excess of Target Bonus and may, within 21 days after the relevant Bonus Notification Date, elect to utilize up to one hundred percent of the excess over Target Bonus for the purchase of Shares in the Company during the following Purchase Period. (b) During the following Purchase Period, each Eligible Employee (or the Company if applicable) shall purchase a number of Shares equal to the quotient of the amount determined in Section 2.2(a) (or Section 2.2(c) if applicable) and the Share Price, rounded down to the nearest whole number. (c) In the event that an Eligible Employee is required to make an election pursuant to Section 2.2(a) within 21 days after the relevant Bonus Notification Date but does not make such an election, then the Company shall withhold from such Eligible Employee an amount equal to one-third of such Eligible Employee’s Bonus in excess of the Target Bonus and the Company shall purchase on behalf of such Eligible Employee, during the following Purchase Period, a number of Shares in the Company as determined by Section 2.2(b) 2.3. Procedure for Share Matching (a) Subject to Sections 3 and 4 below, for every two Shares purchased by an Eligible Employee pursuant to Section 2.1, the Company shall provisionally provide to such Eligible Employee by reason of his or her employment one additional Matching Share. (b) Subject to Sections 3 and 4 below, for every one Share purchased by or on behalf of an Eligible Employee pursuant to Section 2.2, the Company shall provisionally provide to such Eligible Employee one additional Matching Share. (c) Subject to Sections 4.2, 5.1, and 5.2, Matching Shares shall not be transferred by the Company to Eligible Employees until the conditions set forth in Section 3 are satisfied. 3. CONDITIONS RELATING TO MATCHING SHARES 3.1. Requirement to Remain in Employment Subject to Sections 4.4, 5.1, and 5.2, each Eligible Employee must remain employed by the Company for a period of three years after the Election Date, at which time all Matching Shares granted by the Company for such utilized bonus shall become vested and shall be transferred to the Eligible Employee. 3.2. Forfeit of Matching Shares Subject to Sections 4.4, 5.1, and 5.2, if an Eligible Employee leaves the employment (for any reason whatsoever) of the Company before the Matching Shares have been transferred to him, then such Matching Shares shall be forfeited by such Eligible Employee and, upon such a forfeiture, the Eligible Employee shall not possess any rights or claims of any kind to or under the forfeited Matching Shares. 4. RESTRICTIONS ON MATCHING SHARES 4.1. Maximum Aggregate Number of Matching Shares The maximum aggregate number of Matching Shares which may be issued under the Plan, or purchased from the Company in accordance with Section 6.1, shall be 190,000 (which represents the 4 95,000 set forth in the Plan as originally adopted, as adjusted to give effect to the 2-for-1 stock split in the Shares that was effected in 2007), subject to any future increase in this limit which may be adopted by and at the discretion of the Committee with approval by the stockholders of the Company to the extent such approval is required by applicable law. 4.2. Matching Shares may not be sold or transferred Matching Shares provisionally provided to Eligible Employees under this Plan shall be personal to such Eligible Employee and shall not be capable of being sold, transferred, assigned, or charged until the conditions set forth in Section 3 are satisfied. 4.3. No Rights Under Matching Shares Eligible Employees shall have no voting or other rights under the Matching Shares provisionally provided to such Eligible Employees until the conditions set forth in Section 3 are satisfied. 4.4. Right to Matching Shares Prematurely Notwithstanding any other provision of these Rules, Matching Shares may, at the discretion of the Committee, be transferred by the Company to an Eligible Employee (or a personal representative in the case of death) following the date on which such Eligible Employee ceases to hold any office or employment with the Company or a Subsidiary on account of: (a) death, injury, or disability, as evidenced to the satisfaction of the Committee; (b) redundancy (within the meaning of the Employment Rights Act 1996); (c) retirement on reaching age 65 or such earlier retirement date as agreed with the Company; (d) the transfer of the undertaking or part-undertaking in which the Eligible Employee is employed to a person other than the Company or a Subsidiary; (e) the Company or Subsidiary by which the Eligible Employee is employed ceasing to be under the Control of the Company; or (f) termination of employment by the Company or Subsidiary for a reason other than gross misconduct. 4.5. Admission to NASDAQ If and so long as the Matching Shares are listed on NASDAQ the Company shall use its best endeavours to procure that as soon as practicable after the allotment of any Matching Shares pursuant to the Plan, application shall be made to NASDAQ for permission to deal in these Matching Shares unless such application has already been made. 4.6. Ranking of Matching Shares Subject to the provisions of Sections 3 and 4, all Matching Shares issued pursuant to this Plan shall, as to voting, dividend, and other rights (including those arising on a liquidation), not rank pari passu in all respects with the Shares then in issue until such Matching Shares are transferred by the Company to the Eligible Employee. 5. TAKE-OVER, RECONSTRUCTION AND AMALGAMATION AND LIQUIDATION 5.1. Take-over pursuant to General Offer If any company (“the Acquiring Company”) becomes a Parent of the Company as a result of making either a tender offer to acquire the whole of the Company’s issued share capital (other than any shares already owned by the Acquiring Company or any Subsidiary of the Acquiring Company) and which is made on a condition that if it is satisfied the Acquiring Company will become the Parent, then all restrictions placed on the Matching Shares pursuant to this Plan shall be removed. 5  5.2. Voluntary Winding Up of the Company If a resolution is passed for the voluntary winding-up of the Company, then all restrictions placed on the Matching Shares pursuant to this Plan shall be removed. 6. ADMINISTRATION 6.1. Maintenance of Unissued Share Capital The Company shall at all times either keep available sufficient unissued Shares to satisfy the issuance of Matching Shares under the Plan (taking account of any other obligations of the Company to allot unissued or treasury Shares) or shall ensure that sufficient issued Shares will be available to satisfy the terms of this Plan. Notwithstanding anything in the Plan to the contrary, to the extent that any terms of the Plan permit or require an Eligible Employee to purchase Shares, an Eligible Employee shall (i) purchase such Shares directly from the Company at the then Fair Market Value; or (ii) purchase such Shares on the open market. Shares purchased from the Company shall be subject to the limit regarding the total number of Shares which may be issued under the Plan or purchased from the Company as specified in Rule 4.1. 6.2. The Committee’s Power to Administer Plan The Committee may make such regulations for the administration of the Plan as it deems fit, provided that no regulation shall be valid to the extent it is inconsistent with the Rules. 6.3. The Committee’s Decision is Final and Conclusive The decision of the Committee in any dispute relating to an issuance pursuant to this Plan, or any other matter in respect of the Plan, shall be final and conclusive. 6.4. Costs of Administering Plan The costs of introducing and administering the Plan shall be borne by the Company. 7. ALTERATIONS 7.1. Power to alter Rules Subject to Section 7.2, the Committee may in its discretion alter the Rules, provided that no such alteration shall be made without stockholder approval to the extent such approval is required by law. 7.2. Alterations which affect subsisting rights of former or current Eligible Employees The Committee may not alter the Rules such that such alteration would abrogate or adversely affect the subsisting rights of former or current Eligible Employees. 8. GENERAL 8.1. Effective Date The Plan shall become effective as of the date it is approved by the Board of Directors. 8.2. Termination of the Plan The Plan shall terminate on the tenth anniversary of the date on which it is approved by the Committee or at any earlier time by the passing of a resolution by the Committee. Termination of the Plan shall be without prejudice to the subsisting rights of former or current Eligible Employees. 8.3. Governing Law This Plan shall be governed by and construed in accordance with English Law. 6 Exhibit 10.19 DATED December 21, 2011 CONFORMED COPY COMPROMISE AGREEMENT Without prejudice and subject to contract Eversheds LLP Eversheds House 70 Great Bridgewater Street Manchester M1 5ES (1) Innospec Inc (2) Innospec Limited (3) Andrew Hartley WITHOUT PREJUDICE AND SUBJECT TO CONTRACT THIS AGREEMENT is made on 21 December 2011 BETWEEN: 2 (4) Innospec Inc of 8375 South Willow Street, Littleton, Colorado, 80124 USA (“the Parent” ). (5) Innospec Limited whose registered office is at Innospec Manufacturing Park, Oil Sites Road, Ellesmere Port, CH65 4EY ( “the Employer” ). (6) Andrew Hartley of Seymour House, 12 Seymour Chase, Knutsford, Cheshire, WA16 4BY, UK ( “the Executive” ). 1. Definitions 1.1 In this Agreement the following expressions have the following meanings: “the Acts” the Equal Pay Act 1970, the Sex Discrimination Act 1975, the Race Relations Act 1976, the Employment Rights Act 1996, the Disability Discrimination Act 1995, the Working Time Regulations 1998, the National Minimum Wage Act 1998, the Public Interest Disclosure Act 1998, the Employment Relations Act 1999, the Transnational Information and Consultation of Executives Regulations 1999, the Employment Equality (Sexual Orientation) Regulations 2003, the Employment Equality (Religion or Belief) Regulations 2003, the Employment Equality (Age) Regulations 2006 and paragraphs (c) and (d) of section 147(3) of the Equality Act 2010 all as subsequently consolidated, modified or re-enacted from time to time; “the Group” means any company wherever registered or incorporated which is for the time being a subsidiary or a holding company of the Parent or the Employer or a subsidiary of any such company (as “subsidiary” and “holding company” are defined in Section 1159 of the Companies Act 2006 (as amended) or which is an associated company of any such company (as “associated company” is defined in the Income and Corporation Taxes Act 1988 (as amended)); “the Pension Scheme” the Innospec Limited Pension Plan of which the Executive is a deferred member. “PAYE deductions” deductions made to comply with or to meet any liability of the Employer to account for tax pursuant to regulations made under Chapter 2 of Part 11 Income Tax (Earnings and Pensions) Act 2003 and to comply with any obligation to make a deduction in respect of national insurance contributions; “the Service Agreement” the terms and conditions governing the Executive’s employment dated 2 April 2006.  In consideration for the Executive agreeing to the provisions of clause 9 below, the Employer and Parent agree, without any admission of liability: 2. Basis of Agreement 2.1 The parties have entered into this Agreement to record and implement the terms upon which they have agreed to settle all outstanding claims which the Executive has or may have against the Parent, the Employer or the Group arising out of or in connection with or as a consequence of his employment and its proposed termination and the Parent, the Employer or the Group has or may have against the Executive arising out of or in connection with or as a consequence of his directorships, employment and their proposed termination, excluding any claims that may arise where the Executive has been wilfully dishonest or otherwise involved in criminal activities. The terms set out in this Agreement constitute the entire Agreement between the parties and are without admission of liability on the part of the Parent the Employer or the Group. 2.2 The Parent and the Employer are entering into this Agreement for themselves and as agent for and trustee of all Group companies and are duly authorised to do so. The parties intend that each Group company should be able to enforce in its own right the terms of this Agreement which expressly or impliedly confer a benefit on that company subject to and in accordance with the provisions of the Contracts (Right of Third Parties) Act 1999. 3. Termination 3.1 The Executive’s employment will terminate by reason of redundancy on 31 December 2011 (“the Termination Date”). 3.2 The Employer will pay at the next available opportunity the Executive’s salary, and any accrued but untaken holiday pay (subject to tax, national insurance and pension deductions) and will continue to provide the Executive with all other contractual benefits pursuant to the Service Agreement in the usual way until the Termination Date. 3.3 Unless specifically provided for in this agreement the Executive’s entitlement under or participation in any other benefit plans provided by the Parent and the Employer will cease with effect from the Termination Date. 4. Termination arrangements 4.1 to pay to the Executive the sums of 4.1.1 £117,177 in lieu of notice; 4.1.2 £13,650 in lieu of car allowance; and subject to PAYE deductions. 3 4.1.3 £98,428 in respect of bonus earned under the Management Incentive Compensation Plan (MICP) for the calendar year 2011, 4.2 to make a Termination Payment of £64,500 which includes any entitlement to statutory redundancy or any other sums arising from the Executive’s employment and its termination. The parties believe that in accordance with the relevant legislation the first £30,000 of the Termination Payment is not subject to tax and/or national insurance contributions and will be paid gross, the balance of the Sum will be subject to income tax deductions but not employee national insurance deductions.  (i) the Executive incurs legal fees in relation to actions carried out by him during his period of employment in the execution of his duties as a director or officer of the Parent, the Employer or any Group Company (including without limitation in relation to any regulatory authorities’ investigation into the Parent, the Employer or Group) ; and (ii) the cost of such legal fees are not recoverable under the Employer’s liability insurance for directors and officers in force from time to time (the “D&O Policy”), then, in full and final settlement of any potential claim against the Parent, the Employer or the Group in respect of such legal fees, the Employer agrees to pay such legal fees up to a maximum of £100,000 exclusive of VAT Such payment is subject to the production by the Executive of such evidence of such legal fees as the Employer may reasonably require and will be paid within a reasonable period of time, and in any event within two months of receipt by the Employer of such evidence. Any gain the Executive may make in terms of the exercise of these options is capped at $9.24 for each SEU; The SEUs must be exercised within 12 months of the Termination Date 4 4.3 Payment of the sums due under clauses 4.1 and 4.2 to be made within 21 days of the Termination Date subject to the Employer receiving a copy of this Agreement signed by the Executive and Advisor. 4.4 to continue and maintain Directors and Officers insurance cover for any period in which the Executive was or would be potentially liable as a director or officer or former director or officer of the Employer or any other company in the Group. 4.5 The Employer confirms that to the extent that 4.6 to confirm that for the purposes of Rule 5.3.3 of the Pension Scheme, the Executive will be treated as leaving at the Employer’s request and to procure that the Executive’s entitlement to benefits arising from the Pension Scheme will be calculated according to the rules of the Pension Scheme. 4.7 to exercise their discretion (the Compensation Committee of the Parent having exercised their discretion) to vest the options under the PRSOP Plan granted to the Executive on 24 March 2009. The option applies to 7908 shares and must be exercised within 12 months from the Termination Date. All other options granted to the Executive under the PRSOP lapse. 4.8 to grant the Executive (the Compensation Committee of the Parent having exercised their discretion) all options under the CSOP Plan which will vest on the Termination Date and must be exercised within 12 months of the Termination Date. The options under the CSOP are as listed below. Date granted Plan type Number granted Option price 24 March 2009 CSOP A 2 $ 4.62 21 Feb 2007 CSOP A 246 $ 27.09 17 Feb 2010 CSOP B 1758 $ 10.38 24 March 2009 CSOP B 2874 $ 4.62 21 Feb 2007 CSOP B 1022 $ 27.09 4.9 to exercise their discretion (the Compensation Committee of the Parent having exercised their discretion) to vest the SEUs (Phantom options) granted to the Executive on 24 March 2009 as listed below. Date granted Plan type Number granted Option price 24 March 2009 SEU 14763 0 24 March 2009 SEU 5368 4.62  The Employer agrees to provide the Executive with a reference in the terms of the letter at schedule 3 and agrees to respond to all employment reference enquiries in a manner consistent with this reference, subject to any amendments which may be necessary to reflect material facts which come to the knowledge of the Employer following the date of this Agreement 4.10 to exercise their discretion (the Compensation Committee of the Parent having exercised their discretion) to vest the 2361 SEUs (Phantom options) with an option price of $10.38 granted to the Executive on 17 February 2010. The SEUs must be exercised within 12 months of the Termination Date 4.11 to continue to provide cover for the Employer and his immediate family under its Private Health Plan with SimplyHealth until 30 June 2012. 4.12 to confirm that, the Executive has no rights in relation to options granted under the Co-Invest Plan and that these options will lapse on the Termination Date. 5. Legal Fees and Outplacement 5.1 The Employer agrees, subject to receipt of an invoice from the Executive’s Adviser, to pay to the Adviser the Executive’s reasonable legal fees up to a maximum of £1500 exclusive of VAT incurred exclusively in connection with this Agreement. Any invoice should be addressed to the Executive but expressed to be payable by the Employer and sent under private and confidential cover to Cathy Hessner at the Employer’s address as set out in this Agreement. 5.2 The Employer will meet the cost of providing the Executive with outplacement support up to a maximum cost of £8,500 plus VAT from a provider to be chosen by the Employer. 6. Return of property 6.1 On or before the Termination Date the Executive will return to the Parent or the Employer, all credit cards, keys, his security pass, laptop computer, Blackberry, mobile phone, all computer disks, facsimile machine, all documents and copies together with all other property belonging to the Parent, Employer or the Group or relating to its or their business in his possession or control except for such property as the parties agree in writing that the Executive may retain. 7. Reference 8. Warranties and representations 8.1 The Executive warrants and represents to the Parent and the Employer that up to and as at the date this Agreement becomes binding in accordance with Clause 15 the Executive: 8.1.1 has not knowingly committed any repudiatory breach of any duty owed to the Parent, the Employer or any Group company. ; 8.1.2 has not done or failed to do anything amounting to a repudiatory breach of the express or implied terms of his employment with the Parent or the Employer or which, if it had been done or omitted after the execution of this Agreement, would have been in breach of any of its terms; 5 8.1.3 is not aware of any matters relating to any acts or omissions by him or any director, officer, Executive or agent of the Parent or the Employer (or any Group company) which if disclosed to the Parent or the Employer would or might reasonably affect its decision to enter into this Agreement;  6 8.1.4 confirms there are no circumstances of which he is aware or of which he ought to be aware which would constitute a repudiatory breach on his part of his contract of employment which would entitle or have entitled the Parent or the Employer to terminate his employment without notice. 8.2 The Executive undertakes to forthwith notify the Parent and the Employer if at any time in the period from the date of this Agreement to the Termination Date he is in breach of any of sub clauses 8.1.1 to 8.1.4 above or he believes that he may have any of the claims set out in clause 10.1 which arise as a result of any acts or omissions by the Parent or the Employer which occur between the date of this Agreement and the Termination Date. 8.3 The Executive agrees to comply with reasonable requests to be available and to cooperate with and assist the Parent, the Employer or its advisers in relation to any administrative, regulatory, judicial or quasi-judicial proceedings including but not limited to attending interviews with the Serious Fraud Office. The Executive acknowledges that this could involve, but is not limited to, pursuing or defending any regulatory or legal process, providing information in relation to any such process, providing a witness statement and giving evidence in person on behalf of the Parent and the Employer. The Employer shall reimburse the Executive for any reasonable fees and expenses and any loss of earnings incurred in complying with his obligations under this clause. 8.4 The Executive agrees to provide appropriate support and assistance to the Employer in relation to the handover of any duties formerly performed by the Executive for no than 25 hours per month in the period from the Termination Date to 31 March 2012. Such assistance may include meetings and conference calls with the Vice President, General Counsel and Chief Compliance Officer, David Williams and other employees of the Parent or the Employer. 8.5 The Executive agrees to be responsible for the payment of any tax in respect of any of the sums payable or services or benefits provided under clauses 4 and 8 (other than for the avoidance of doubt, any tax withheld by the Employer in paying the sums to the Executive) and the Executive agrees to indemnify the Employer and to keep the Employer indemnified on a continuing basis against all liabilities to taxation (including, but not limited to, any interest, penalties and costs other than any interest, penalties or costs incurred as a result of any delay or failure on the part of the Employer to deal promptly with payment of any tax the Employer is liable to pay under this Agreement or any demands for taxation or correspondence from the Her Majesty’s Revenue and Customs (“HMRC”)) which the Employer may incur in respect of or by reason of payment of those sums or provision of those services or benefits to the Executive. In consideration of this undertaking, the Employer agrees that, if it receives any assessment relating to income tax which would be the subject of this indemnity, it will, before making any payment to the relevant authorities pursuant to such assessment or requiring the Executive to make any payment to it pursuant to this indemnity, allow the Executive a reasonable opportunity to challenge such assessment and to provide him with all documentation and co-operation that he may reasonably request in relation thereto. 9. Confidentiality and other restrictions 9.1 In consideration for the payment of £500.00 which sum will be subject to PAYE deductions: 9.2 The Executive accepts and agrees that his express and implied duties relating to confidential information, restrictive covenants and intellectual property rights as set out in the Service Agreement continue after the Termination Date 9.3 The Executive agrees and undertakes not to divulge to any person, firm or company or use for his own benefit or the benefit of any person, firm or company any trade secret or information of a private, secret  or confidential nature concerning the business, finances or affairs of the Parent, the Employer or any Group company or any of its/their respective customers, clients or suppliers (including but not limited to terms of contracts or arrangements, existing and potential projects, accounts, information regarding customers, clients or suppliers, disputes, business development and/or marketing programmes and plans) which have or may have come to his knowledge during the course of his employment with the Parent, he Employer or any company in the Group. 9.4 The Parent, Employer and the Executive agree and undertake that they will not: 9.4.1 make or publish any statement to a third party concerning the terms of this Agreement, the dispute settled by it or the circumstances surrounding the termination of the Executive’s employment; provided that this clause will not prevent the Parent and the Employer from complying with their disclosure obligation under the Companies Acts and the NASDAQ Stock Exchange listing rules and the Executive will not be prevented from making a disclosure: 9.4.2 make or publish any derogatory or disparaging statement or do anything in relation to the other (and in the Executive’s case to the Parent, Employer or any company in the Group, or officers or executives of the Parent, the Employer or any company in the Group) which is intended to or which might be expected to damage or lower their respective reputations. (i) for the purposes of seeking legal advice in relation to this Agreement provided the professional adviser is bound by a duty of confidence; (ii) to the proper authorities as required by law; (iii) to his wife or partner, immediate family and professional advisors provided such person agrees to maintain confidentiality 10. Full and final settlement 10.1 This Agreement has effect for the purpose of compromising without any admission of liability on the part of the Parent, the Employer or any Group companies by means of full and final settlement all claims whether known or not in all jurisdictions under contract, tort, statute or otherwise which the Executive has or may have against the Parent, the Employer or any Group companies and their respective officers and Executives arising out of or in connection with or as a consequence of his employment, or the termination of his employment including in particular for the avoidance of doubt the following claims which the Executive has raised or intimated: 10.1.1 damages for breach of contract howsoever arising including in respect of stigma; 10.1.2 pay in lieu of notice or damages for termination of employment without notice or on short notice; 10.1.3 outstanding pay, car allowance, holiday pay (including under the Working Time Regulations 1998), overtime, bonuses, commission and benefits in kind; 10.1.4 unlawful deductions from wages under the Employment Rights Act 1996; 10.1.5 unfair dismissal; 10.1.6 a redundancy payment whether statutory or other; 10.1.7 discrimination, harassment, victimisation or detriment under the Sex Discrimination Act 1975; 7 10.1.8 discrimination, harassment, victimisation or detriment under the Race Relations Act 1976;  10.1.9 disability discrimination or victimisation under the Disability Discrimination Act 1995; 10.1.10 damages or compensation for personal injury of any kind to the extent that an employment tribunal would have jurisdiction over such a claim; 10.1.11 detriment suffered under the Employment Rights Act 1996; 10.1.12 a breach of the Working Time Regulations 1998; 10.1.13 damages under the Data Protection Act 1998; 10.1.14 a claim under Part VII of the Transnational Information and Consultation of Executives Regulations 1999; 10.1.15 any future claim under section 192 of the Trade Union and Labour Relations (Consolidation) Act 1992 (“TULRCA”) for failure to pay remuneration under any protective award that may in the future be made under section 189 of TULRCA; 10.1.16 discrimination on the grounds of sexual orientation under the Employment Equality (Sexual Orientation) Regulations 2003; 10.1.17 discrimination on the grounds of religion or belief under the Employment Equality (Religion or Belief) Regulations 2003; 10.1.18 discrimination on the grounds of age under the Employment Equality (Age) Regulations 2006 10.1.19 save as provided for in this agreement any claim relating to awards or prospective awards under the Employer’s Performance Share Plans or any Share Award Schemes including the PRSOP, CSOP, SEU and Colnvest Plans; 10.1.20 a complaint under section 120 of the Equality Act 2010 relating to: age discrimination or harassment relating to age; disability discrimination or harassment relating to disability; gender reassignment discrimination or harassment relating to gender reassignment; marriage or civil partnership discrimination; pregnancy and maternity discrimination or discrimination because of he protected characteristic of pregnancy or maternity; race discrimination or harassment related to race; religious or belief-related discrimination or harassment related to religion or belief; sex discrimination, harassment related to sex, or sexual harassment under section 26(2); harassment under section 26(3) (less favourable treatment because of a rejection of or submission to harassment related to sex, or gender reassignment, or sexual harassment); sexual orientation discrimination or harassment related to sexual orientation; victimisation 10.1.21 a complaint relating to a breach of an equality clause under the Equality Act 2010; 10.1.22 a complaint relating to a breach of an equality rule or non-discrimination rule under the Equality Act 2010 but excluding any claim in respect of pension rights accrued as at the Termination Date any personal injury claims of which the Executive was not aware at the date of signing this Agreement, and any claim or action to enforce the terms of this Agreement. 8 10.2 This Agreement has effect for the purpose of compromising without any admission of liability on the part of the Executive by means of full and final settlement all claims whether known or not in all jurisdictions under contract, tort, statute or otherwise which the Parent, the Employer or any Group companies and their respective officers and Executives has or may have against the Executive arising out of or in connection with or as a consequence of his employment, directorships or the termination of either, provided always that the Executive has in accordance with the warranties at Clauses 8.1.1 to 8.1.4 of this Agreement disclosed to the Parent and the Employer any matters within his knowledge  which might have entitled the Parent, the Employer or any Group Company to pursue claims against him and that this clause does not apply to any claims that may arise where the Executive has been wilfully dishonest or otherwise involved in criminal activities 11. For the avoidance of doubt, if any claims referred to in Clause 10 of this Agreement have not been validly excluded by the provisions of this Agreement and if the Executive brings any such claims and an employment tribunal or other court of competent jurisdiction finds that the Executive is entitled to any remedy against the Parent, the Employer or any Group companies: 11.1.1 If a monetary award is made the Parent, Employer, or relevant Group company, will be entitled to set off the Termination Payment (and the monetary value of any benefits provided under this Agreement) against any such monetary award; or The Executive confirms that he will resign from any offices or directorships he holds in connection with the Parent, the Employer and the Group by signing letters of resignation in the form annexed to Schedule 2 to this Agreement. 11.1.2 If a non-monetary award is made, the Executive will repay the Termination Payment (and the monetary value of any benefits provided under this Agreement) to the Parent, the Employer, or relevant Group company in full. 12. Directorship 13. No knowledge of other claims 13.1 The Executive confirms that he is aware of no other claim or grounds to make a claim against the Parent, Employer or any Group companies in relation to any other matters howsoever arising. 13.2 The Executive represents and warrants that: 13.2.1 he has instructed the Adviser to advise as to whether he has or may have any claims, including statutory claims, against the Parent or the Employer arising out of or in connection with his employment or its termination; 13.2.2 he has provided the Adviser with all available information which the Adviser requires or may require in order to advise whether he has any such claims; and 13.2.3 the Adviser has advised him that on the basis of the information available to the Adviser his only claims or particular complaints against the Parent or the Employer whether statutory or otherwise, are those listed in Clause 10 of this Agreement and that he has no other claim against the Parent or the Employer whether statutory or otherwise. 14. Compliance with statutory provisions 14.1 This Agreement is intended to satisfy the conditions regulating compromise agreements and compromise contracts under such of the Acts as are relevant. 14.2 The Executive confirms that: 14.2.1 he has received advice from a relevant independent adviser (within the meaning of the Acts) as to the terms and effect of this Agreement and in particular its effect on his ability to pursue his rights before an Employment Tribunal; 14.2.2 the adviser at 14.2.1 above was Michael Burns of DLA Piper UK LLP (“the Adviser”). 9 14.2.3 he will procure that the Adviser signs the Certificate in Schedule 1 .  10 15. Without prejudice 15.1 Notwithstanding that this Agreement is marked “without prejudice and subject to contract”, it will, when dated and signed by all the parties named below and accompanied by the Certificate in Schedule 1 signed by the Adviser become an open and binding agreement between the parties. 16. Governing law and jurisdiction 16.1 This Agreement is governed by the law of England and Wales and any dispute is subject to the exclusive jurisdiction of the courts and tribunals of England and Wales. SCHEDULE 1 ADVISER’S CERTIFICATE I confirm that: 11 17. I am a relevant independent adviser as defined in the Acts (as defined in the Agreement between Andrew Hartley (“the Executive”) and Innospec Inc (“the Parent”) and Innospec Limited (“the Employer”) to which this Certificate is annexed). 18. I have advised the Executive of the terms and the effect of the Agreement and in particular its effect on his ability to pursue a claim before an Employment Tribunal. 19. There is in force a contract of insurance covering the risk of a claim by the Executive in respect of loss arising in consequence of the advice. Adviser’s signature Adviser’s name Michael Burns Title Solicitor Adviser’s business address DLA Piper UK LLP 101 Barbirolli Square Bridgewater Manchester M3 2DL SCHEDULE 2 LETTER OF RESIGNATION [DATE] Dear Sir I confirm my resignation from my position as a Director and Officer of the Parent and Group Companies as listed in Appendix 1 to this letter Yours sincerely Andrew Hartley 12 To: The Company Secretary The Company Secretary Innospec Limited Innospec Inc 8375 South Willow Street Littleton, Colorado 80124 USA Innospec Manufacturing Park Oil Sites Road Ellesmere Port CH65 4EY SCHEDULE 3 REFERENCE To: [DATE] Dear ANDREW HARTLEY Andrew Hartley was employed by Innospec Limited from 1 November 2004 to 31 December 2011. During his employment with Innospec, Andrew initially served as the Vice President and General Counsel for Innospec Inc. and latterly as the Vice President and General Counsel for the Corporation covering Europe, Middle East and Africa and Asia Pacific. Andrew was an Officer of Innospec Inc and a member of the senior executive team. He was also a Director of a number of Group Companies in the UK, USA and Europe. Innospec is a circa $650 million revenue international speciality chemical business listed on NASDAQ in the US and employs almost 850 employees in 20 countries. Innospec has manufacturing sites in the UK, USA, France and Germany and a number of regional sales offices in Asia Pacific, the USA, Europe, Middle East and Africa. As VP and General Counsel, Andrew led the Legal team based in the UK and was responsible for the provision of legal advice covering a range of areas including corporate, commercial and intellectual property matters. In addition, he was responsible for managing the provision of external legal advice and the associated budget. Andrew also contributed to the establishment of our Enhanced Compliance programme, which included the development of an on line training programme for all employees through a third party provider. Andrew was also responsible for managing the provision of insurance and risk management services across the Corporation, including the management of the Company’s captive insurance company. Andrew left Innospec on 31 December 2011 due to redundancy and we wish him every success in the future. This reference is given in strict confidence and, as is our unvarying practice , solely for the purpose for which it was requested and without liability on the part of Innospec Limited or Innospec Inc or any employee of Innospec Limited or Innospec Inc. Yours sincerely Dr C Hessner Senior Vice President, Human Resources 13 IN WITNESS whereof this Agreement has been signed on behalf of the Parent, the Employer and the Executive. 14 SIGNED by Joachim Roeser ) Duly authorised for and on behalf of ) Innospec Inc ) JOACHIM ROESER and the Group ) SIGNED by Catherine Hessner ) Duly authorised for and on behalf of ) Innospec Limited ) CATHERINE HESSNER and the Group ) SIGNED by Andrew Hartley ANDREW HARTLEY the Executive In the presence of: Name: LAURA WILBRAHAM Signature: LAURA WILBRAHAM Address: RESIDENTIAL ADDRESS COMPLETED ON ORIGINAL Exhibit 12.1 EXHIBIT 12.1 – STATEMENT REGARDING COMPUTATION OF FINANCIAL RATIOS (in millions, except financial ratios, share and per share data) Shares in thousands, earnings per share attributable to Innospec Inc. in dollars. 2011 2010 2009 2008 2007 1. NET INCOME ATTRIBUTABLE TO INNOSPEC INC. AS A PERCENTAGE OF SALES A Net income attributable to Innospec Inc. $ 48.9 $ 73.7 $ 6.4 $ 12.5 $ 29.5 B Net sales $ 774.4 $ 683.2 $ 598.5 $ 640.5 $ 602.4 A % of B 6.3 % 10.8 % 1.1 % 2.0 % 4.9 % 2. EFFECTIVE TAX RATE AS A PERCENTAGE C Income taxes $ 3.7 $ (3.0 ) $ 11.9 $ 6.3 $ 18.2 D Income before income taxes $ 52.6 $ 70.7 $ 18.3 $ 18.9 $ 47.8 C % of D 7.0 % -4.2 % 65.0 % 33.3 % 38.1 % 3. CURRENT RATIO E Current assets $ 320.3 $ 321.9 $ 282.9 $ 256.6 $ 256.1 F Current liabilities $ 146.0 $ 158.9 $ 179.9 $ 188.1 $ 160.7 Ratio of E to F 2.2 2.0 1.6 1.4 1.6 4. EARNINGS PER SHARE ATTRIBUTABLE TO INNOSPEC INC. G Net income attributable to Innospec Inc. $ 48.9 $ 73.7 $ 6.4 $ 12.5 $ 29.5 H Basic shares outstanding 23,568 23,756 23,642 23,595 23,920 I Diluted shares outstanding 24,520 24,814 24,714 24,391 24,838 G/H Basicearnings per share attributable to Innospec Inc. $ 2.07 $ 3.10 $ 0.27 $ 0.53 $ 1.23 G/I Dilutedearnings per share attributable to Innospec Inc. $ 1.99 $ 2.97 $ 0.26 $ 0.51 $ 1.19 Exhibit 14 CODE OF ETHICS INNOSPEC INC. DEMANDS THAT ITS DIRECTORS, OFFICERS AND EMPLOYEES MAINTAIN THE HIGHEST ETHICAL STANDARDS IN CARRYING OUT BUSINESS ACTIVITIES. This Code expresses the principles of our business ethics and is intended to assist all directors, officers and employees in meeting the high standards of personal and professional integrity required of them. Strict adherence to the provisions of this Code is a condition of employment. This Code applies to all directors, officers and employees (“employees”) of Innospec Inc., its subsidiary companies and any joint ventures that adopt this Code (“the Company”). General Policy The Company observes both the letter and the spirit of the laws of every country where it conducts business. In any situation not governed by statute or explicit regulations, or where the law is ambiguous or conflicting, the Company’s affairs will be conducted in accordance with the Company’s high standards of business practice. As the Company operates internationally it may encounter laws and customs applicable in one country which conflict with the law of another. Such instances should be referred to the Corporate Secretary for advice. Policies Each employee has the personal responsibility to ensure that his or her actions comply with this Code and any and all applicable governmental laws, rules and regulations. If you have any questions or concerns about illegal or unethical acts, you may discuss the matter on an anonymous basis with the Corporate Secretary (see Section 17 “Reporting Concerns (Whistleblowing)” for further details). Each employee is expected to read the entire Code and to adhere to its principles. Failure to abide by this Code or the law will lead to disciplinary measures appropriate to the violation, up to and including dismissal. Directors and senior officers (including senior financial officers) are expected to demonstrate leadership on ethical matters and to observe the highest standards of ethical conduct. These individuals are responsible for promoting open and honest communications within the Company and must show respect and consideration for each Company employee. They must at all times be diligent in observing this Code and in being alert for instances of unethical or illegal conduct. The Company has a responsibility to communicate effectively with shareholders so that they are provided with full and accurate information, in all material respects, about the Company’s financial condition and results of its operations. Our public communications, including reports and documents filed or submitted to the US Securities and Exchange Commission, such as a 10Q, 10K, Annual Report and Proxy Statement shall include full, fair, accurate and understandable disclosure and shall be made in a timely manner. 1. Responsibility and Accountability 2. Additional Responsibilities of Directors and Senior Officers 3. Quality of Public Disclosures  An employee’s primary employment obligation is to the Company. No employee shall engage in any business or other activity whether in an employed, self-employed or unpaid capacity which may give rise to a conflict with the Company’s interests. General Guidance. Business decisions and actions must be based on the best interests of the Company, and must not be motivated by personal considerations or relationships. Relationships with prospective or existing suppliers, contractors, customers, competitors or regulators must not affect our independent and sound judgement on behalf of the Company. General guidelines to help employees better understand several of the most common examples of situations that may cause a conflict of interest are listed below. However, employees are required to disclose to the Corporate Secretary any situation that may be, or appears to be, a conflict of interest. When in doubt, it is best to disclose. Senior Officers. Senior officers must disclose to the board of directors any material transaction or relationship that could reasonably be expected to give rise to a conflict of interest. Outside Employment. Employees may not work for or receive payments for services from any competitor, customer, distributor or supplier of the Company without the advance approval of the Corporate Secretary. Any outside activity must be strictly separated from Company employment and should not harm the Company’s interests, the business of the Company or job performance at the Company. Board Memberships. Serving on the board of directors or a similar body for an outside company or government agency requires the advance approval of the Corporate Secretary. Helping the community by serving on boards of not-for-profit or charitable community organisations is encouraged, and does not require prior approval. However, in all cases employees owe a duty to the Company to advance its legitimate interests when the opportunity to do so arises. Family Members and Close Personal Relationships. Employees may not seek to obtain special treatment from the Company for family members or friends or for businesses in which family members or friends have an interest. Investments. Employees may not allow their investments to influence, or appear to influence, their independent judgement on behalf of the Company. The appearance of a conflict of interest is most likely to arise if an employee has an investment in a competitor, supplier, customer, or distributor and his decisions may have a business impact on this outside party. If an employee has any doubt about how an investment might be perceived, it should be disclosed to the Corporate Secretary. Employees are also prohibited from directly or indirectly buying, or otherwise acquiring rights to any property or materials, when the employee knows that the Company is or may be interested in pursuing such an opportunity. The Company is committed to the elimination of fraud or other criminal offences, to the rigorous investigation of any suspected wrong doing, and, where fraud or other criminal act is proven, to ensure that wrong doers are appropriately dealt with. If you believe you have good reason to suspect a colleague or other person of a fraud or an offence involving the Company or a serious infringement of Company rules, such as: 4. Conflicts of Interest 5. Fraud or Other Criminal Conduct - 2 - • theft of Company property  • abuse of Company property or abuse of a position of trust you should take the action outlined in paragraph 17 of this Code – Reporting Concerns (Whistleblowing). The Company competes vigorously for business and is committed to complying with the antitrust and competition laws of those jurisdictions where its products and services are manufactured and sold. Employees shall not engage in practices that would constitute a violation of applicable antitrust and competition laws. Employees shall comply with the Company’s Competition Law Compliance Policy and Guidelines. An employee must not offer or receive bribes or other payments which are intended to influence a business decision or compromise independent judgement; must not give money, services or gifts in order to obtain business for the Company, and must not receive money, services or gifts for having given Company business to an individual or organisation. With regard to government and other officials all employees must comply with the Company’s Foreign Corrupt Practices Act Compliance Policy. Before trading in the shares of Innospec Inc. employees shall comply with the policy on Trading in Innospec Inc. Stock. An employee shall not buy or sell the stock of Innospec Inc. when in possession of material non-public information that might reasonably be expected to affect the market value of the stock. The health and safety of our employees and any other person who may be affected by our operations is paramount. The Company and its employees will act positively to prevent injury, ill health, damage and loss arising from its operations as well to comply with all regulatory or other legal requirements pertaining to safety, health and the environment. All employees are required to be aware of health, safety and environmental issues and to be familiar with applicable laws and Company policies applicable to their area of business. No funds or assets of the Company may be contributed to any political party or organisation or to any individual who either holds public office or is a candidate for public office except where such a contribution is permitted by applicable law and has been authorised by the Chief Executive Officer and Corporate Secretary. - 3 - • deception or falsification of records (eg: fraudulent financial reporting, fraudulent time or expense claims) 6. Antitrust Compliance 7. Commercial and Political Inducement Payments 8. Stock Trading 9. Health, Safety and the Environment 10. Political Contributions  Each employee is required to keep confidential and not to disclose or use the confidential information belonging to the Company or belonging to a third party which has been received by the Company pursuant to a confidentiality agreement or received by the Company in circumstances where it is clear that the information is proprietary and confidential. Furthermore employees shall comply with the terms of all confidentiality or other agreements relating to information received from third parties. The foregoing shall not apply where the disclosure is made with the written consent of the Company or where the disclosure is required by law. Any documents or media containing confidential information must be given up to the Company when the employee leaves the Company’s employment. The following is a non-exclusive list of confidential information: 11. Confidentiality (i) the financial and sales results of the Company, before they are in the public domain. (ii) trade secrets, including any business or technical information, such as formulae, recipes, processes, research programmes or information that is valuable because it is not generally known. (iii) any invention or process developed by an employee using Company facilities or trade secret information resulting from any work for the Company, or relating to the Company’s business. (iv) proprietary information such as customer sales lists and customers’ confidential information. Employees are prohibited from: (v) any transaction that the Company is or may be considering which had not been publicly disclosed. 12. Corporate Opportunities (i) taking for themselves personally opportunities that are discovered through the use of Company property, information or position; (ii) using Company property, information or position for personal gain; and Employees owe a duty to the Company to advance its legitimate interests when the opportunity to do so arises. From time to time employees may be presented with gifts from other business organisations. Any such gift which is offered, or is possibly offered, in the expectation of, or to solicit, favourable consideration of any nature must be refused and the fact of its having been offered, reported immediately to management. Employees must not accept services, goods, entertainment, favours or any form of recompense of more than $50 from any supplier, contractor, sub-contractor, agent, customer or competitor, unless they receive the approval of their line manager for gifts over $50 and the additional approval of Legal & Compliance for gifts over $100. There are certain situations in which an employee may accept a personal benefit from someone with whom they transact business, such as: (iii) competing with the Company. 13. Unsolicited Gifts (i) accepting something of value if the benefit is available to the general public under the same conditions. - 4 - (ii) accepting travel arrangements, accommodations and entertainment of reasonable value in the course of a meeting or other occasion to conduct business or foster business relations.  No cash gifts or loans are permitted. Each employee should undertake to deal fairly with the Company’s customers, suppliers, competitors and employees. Additionally, no one should take advantage of another through manipulation, concealment, abuse of privileged information, misrepresentation of material facts or any other unfair dealing practices. Employees must disclose prior to or at the commencement of their employment the existence of any employment agreement, non-compete or non-solicitation agreement, confidentiality agreement or similar agreement with a former employer that in any way restricts or prohibits the performance of any duties or responsibilities of their positions with the Company. Copies of such agreements should be provided to permit evaluation of the agreement in light of the employee’s position. In no event shall an employee use any trade secrets, proprietary information or other similar property, acquired in the course of his or her employment with another employer, in the performance of his or her duties for or on behalf of the Company. All employees should protect the Company’s property and assets and ensure their efficient and proper use. Theft, carelessness and waste can directly impact the Company’s profitability, reputation and success. Permitting Company property (including data transmitted or stored electronically and computer resources) to be damaged, lost, or used in an unauthorised manner is strictly prohibited. Employees may not use the Company’s or any other official stationery for personal purposes. Company Policy (iii) accepting meals or refreshments provided the value received from any one government official or state-owned enterprise does not exceed $150 per meal and does not occur more than twice in any 12 month period. 14. Fair Dealing 15. Protection and Proper Use of Company Property 16. Directors Loans and Expenses The Company policy is that no loans or quasi-loans should be made to any director or senior executive. Difficult questions may arise as to whether expense arrangements amount to the making of a loan, accordingly: 1. Prior to entering into any transaction or arrangement where doubt arises advice should be sought from the General Counsel as to whether the transaction or arrangement is permissible and, if so, the procedure that must be followed. 2. The private (ie: family or non-business) elements of any business travel arrangements should be quantified and paid for by a director or senior executive. - 5 - 3. Foreign currency and/or travellers cheques provided to directors and senior executives should not exceed $5,000 and should not be used for private expenses. Upon return from a business trip, unused currency or travellers cheques should be returned to the Company immediately, together with an expense report to account for those used.  The Company takes a very serious view of any fraudulent behaviour, serious malpractice or any other violation of this Code, and any such will be investigated. If evidence of such occurrence comes to light, it will be dealt with quickly and disciplinary action will be taken against any employee found guilty of such actions. The disciplinary action taken will be appropriate to the violation, up to and including dismissal. Any employee who suspects that there are violations of this Code or other serious misconduct is encouraged to report it to the Company. In return, the Company agrees to protect any such employees from reprisals and to respect confidentiality. Any victimisation of employees reporting malpractice or attempt to deter them from raising such a concern will be treated as a serious disciplinary offence. Reporting Procedure. If any employee reasonably suspects that there are violations of this Code or other serious misconduct, then he or she should report this immediately to their own line manager. Line Managers must report such issues immediately to the General Counsel. However, if for any reason they are reluctant to do so, then they should report their concerns using the specially designated multi-lingual whistle blowing hotline service with Expolink. Details of the service and freephone numbers have been distributed to all employees and are available on the Intranet. Reports will be passed to: 17. Reporting Concerns (Whistle Blowing) 1. the General Counsel; or Feedback will be provided to the caller if requested. Under no circumstances should employees speak to representatives of the press, radio, TV or other third party unless expressly authorised by the Chief Executive Officer. This Code shall be administered and monitored by the Company’s board of directors. Any questions and further information on this Code should, in the first instance, be directed to the Corporate Secretary. Employees of the Company are expected to follow this Code, and to represent the Company (and its subsidiaries) in a responsible manner in all regions and territories, at all times. Generally, there should be no waivers to this Code. However, in rare circumstances conflicts may arise that necessitate waivers. Waivers will be determined on a case-by-case basis by the Company’s Chief Executive Officer, together with the Corporate Secretary, who may consult with the Company’s outside legal counsel, if necessary. Waivers for directors and executive officers and senior financial officers, however, must be determined by the board of directors. For members of the board of directors, executive officers and senior financial officers, the board of directors shall have the sole and absolute discretionary authority to approve any deviation or waiver from this Code, and all such deviations or waivers shall be disclosed promptly to our shareholders. - 6 - 2. the Chairman of the Corporate Governance Committee. 18. Administration and Waiver of Code of Ethics Exhibit 21.1 EXHIBIT 21.1 PRINCIPAL SUBSIDIARIES OF THE REGISTRANT Alcor Chemie Vertriebs GmbH (Switzerland) Innospec Active Chemicals LLC (USA) Innospec Deutschland GmbH (Germany) Innospec Developments Limited (U.K.) Innospec Environmental Limited (U.K.) Innospec Finance Limited (U.K.) Innospec France SA (France) Innospec Fuel Specialties LLC (USA) Innospec Holdings Limited (U.K.) Innospec International Limited (U.K.) Innospec Leuna GmbH (Germany) Innospec Limited (U.K.) Innospec Trading Limited (U.K.) Innospec Widnes Limited (U.K.) OBOAdler Company Limited (U.K.) Societa Italiana Additivi Per Carburanti S.r.l. (Italy) Exhibit 23.1 Consent of Independent Registered Public Accounting Firm The Board of Directors Innospec Inc.: We consent to the incorporation by reference, in the registration statements (Nos. 333-131687 and 333-124139) on Form S-8 of Innospec Inc., of our report dated February 17, 2012, with respect to the consolidated balance sheet of Innospec Inc. and its subsidiaries as of December 31, 2011, and the related consolidated statements of income, comprehensive income/(loss) and accumulated other comprehensive loss, cash flows and stockholders’ equity for the year then ended, and the effectiveness of internal control over financial reporting as of December 31, 2011, which report appears in the December 31, 2011 annual report on Form 10-K of Innospec Inc.. KPMG Audit Plc Manchester, United Kingdom February 17, 2012 Exhibit 23.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-131687 / 333-124139 / 333-174050 / 333-174439) of Innospec Inc. of our report dated February 18, 2011 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K. /s/ PricewaterhouseCoopers LLP Manchester, United Kingdom February 17, 2012 Exhibit 31.1 CERTIFICATION OF PATRICK S. WILLIAMS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Patrick S. Williams, certify that: 1. I have reviewed this annual report on Form 10-K of Innospec Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. / S / PATRICK S. WILLIAMS Patrick S. Williams President and Chief Executive Officer February 17, 2012 Exhibit 31.2 CERTIFICATION OF IAN P. CLEMINSON PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ian P. Cleminson, certify that: 1. I have reviewed this annual report on Form 10-K of Innospec Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. / S / IAN P. CLEMINSON Ian P. Cleminson Executive Vice President and Chief Financial Officer February 17, 2012 Exhibit 32.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form 10-K of Innospec Inc. (the “Company”) for the period ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Patrick S. Williams, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that: 1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and The foregoing certification is being furnished solely pursuant to 18 U.S.C. §1350 and is not being filed as part of this Report or as a separate disclosure document. A signed original of this written statement required by 18 U.S.C. §1350 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission upon request. 2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. / S / PATRICK S. WILLIAMS Patrick S. Williams President and Chief Executive Officer February 17, 2012 Exhibit 32.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form 10-K of Innospec Inc. (the “Company”) for the period ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ian P. Cleminson, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that: 1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and The foregoing certification is being furnished solely pursuant to 18 U.S.C. §1350 and is not being filed as part of this Report or as a separate disclosure document. A signed original of this written statement required by 18 U.S.C. §1350 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission upon request. 2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. / S / IAN P. CLEMINSON Ian P. Cleminson Executive Vice President and Chief Financial Officer February 17, 2012 

Continue reading text version or see original annual report in PDF format above